FG Syndrome 1

Mendelian MONDO:0010590 Pathograph 25 Show in embeddings browser hereditary disease syndromic intellectual disability

FG syndrome 1 (FGS1, Opitz-Kaveggia syndrome) is a rare X-linked multiple congenital anomaly-intellectual disability syndrome caused by the recurrent MED12 c.2881C>T (p.Arg961Trp) missense variant at Xq13. The recognizable phenotype comprises congenital hypotonia, feeding difficulties and severe constipation, cognitive impairment ranging from borderline to severe, agenesis or hypoplasia of the corpus callosum, relative or absolute macrocephaly, a distinctive facial gestalt (tall prominent forehead, frontal hair upsweep, downslanted palpebral fissures, small simple ears), anal anomalies, congenital heart defects, broad thumbs and halluces, and a characteristic friendly, loquacious, eager-to-please personality with hyperactivity and short attention span. Mechanistically, MED12 is a subunit of the dissociable CDK8 kinase module of the Mediator complex, and p.Arg961Trp causes a pathway-selective transcriptional-regulatory defect rather than complete loss of MED12 function, disrupting REST/NRSF-dependent neuronal gene silencing, GLI3-dependent Sonic hedgehog target transcription, and immediate-early gene regulation. The molecularly defined entity must be distinguished from the older, purely clinical "FG syndrome" label, which is genetically heterogeneous: fewer than 3% of individuals given that clinical diagnosis carry the MED12 p.Arg961Trp variant.

Ask OpenScientist

Ask a research question about FG Syndrome 1. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
9
Pathophys.
56
Phenotypes
1
Gaps
25
Pathograph
1
Genes
2
Variants
10
Medical Actions
4
Differentials
3
References
1
Deep Research
🏷

Classifications

Harrison's Part
GENETICS ENVIRONMENT DISEASE NEUROLOGIC
👪

Inheritance

1
X-linked recessive inheritance HP:0001419
FGS1 is inherited in an X-linked manner. Affected individuals are hemizygous males; heterozygous carrier females in the reported FGS1 families are clinically and intellectually unaffected, so the pattern behaves as X-linked recessive. No de novo cases with a confirmed MED12 p.Arg961Trp variant have been documented in the core cohort; transmission is through obligate carrier mothers.
X-linked recessive inheritance
Show evidence (3 references)
PMID:20301719 SUPPORT Human Clinical
"Carrier females in families with FGS1 and LS are typically unaffected."
GeneReviews states that heterozygous carrier females in FGS1 families are typically unaffected, consistent with X-linked recessive expression.
PMID:19938245 SUPPORT Human Clinical
"There are no mentally retarded females in these 10 families. All mothers in our series are intellectually normal and all are heterozygous for the p.R961W mutation in MED12."
Direct cohort observation that obligate heterozygous mothers are intellectually normal, supporting recessive X-linked expression in this disorder.
PMID:19938245 SUPPORT Human Clinical
"There have been no de novo patients with a confirmed MED12 mutation."
Supports the statement that all molecularly confirmed FGS1 cases in the core cohort were maternally transmitted rather than de novo.
?

Discussions and Knowledge Gaps

1
Do the REST-silencing, GLI3-SHH, and immediate-early gene defects demonstrated in patient-derived EBV-immortalized lymphoblastoid cells actually operate in the human tissues that are malformed in FGS1 (developing cortex and callosal projection neurons, enteric nervous system, cardiac outflow tract, anorectal mesenchyme)?
HUMAN MODEL MISMATCH OPEN fgs1_tissue_relevance_of_mechanism
Attached to
pathophysiology#Impaired Neuronal Differentiation and Cortical Development pathophysiology#Failure of Corpus Callosum Formation
All three mechanistic arms of FGS1 rest on lymphoblastoid cell lines or engineered MED12-null rescue systems. Lymphoblasts do not model developing cortical neurons, enteric neurons, cardiomyocytes, or anorectal mesenchyme, and the immediate-early gene effect is explicitly reported to be cell-type specific. Evidence therefore exists but its translational validity to the affected human tissues is the open question, which is a model-fidelity gap rather than an absence of data. No knock-in model reproducing the complete human FGS1 phenotype has been reported.
Proposed experiments
Isogenic MED12 p.Arg961Trp knock-in human iPSC lineage panel
fgs1_isogenic_ipsc_lineage_panel
Generate isogenic MED12 p.Arg961Trp knock-in human iPSC lines and differentiate them into cortical neurons, enteric neural crest derivatives, and cardiomyocytes. Profile REST target derepression, GLI3-dependent SHH target expression (CREB5, BMP4, NEUROG2), and stimulus-evoked immediate-early gene responses, comparing each lineage against the published lymphoblastoid signatures.
Decision criterion
Concordance of the neural, enteric, and cardiac signatures with the lymphoblastoid findings would support tissue generality; lineage-restricted or divergent signatures would establish that lymphoblastoid data cannot be extrapolated to the malformed tissues.
MED12 p.Arg961Trp knock-in mouse phenotyping
fgs1_knockin_mouse_phenotyping
Generate and phenotype a Med12 p.Arg961Trp knock-in mouse for callosal, anorectal, cardiac, and behavioural phenotypes, with parallel transcriptomic profiling of the affected tissues during the relevant developmental windows.
Decision criterion
Recapitulation of callosal and anorectal defects would establish an in vivo model for FGS1; failure to recapitulate would itself constitute an informative human-model mismatch requiring human-derived systems.
Show evidence (2 references)
PMID:28369444 SUPPORT In Vitro
"Moreover, the effect of MED12 mutations has cell-type specificity on IEG expression."
Explicit demonstration that the mechanistic readout is cell-type dependent, which is precisely why lymphoblastoid findings cannot be assumed to hold in the affected tissues.
PMID:33925166 SUPPORT Other
"We propose an isogenic iNeuron model to establish the unique gene expression patterns that are associated with the specific MED12 variants."
Independent expert proposal of exactly the isogenic neuronal model needed to resolve the mismatch, confirming this is a recognized open question.
⚙

Pathophysiology

9
MED12 p.Arg961Trp Alters CDK8 Kinase Module Function
MED12 is a subunit of the dissociable CDK8 kinase module (MED12, MED13, cyclin C, CDK8) that reversibly associates with core Mediator and acts as the hub through which DNA-bound transcription factors communicate with RNA polymerase II. The recurrent germline hemizygous c.2881C>T (p.Arg961Trp) missense substitution does not abolish MED12 function globally; the evidence favors a pathway-selective altered-function defect that impairs recruitment of, or response to, particular regulatory complexes while sparing others. This distinguishes FGS1 from complete MED12 loss of function, which has broader and developmentally more severe consequences.
MED12 hgnc:11957 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves MED12 (hgnc:11957). hgnc:11957 is a gene from the HUGO Gene Nomenclature Committee.
Mediator CDK8 kinase module GO:1990508 Gene Ontology (GO) Relation: this pathophysiological event involves this protein complex This pathophysiological event involves Mediator CDK8 kinase module, annotated with CKM complex (GO:1990508). GO:1990508 is a protein complex from the Gene Ontology.
regulation of transcription by RNA polymerase II GO:0006357 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves regulation of transcription by RNA polymerase II (GO:0006357). GO:0006357 is a biological process from the Gene Ontology.
transcription corepressor activity GO:0003714 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves transcription corepressor activity (GO:0003714). GO:0003714 is a molecular function from the Gene Ontology.
Downstream
Impaired REST-Dependent Silencing of Neuronal Genes The MED12 interface within Mediator is the physical link between REST/NRSF and G9a-dependent repressive chromatin marking; the FGS1 missense change disrupts that corepressor function.
Derepression of GLI3-Dependent Sonic Hedgehog Target Transcription MED12 normally restrains GLI3-dependent SHH target-gene transcription; the FGS1 variant fails to restore that suppression and shows reduced CDK8 recruitment at GLI3 target sites.
Dysregulated Immediate-Early Gene Response Each MED12 patient variant, including p.Arg961Trp, produces its own immediate-early gene expression signature tracking MED12/Pol II promoter occupancy.
Show evidence (4 references)
PMID:17334363 SUPPORT Human Clinical
"We report here that the original family for whom the condition is named and five other families have a recurrent mutation (2881C>T, leading to R961W) in MED12 (also called TRAP230 or HOPA), a gene located at Xq13 that functions as a thyroid receptor-associated protein in the Mediator complex."
Establishes the causal recurrent variant and localizes the defect to a Mediator complex subunit.
PMID:33925166 SUPPORT Other
"The kinase module consists of MED12, MED13, Cyclin C (CCNC), and cyclin-dependent kinase 8 (CDK8), and the paralogs MED12L, MED13L, and CDK19."
Places MED12 within the dissociable Mediator kinase module, defining the molecular context of the lesion.
PMID:33925166 SUPPORT Other
"MED12 interacts with DNA-bound transcription factors and hence acts as a hub for the communication of transcription factors with the kinase subunit and core Mediator"
Explains why a single MED12 missense change can selectively perturb the transcription-factor-specific arms of Mediator signalling.
+ 1 more reference
Impaired REST-Dependent Silencing of Neuronal Genes
Mediator, the G9a histone methyltransferase, and the RE1 silencing transcription factor (REST/NRSF) form a protein interaction network that keeps neuronal genes silenced in non-neuronal cells, with the MED12 interface linking REST to G9a-dependent histone H3K9 dimethylation. Missense MED12 changes causing FG and Lujan syndromes disrupt this REST corepressor function, so neuronal genes escape scheduled repression. Rescue experiments indicate that p.Arg961Trp specifically fails to restore REST-mediated silencing while retaining beta-catenin rescue capacity, marking this as a pathway-selective, kinase-independent defect.
neural progenitor cell CL:0011020 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neural progenitor cell (CL:0011020). CL:0011020 is a cell type from the Cell Ontology.
negative regulation of transcription by RNA polymerase II GO:0000122 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves negative regulation of transcription by RNA polymerase II (GO:0000122). GO:0000122 is a biological process from the Gene Ontology. chromatin organization GO:0006325 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves chromatin organization (GO:0006325). GO:0006325 is a biological process from the Gene Ontology.
Downstream
Impaired Neuronal Differentiation and Cortical Development REST/NRSF silences neuronal genes in non-neuronal and progenitor cells, so unscheduled derepression is proposed to disturb the timing of neuronal differentiation directly; the link has not been demonstrated in affected human fetal tissue.
Failure of Corpus Callosum Formation Callosal projection neurons must differentiate on schedule before their axons can cross the midline, so mistimed REST-dependent derepression is proposed to act on callosal formation via the neuronal-differentiation defect above rather than independently of it; not demonstrated in affected human fetal tissue.
Show evidence (2 references)
PMID:18691967 SUPPORT In Vitro
"We show that the MED12 interface in Mediator links REST with G9a-dependent histone H3K9 dimethylation to suppress neuronal genes in nonneuronal cells. Notably, missense mutations in MED12 causing the X-linked mental retardation (XLMR) disorders FG syndrome and Lujan syndrome disrupt its REST..."
Directly demonstrates that the FG syndrome MED12 missense change abolishes the REST corepressor activity of the MED12 interface.
PMID:18691967 SUPPORT In Vitro
"These findings implicate Mediator in epigenetic restriction of neuronal gene expression to the nervous system and suggest a pathologic basis for MED12-associated XLMR involving impaired REST-dependent neuronal gene regulation."
States the proposed pathogenic mechanism linking impaired REST-dependent regulation to MED12-associated intellectual disability.
Derepression of GLI3-Dependent Sonic Hedgehog Target Transcription
Activated GLI3 physically targets the MED12 interface within Mediator to reverse Mediator-dependent suppression of Sonic hedgehog target-gene transcription, placing MED12 as a direct restraint on the pathway. In patient-derived lymphoblastoid lines carrying MED12 XLID variants, transcripts of the GLI3-dependent SHH targets CREB5, BMP4, and NEUROG2 are significantly elevated, and p.Arg961Trp fails to restore normal SHH inhibition while showing reduced CDK8 recruitment at GLI3 sites. Because SHH-GLI signalling patterns the forebrain, craniofacial skeleton, limb, gut, and heart, this arm offers a plausible unifying explanation for the multi-system malformation pattern of FGS1.
smoothened signaling pathway GO:0007224 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves smoothened signaling pathway (GO:0007224). GO:0007224 is a biological process from the Gene Ontology. regulation of transcription by RNA polymerase II GO:0006357 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves regulation of transcription by RNA polymerase II (GO:0006357). GO:0006357 is a biological process from the Gene Ontology.
Downstream
Failure of Corpus Callosum Formation GLI3 dose sets dorsoventral forebrain and midline patterning, and callosal agenesis is a recognised feature of GLI3-related disorders, making this the most plausible of the three arms for the callosal defect; not demonstrated directly in affected human tissue.
Impaired Neuronal Differentiation and Cortical Development SHH-GLI3 signalling regulates cortical progenitor proliferation and the neurogenic-to-gliogenic transition, so altered GLI3-dependent output is a plausible route to disturbed neuronal differentiation; not demonstrated directly in affected human tissue.
Anorectal Malformation SHH-GLI3 signalling patterns hindgut and cloacal septation, and anorectal malformation is part of the Gli3-mutant and SHH-pathway phenotype, making this arm the plausible route to the anorectal defect; not demonstrated directly in affected human tissue.
Cardiac Septation Defect Hedgehog signalling in second-heart-field and atrial septal progenitors is required for normal septation, so altered GLI3-dependent output is a plausible route to the septal defect; not demonstrated directly in affected human tissue.
Craniofacial and Skeletal Dysmorphogenesis GLI3 is the principal SHH effector in frontonasal, palatal and limb patterning, and craniofacial and digital anomalies are cardinal features of GLI3-related disorders, making this arm the plausible route to the dysmorphic features; not demonstrated directly in affected human tissue.
Show evidence (5 references)
PMID:23091001 SUPPORT In Vitro
"In FG/R961W and Lujan/N1007S patient-derived cells, we document enhanced SHH pathway activation and GLI3-target gene induction coincident with impaired recruitment of CDK8 onto promoters of GLI3-target genes, but not non-GLI3-target genes."
The variant-specific demonstration of this arm: derepression is shown in cells carrying p.Arg961Trp itself, and is promoter-selective rather than a global transcriptional collapse.
PMID:23091001 SUPPORT In Vitro
"MED12 mutations R961W and N1007S causing FG and Lujan syndromes, respectively, disrupt a Mediator-imposed constraint on GLI3-dependent Sonic Hedgehog (SHH) signaling."
Names the FGS1 allele explicitly and identifies the disrupted constraint, establishing the mechanism for this disease rather than for MED12 generally.
PMID:17000779 SUPPORT In Vitro
"We propose that activated Gli3 physically targets the MED12 interface within Mediator in order to functionally reverse Mediator-dependent suppression of Shh target gene transcription."
Establishes MED12 as a direct modulator of GLI3-dependent hedgehog target transcription. PARTIAL because this work characterises the MED12-GLI3 interface in general and does not study the FGS1 p.Arg961Trp allele; it supplies the background mechanism, not the disease-specific finding.
+ 2 more references
Dysregulated Immediate-Early Gene Response
In EBV-immortalized lymphoblastoid cells from patients, individual MED12 variants including p.Arg961Trp generate variant-specific expression patterns of the immediate-early genes JUN, FOS, and EGR1, mirrored by the presence or absence of the MED12-containing complex and RNA polymerase II at their promoters. The effect is cell-type specific, and downstream late-response genes involved in neural plasticity and neuronal gene specification are consequently disturbed. This arm supports a model in which stimulus-responsive transcription, rather than constitutive housekeeping transcription, is the vulnerable process.
transcription by RNA polymerase II GO:0006366 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves transcription by RNA polymerase II (GO:0006366). GO:0006366 is a biological process from the Gene Ontology.
Downstream
Impaired Neuronal Differentiation and Cortical Development Immediate-early gene programmes couple extracellular cues to the activity-dependent transcription that neuronal differentiation and circuit maturation depend on, so variant-specific IEG dysregulation is proposed to impair that step; the evidence base is lymphoblastoid rather than tissue-resident, so the neural relevance is inferred.
Failure of Corpus Callosum Formation Midline axon guidance and callosal targeting are activity- and stimulus-responsive, so disturbed IEG programmes are proposed to reach the callosal defect through the neuronal-differentiation step above; the evidence base is lymphoblastoid rather than tissue-resident.
Show evidence (2 references)
PMID:28369444 SUPPORT In Vitro
"Here, we investigated several MED12 patients mutations (p.R206Q, p.N898D, p.R961W, p.N1007S, p.R1148H, p.S1165P and p.R1295H) and show that each MED12 mutations cause specific expression patterns of JUN, FOS and EGR1 immediate early genes (IEGs), reflected by the presence or absence of MED12..."
Demonstrates that p.Arg961Trp, among other MED12 variants, produces a distinct immediate-early gene signature tied to MED12 promoter occupancy.
PMID:28369444 SUPPORT In Vitro
"Our results suggest that the differences between MED12-related phenotypes are essentially the result of distinct IEGs expression patterns"
Proposes variant-specific immediate-early gene dysregulation as the basis for the distinct clinical syndromes within the MED12 allelic series.
Failure of Corpus Callosum Formation
Agenesis or hypoplasia of the corpus callosum was present in all 13 individuals of the molecularly confirmed cohort who underwent neuroimaging, making it the single most characteristic structural consequence of the MED12 lesion. The developmental step that fails is midline commissural axon guidance and callosal tract formation. The link from the upstream transcriptional arms to this specific structure is biologically coherent but has not been demonstrated in affected human fetal brain.
neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
corpus callosum development GO:0022038 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves corpus callosum development (GO:0022038). GO:0022038 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"The most characteristic anomalies were agenesis or hypoplasia of the corpus callosum (13 of 13)"
Establishes callosal agenesis/hypoplasia as the dominant structural finding, with its own denominator (13 of 13 imaged individuals).
Impaired Neuronal Differentiation and Cortical Development
Loss of scheduled neuronal gene regulation is proposed to perturb neuronal differentiation and cortical development, yielding the universal cognitive impairment and the congenital hypotonia of FGS1. This node carries the cellular consequence; the evidence for the underlying regulatory defect is lymphoblastoid and engineered-rescue rather than neural, which is the subject of the HUMAN_MODEL_MISMATCH discussion.
neural progenitor cell CL:0011020 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neural progenitor cell (CL:0011020). CL:0011020 is a cell type from the Cell Ontology. neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
neuron differentiation GO:0030182 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves neuron differentiation (GO:0030182). GO:0030182 is a biological process from the Gene Ontology.
Show evidence (2 references)
PMID:30729724 SUPPORT In Vitro
"These results support a critical role of MED12 in regulating Gli3-dependent SHH signaling and in developing ID and related congenital malformations in XLID syndromes."
Links the MED12-dependent transcriptional defect to intellectual disability, the organism-level readout of impaired neuronal differentiation.
PMID:18691967 SUPPORT In Vitro
"These findings implicate Mediator in epigenetic restriction of neuronal gene expression to the nervous system and suggest a pathologic basis for MED12-associated XLMR involving impaired REST-dependent neuronal gene regulation."
States the proposed route from impaired REST-dependent neuronal gene regulation to the neurodevelopmental phenotype.
Anorectal Malformation
Anal fistula, stenosis, and atresia occurred in 11 of 19 evaluable molecularly confirmed males. Hindgut and anorectal septation is a classic hedgehog-patterning-dependent process, which is why the GLI3 arm is the most plausible upstream route; enteric neuron development is placed here rather than on a pan-organ node because the severe constipation of FGS1 persists even without a structural anorectal defect.
enteric neuron CL:0007011 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves enteric neuron (CL:0007011). CL:0007011 is a cell type from the Cell Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"anal fistula, stenosis and atresia (11 of 19)"
Gives the anorectal malformation its own denominator (11 of 19 evaluable individuals), distinct from the callosal and cardiac findings.
Cardiac Septation Defect
Congenital cardiac anomalies, including septal defects, were documented in 11 of 18 evaluable molecularly confirmed males. This is the rationale for baseline echocardiography at diagnosis.
ventricular septum development GO:0003281 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal ventricular septum development (GO:0003281). GO:0003281 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"congenital cardiac anomalies (11 of 18)"
Gives the cardiac malformation its own denominator (11 of 18 evaluable individuals).
Craniofacial and Skeletal Dysmorphogenesis
The recognizable facial gestalt was present in all 13 fully evaluated mutation-positive males, accompanied by broad thumbs and halluces, syndactyly, pectus deformity, vertebral and rib anomalies, joint contractures, and hip dysplasia. Craniofacial and limb patterning are hedgehog-dependent, making the GLI3 arm the most plausible upstream route.
neural crest cell differentiation GO:0014033 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal neural crest cell differentiation (GO:0014033). GO:0014033 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Show evidence (2 references)
PMID:19938245 SUPPORT Human Clinical
"These features were seen most often in affected male patients: characteristic facies (13 of 13)"
Establishes the craniofacial gestalt as a near-universal finding in the confirmed cohort.
PMID:19938245 SUPPORT Human Clinical
"skeletal anomalies including joint contractures, hip dysplasia, pectus deformities, vertebral and rib anomalies, syndactyly or oligodactyly of the fingers, and ocular anomalies were frequent."
Enumerates the skeletal component of this node; no per-feature denominator is given, which is why the corresponding phenotype rows carry no frequency band.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for FG Syndrome 1 Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

56
Cardiovascular 2
Congenital heart defect FREQUENT Abnormal heart morphology HP:0001627 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal heart morphology (HP:0001627). HP:0001627 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:19938245 SUPPORT Human Clinical
"congenital cardiac anomalies (11 of 18)"
Direct quantitative support for a FREQUENT band (11/18 = 61%).
PMID:20301719 SUPPORT Human Clinical
"routine management of seizures, strabismus and other ocular anomalies, imperforate anus, chronic constipation, joint contractures, genitourinary anomalies, congenital heart defects, hearing loss, palate anomalies, and dental anomalies"
GeneReviews management section confirms congenital heart defects as a manifestation requiring routine management in MED12-related disorders.
Atrial septal defect HP:0001631 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Atrial septal defect (HP:0001631). HP:0001631 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"An atrial septal defect resolved by the age of 4 years."
Case-level documentation of ASD in a molecularly confirmed male. Supports presence, not a frequency band.
Digestive 6
Chronic constipation VERY_FREQUENT HP:0012450 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Chronic constipation (HP:0012450), qualified as temporality chronic. HP:0012450 is a phenotype from the Human Phenotype Ontology.
Temporal: CHRONIC
Show evidence (2 references)
PMID:20301719 SUPPORT Human Clinical
"FGS1 is further characterized by absolute or relative macrocephaly, tall forehead, downslanted palpebral fissures, small and simple ears, constipation and/or anal anomalies, broad thumbs and halluces, and characteristic behavior."
GeneReviews lists constipation and/or anal anomalies as a defining FGS1 feature.
PMID:18805826 SUPPORT Human Clinical
"FG syndrome (FGS) is an X-linked disorder characterised by mental retardation, hypotonia, particular dysmorphic facial features, broad thumbs and halluces, anal anomalies, constipation, and abnormalities of the corpus callosum."
Lists constipation among the core FGS features. Scored PARTIAL because this sentence defines the historical pre-molecular label in a paper that then shows 29 of 30 such patients are MED12-negative, so it is only indirect support for the molecularly defined entity.
Feeding difficulties VERY_FREQUENT HP:0011968 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Feeding difficulties (HP:0011968). HP:0011968 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"Congenital hypotonia and poor gastrointestinal function, including feeding difficulties that required medical or occupational/ physical therapy, poor oral motor function, decreased gastric motility, reflux, and chronic constipation, are characteristic of FG syndrome and were present in all..."
States directly that feeding difficulties requiring intervention were present in all affected individuals, supporting a VERY_FREQUENT band for the trait itself.
Gastroesophageal reflux HP:0002020 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Gastroesophageal reflux (HP:0002020). HP:0002020 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"decreased gastric motility, reflux, and chronic constipation"
Names reflux as a component of the gastrointestinal dysfunction characteristic of molecularly confirmed FGS1. The surrounding sentence asserts that the combined gastrointestinal picture was present in all affected individuals, but does not give a reflux-specific count, so no band is asserted.
Anal atresia HP:0002023 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Anal atresia (HP:0002023). HP:0002023 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:18973276 SUPPORT Human Clinical
"reported on a family of five affected males with distinctive facial appearance, mental retardation, macrocephaly, imperforate anus and hypotonia."
Documents imperforate anus (anal atresia) as a cardinal feature in the founding Opitz-Kaveggia family, in which the p.Arg961Trp variant was later confirmed.
Megacolon HP:6000852 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Megacolon (HP:6000852). HP:6000852 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:19938245 SUPPORT Human Clinical
"Megacolon, pyloric stenosis, renal cysts and stones, cryptorchidism, skeletal anomalies including joint contractures, hip dysplasia, pectus deformities, vertebral and rib anomalies, syndactyly or oligodactyly of the fingers, and ocular anomalies were frequent."
Names megacolon among the additional FGS1 anomalies. The word "frequent" is applied collectively to a multi-item list with no per-feature denominator, so no frequency band is asserted.
PMID:19938245 SUPPORT Human Clinical
"He had surgery for pyloric stenosis and a partial colonic resection for megacolon."
Case-level documentation that megacolon required surgical resection in a molecularly confirmed male.
Inguinal hernia HP:0000023 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Inguinal hernia (HP:0000023). HP:0000023 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:17574621 SUPPORT Human Clinical
"In boys the most common abnormalities were cryptorchidism (24%), hypospadias (14%) and hernia or hydrocele (13%)."
The only per-feature quantitative estimate available: 13%, which would fall in the OCCASIONAL band, and even that is the composite of hernia and hydrocele rather than inguinal hernia alone. PARTIAL, and not used to assign a band, for the same reason as cryptorchidism: the series is clinically rather than molecularly defined, so its denominator is not an FGS1 denominator.
PMID:24123922 SUPPORT Human Clinical
"Associated defects included anal stenosis or other malformations of the intestinal tract and heart, hernias, and craniosynostosis"
Expert review names hernias among the associated defects in classic FGS1.
Ear 2
Low-set ears HP:0000369 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Low-set ears (HP:0000369). HP:0000369 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"small, simple, low-set, prominent ears"
Names low-set position among the key facial elements that define the FGS1 gestalt. Separated from the Small ears and Simple ears rows so ear position is independently queryable; the source does not give a position-specific count.
Hearing loss Hearing impairment HP:0000365 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hearing impairment (HP:0000365). HP:0000365 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"congenital heart defects, hearing loss, palate anomalies, and dental anomalies"
GeneReviews names hearing loss among the manifestations requiring routine management in MED12-related disorders.
Eye 2
Ocular hypertelorism HP:0000316 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypertelorism (HP:0000316). HP:0000316 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24123922 SUPPORT Human Clinical
"Facial characteristics included a prominent forehead, upswept frontal hairline, downslanting palpebral fissures, ocular hypertelorism, and small prominent ears with a simplified helical pattern."
Expert review lists ocular hypertelorism among the FGS1 facial characteristics.
Strabismus OCCASIONAL HP:0000486 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Strabismus (HP:0000486). HP:0000486 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"strabismus/exotropia in 3 patients"
Direct count (3 of 23 = 13%), supporting the OCCASIONAL band for strabismus specifically.
Genitourinary 4
Cryptorchidism HP:0000028 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cryptorchidism (HP:0000028). HP:0000028 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:17574621 SUPPORT Human Clinical
"In boys the most common abnormalities were cryptorchidism (24%), hypospadias (14%) and hernia or hydrocele (13%)."
The only per-feature quantitative estimate available for this phenotype: 24%, which would fall in the OCCASIONAL band. PARTIAL, and deliberately NOT used to assign a band, because the 228-patient series was assembled on clinical diagnosis and predates routine MED12 testing, so its denominator is the historical clinical FG syndrome population of which fewer than 3% is molecularly confirmed FGS1. Banding FGS1 from a cohort that is ~97% not-FGS1 would assert more than the source supports.
PMID:19938245 SUPPORT Human Clinical
"Megacolon, pyloric stenosis, renal cysts and stones, cryptorchidism, skeletal anomalies including joint contractures, hip dysplasia, pectus deformities, vertebral and rib anomalies, syndactyly or oligodactyly of the fingers, and ocular anomalies were frequent."
Names cryptorchidism among the additional anomalies in the mutation-positive cohort — the right population, but the word "frequent" is applied collectively to a ten-item list with no per-feature denominator, so it does not establish a per-feature band. Together with the preceding item this is why the phenotype carries no frequency: the source with the correct population gives only a collective qualitative term, and the source with a per-feature number is drawn from the wrong population. Asserting either band would be an overreach, and preferring the number here would invert the standard applied to Anxiety in this same entry, where a qualitative statement was judged insufficient to license a band.
Hypospadias HP:0000047 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypospadias (HP:0000047). HP:0000047 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:17574621 SUPPORT Human Clinical
"In boys the most common abnormalities were cryptorchidism (24%), hypospadias (14%) and hernia or hydrocele (13%)."
Documents hypospadias as one of the three most common genitourinary findings. PARTIAL, and not used to assign a band, for the same reason as the other two: the 228-patient series predates routine MED12 testing, so fewer than 3% of its denominator is molecularly confirmed FGS1.
PMID:20301719 SUPPORT Human Clinical
"routine management of seizures, strabismus and other ocular anomalies, imperforate anus, chronic constipation, joint contractures, genitourinary anomalies, congenital heart defects, hearing loss, palate anomalies, and dental anomalies"
GeneReviews includes genitourinary anomalies among the manifestations receiving routine management in MED12-related disorders.
Renal cysts HP:0000107 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Renal cyst (HP:0000107). HP:0000107 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"renal cysts and stones"
Names renal cysts among the additional FGS1 anomalies.
Nephrolithiasis HP:0000787 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Nephrolithiasis (HP:0000787). HP:0000787 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"renal cysts and stones"
Names renal stones among the additional FGS1 anomalies; bound separately from the cyst term so nephrolithiasis is independently queryable.
Head and Neck 5
Macrocephaly FREQUENT HP:0000256 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Macrocephaly (HP:0000256). HP:0000256 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:19938245 SUPPORT Human Clinical
"Absolute macrocephaly (head circumference greater than the 98th percentile) was confirmed in fewer than half of patients (7 of 18) as was relative macrocephaly (head circumference percentile greater than height percentile)."
Direct quantitative support for a FREQUENT (not VERY_FREQUENT) band and an explicit correction of the historical assumption that macrocephaly is universal.
PMID:19938245 SUPPORT Human Clinical
"Ten had macrocephaly (five absolute, five relative)."
Provides the fully evaluated subset denominator (10 of 13) for combined absolute and relative macrocephaly.
Relative macrocephaly FREQUENT HP:0004482 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Relative macrocephaly (HP:0004482). HP:0004482 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:20301719 SUPPORT Human Clinical
"FGS1 is further characterized by absolute or relative macrocephaly"
GeneReviews explicitly names relative macrocephaly as a defining FGS1 feature.
PMID:19938245 SUPPORT Human Clinical
"Absolute macrocephaly (head circumference greater than the 98th percentile) was confirmed in fewer than half of patients (7 of 18) as was relative macrocephaly (head circumference percentile greater than height percentile)."
Establishes that relative macrocephaly, like absolute, is present in fewer than half of mutation-positive males. Read strictly this gives only an upper bound: the "(7 of 18)" is parenthetical to absolute macrocephaly, and "as was relative macrocephaly" carries over the predicate alone, so this sentence bounds the figure below 50% without setting a floor. The FREQUENT band is anchored by the count in the following evidence item, not by this sentence. Note also that this is the mutation-POSITIVE denominator; the separate "15 of 18 had macrocephaly" figure elsewhere in this paper belongs to the Italian mutation-NEGATIVE comparison group and must not be applied to FGS1.
PMID:19938245 SUPPORT Human Clinical
"Ten had macrocephaly (five absolute, five relative)."
The count that anchors the band: 5 of the 13 examined mutation-positive males had relative macrocephaly, 38%, within FREQUENT (30-79%). It also corroborates the absolute-macrocephaly figure, 5/13 against 7/18, both approximately 38%.
Characteristic facial gestalt VERY_FREQUENT Abnormal facial shape HP:0001999 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Characteristic FG syndrome facial gestalt, annotated with Abnormal facial shape (HP:0001999). HP:0001999 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"These features were seen most often in affected male patients: characteristic facies (13 of 13)"
Direct quantitative support for the composite facial gestalt. The reported proportion is 13/13 (100%), which would map to OBLIGATE under the default convention; VERY_FREQUENT is used instead as a deliberate departure, because n=13 is a subset of the 23-male cohort and does not license an assertion of invariance.
Downslanted palpebral fissures HP:0000494 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Downslanted palpebral fissures (HP:0000494). HP:0000494 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"tall forehead, downslanted palpebral fissures, small and simple ears"
GeneReviews lists downslanted palpebral fissures among the defining FGS1 facial features.
Craniosynostosis OCCASIONAL HP:0001363 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Craniosynostosis (HP:0001363). HP:0001363 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"Craniosynostosis was found in two patients."
Direct count (2 of 23 = 9%), supporting the OCCASIONAL band.
Integument 1
Prominent fingertip pads HP:0001212 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Prominent fingertip pads (HP:0001212). HP:0001212 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24123922 SUPPORT Human Clinical
"His characteristic facial features included small and simple ears, tall and prominent forehead, frontal hair upsweep, down slanting palpebral fissures, broad thumbs and halluces, fetal fingertips pads, and characteristic friendly behavior"
Describes fetal fingertip pads in the single MED12 p.R961W-positive patient identified in the Lyons diagnostic series.
Limbs 3
Broad thumbs HP:0011304 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Broad thumb (HP:0011304). HP:0011304 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:20301719 SUPPORT Human Clinical
"broad thumbs and halluces"
GeneReviews lists broad thumbs among the defining FGS1 clinical characteristics.
PMID:18805826 SUPPORT Human Clinical
"broad thumbs and halluces"
Lists broad thumbs among the core FGS features. Scored PARTIAL because the sentence characterizes the historical pre-molecular label rather than the MED12-confirmed cohort.
Broad halluces Broad hallux HP:0010055 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Broad hallux (HP:0010055). HP:0010055 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"broad thumbs and halluces"
GeneReviews lists broad halluces among the defining FGS1 clinical characteristics.
Syndactyly HP:0001159 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Syndactyly (HP:0001159). HP:0001159 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"syndactyly or oligodactyly of the fingers"
Directly names finger syndactyly among the reported FGS1 skeletal anomalies.
Musculoskeletal 5
Congenital hypotonia VERY_FREQUENT Neonatal hypotonia HP:0001319 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Neonatal hypotonia (HP:0001319). HP:0001319 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:19938245 SUPPORT Human Clinical
"Congenital hypotonia and poor gastrointestinal function, including feeding difficulties that required medical or occupational/ physical therapy, poor oral motor function, decreased gastric motility, reflux, and chronic constipation, are characteristic of FG syndrome and were present in all..."
States directly that congenital hypotonia was present in all affected individuals in the molecularly confirmed cohort, supporting VERY_FREQUENT for hypotonia specifically rather than for a composite triad.
PMID:20301719 SUPPORT Human Clinical
"FGS1 and LS share the clinical findings of cognitive impairment, hypotonia, and abnormalities of the corpus callosum."
GeneReviews lists hypotonia among the core FGS1 clinical findings.
PMID:19938245 SUPPORT Human Clinical
"Hypotonia improves or resolves with age."
Supports the natural history statement that hypotonia is not progressive.
Joint contractures Flexion contracture HP:0001371 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Flexion contracture (HP:0001371). HP:0001371 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:19938245 SUPPORT Human Clinical
"skeletal anomalies including joint contractures, hip dysplasia, pectus deformities, vertebral and rib anomalies, syndactyly or oligodactyly of the fingers, and ocular anomalies were frequent."
Documents joint contractures within the FGS1 skeletal spectrum. The source word is "frequent" but applies to a loose list of features with no per-feature denominator, so no frequency band is asserted.
PMID:20301719 SUPPORT Human Clinical
"routine management of seizures, strabismus and other ocular anomalies, imperforate anus, chronic constipation, joint contractures, genitourinary anomalies, congenital heart defects, hearing loss, palate anomalies, and dental anomalies"
GeneReviews management guidance confirms joint contractures as a recognized manifestation.
Hip dysplasia HP:0001385 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hip dysplasia (HP:0001385). HP:0001385 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"skeletal anomalies including joint contractures, hip dysplasia, pectus deformities, vertebral and rib anomalies, syndactyly or oligodactyly of the fingers, and ocular anomalies were frequent."
Explicitly names hip dysplasia among the frequent FGS1 skeletal anomalies.
Pectus deformity Pectus excavatum HP:0000767 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pectus excavatum (HP:0000767). HP:0000767 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24123922 SUPPORT Human Clinical
"Skeletal manifestations included stature in the lower range of normal, broad and flat thumbs and halluces, partial syndactyly, pectus excavatum, joint contractures, and spinal curvature."
Expert review names pectus excavatum within the FGS1 skeletal manifestations.
Abnormal vertebral morphology HP:0003468 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal vertebral morphology (HP:0003468). HP:0003468 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"vertebral and rib anomalies"
Directly names vertebral anomalies among the reported FGS1 skeletal findings.
Nervous System 8
Intellectual disability OBLIGATE HP:0001249 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Intellectual disability (HP:0001249). HP:0001249 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:19938245 SUPPORT Human Clinical
"The degree of intellectual disability is variable from borderline to severe. All these individuals have cognitive disability. In most patients, IQ scores were below 70 or equivalent."
Directly supports the presence of cognitive impairment in every member of the confirmed cohort, and its variable severity.
PMID:19938245 SUPPORT Human Clinical
"there have been no convincing reports of FG syndrome in either heterozygous female carriers or in male patients whose intelligence is similar to their unaffected relatives"
This is the basis for OBLIGATE rather than VERY_FREQUENT, and it is a different argument from the counted-denominator one used elsewhere in this entry. Every other phenotype here with a 100% denominator is deliberately banded VERY_FREQUENT because n=13 of a 23-male cohort does not license an assertion of invariance. Intellectual disability departs from that rule because the claim does not rest on the count: no affected male without cognitive impairment has been reported at all, and cognitive impairment is an inclusion criterion for the diagnosis, so the phenotype is definitionally rather than statistically obligate.
PMID:19938245 SUPPORT Human Clinical
"All 13 patients are males with some degree of cognitive impairment"
Confirms cognitive impairment in every fully assessed mutation-positive male. Corroborative only: as with every other 100%-denominator phenotype in this entry, n=13 would not on its own license OBLIGATE. The band rests on the definitional argument in the preceding evidence item, not on this count.
Hyperactivity VERY_FREQUENT HP:0000752 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hyperactivity (HP:0000752). HP:0000752 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:18973276 SUPPORT Human Clinical
"The previously defined behavior phenotype of hyperactivity, affability, and excessive talkativeness is very frequent in young boys with this mutation, along with socially oriented, attention-seeking behaviors."
Explicit "very frequent" qualitative statement in mutation-confirmed males, mapping to the VERY_FREQUENT band.
Anxiety HP:0000739 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Anxiety (HP:0000739). HP:0000739 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:18973276 SUPPORT Human Clinical
"In addition, they were at increased risk for maladaptive behavior, with a propensity towards aggression, anxiety, and inattention."
Documents anxiety as a maladaptive-behavior risk in p.Arg961Trp-confirmed males. No frequency band is assigned: "increased risk" and "a propensity towards" are qualitative and carry no proportion, and the cohort paper gives no denominator for anxiety alone.
PMID:19938245 SUPPORT Human Clinical
"whereas anxiety, which is present in both groups, is less discriminatory"
Records that anxiety occurs in both the mutation-positive and mutation-negative groups, which is why it is not used as a diagnostic discriminator.
Aggressive behavior OCCASIONAL HP:0000718 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Aggressive behavior (HP:0000718). HP:0000718 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:19938245 SUPPORT Human Clinical
"Some individuals can be aggressive, impulsive, and/or obsessive-compulsive."
"Some individuals" maps to the OCCASIONAL band per the literature-term mapping table in docs/frequency-evidence-guidelines.md.
PMID:20981778 SUPPORT Human Clinical
"These individuals had episodic and longstanding behavior patterns, sometimes aggressive or self-abusing, that occurred more frequently in puberty and early adulthood."
Documents the age-dependent emergence of aggressive/self-injurious behavior.
Compulsive behaviors OCCASIONAL HP:0000722 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Compulsive behaviors (HP:0000722). HP:0000722 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"Some individuals can be aggressive, impulsive, and/or obsessive-compulsive."
"Some individuals" maps to the OCCASIONAL band for obsessive-compulsive traits.
Delayed speech and language development FREQUENT HP:0000750 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Delayed speech and language development (HP:0000750). HP:0000750 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:18973276 SUPPORT Human Clinical
"Males with this MED12 mutation had deficits in communication skills compared to their socialization and daily living skills."
Vineland-based demonstration of a specific communication deficit in p.Arg961Trp-confirmed males.
PMID:20301719 SUPPORT Human Clinical
"physical therapy, occupational therapy, and speech therapy for developmental delays"
GeneReviews management recommendations presuppose speech-affecting developmental delay in MED12-related disorders.
Sleep disturbance FREQUENT HP:0002360 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sleep disturbance (HP:0002360). HP:0002360 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20981778 SUPPORT Human Clinical
"Headaches, insomnia and sleep apnea are also common and may exacerbate maladaptive behaviors."
The qualitative term "common" maps to the FREQUENT band, and the statement is made specifically about p.Arg961Trp-confirmed FG syndrome males.
Seizures HP:0001250 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Seizure (HP:0001250). HP:0001250 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:20301719 SUPPORT Human Clinical
"routine management of seizures, strabismus and other ocular anomalies, imperforate anus, chronic constipation, joint contractures, genitourinary anomalies, congenital heart defects, hearing loss, palate anomalies, and dental anomalies"
GeneReviews management guidance confirms seizures as a manifestation requiring routine management in MED12-related disorders.
PMID:24123922 SUPPORT Human Clinical
"The corpus callosum was deficient or absent altogether, with occasional EEG abnormalities."
Documents occasional EEG abnormality in the classic FGS1 description. This supports abnormal cortical electrical activity, not seizures as such, so no frequency band is asserted for seizures from this item.
Growth 1
Short stature HP:0004322 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short stature (HP:0004322). HP:0004322 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24123922 SUPPORT Human Clinical
"Skeletal manifestations included stature in the lower range of normal"
The source describes stature in the lower range of normal rather than frank short stature, so this evidence is scored PARTIAL and no frequency band is asserted. The row is retained to document that height is shifted downward without meeting the threshold for short stature.
Other 17
Agenesis or hypoplasia of the corpus callosum VERY_FREQUENT Aplasia/Hypoplasia of the corpus callosum HP:0007370 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Agenesis or hypoplasia of the corpus callosum, annotated with Aplasia/Hypoplasia of the corpus callosum (HP:0007370). HP:0007370 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:19938245 SUPPORT Human Clinical
"The most characteristic anomalies were agenesis or hypoplasia of the corpus callosum (13 of 13)"
Direct quantitative support. The reported proportion is 13/13 (100%), which would map to OBLIGATE under the default convention; VERY_FREQUENT is used instead as a deliberate departure, because the denominator is the 13-member imaged subset of a 23-male cohort and n=13 does not license an assertion of invariance across all affected individuals.
PMID:20301719 SUPPORT Human Clinical
"FGS1 and LS share the clinical findings of cognitive impairment, hypotonia, and abnormalities of the corpus callosum."
GeneReviews confirms corpus callosum abnormality as a core FGS1 finding.
Anal anomalies FREQUENT Abnormality of the anus HP:0004378 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormality of the anus (HP:0004378). HP:0004378 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"anal fistula, stenosis and atresia (11 of 19)"
Direct quantitative support for a FREQUENT band (11/19 = 58%).
Anal stenosis HP:0002025 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Anal stenosis (HP:0002025). HP:0002025 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"anal fistula, stenosis and atresia (11 of 19)"
Anal stenosis is explicitly named within the quantified anorectal anomaly group.
Dolichocephaly HP:0000268 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dolichocephaly (HP:0000268). HP:0000268 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"The key elements of the clinical phenotype are absolute or relative macrocephaly with a long narrow face; tall forehead; dolicocephalic head shape; an open mouth; small, simple, low-set, prominent ears; and puffy eyelids."
Names dolichocephaly (source spelling "dolicocephalic") among the key elements of the FGS1 phenotype. Presence claim only; no count.
Open mouth HP:0000194 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Open mouth (HP:0000194). HP:0000194 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"an open mouth; small, simple, low-set, prominent ears"
Names open mouth among the key facial elements that define the FGS1 gestalt. Presence claim only; no count.
High forehead HP:0000348 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is High forehead (HP:0000348). HP:0000348 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"tall forehead, downslanted palpebral fissures, small and simple ears"
GeneReviews enumerates the component facial features, including the tall forehead bound here.
Frontal upsweep of hair HP:0002236 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Frontal upsweep of hair (HP:0002236). HP:0002236 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24123922 SUPPORT Human Clinical
"Facial characteristics included a prominent forehead, upswept frontal hairline, downslanting palpebral fissures, ocular hypertelorism, and small prominent ears with a simplified helical pattern."
Expert review enumerates the frontal hair upsweep among the FGS1 facial characteristics.
Small ears VERY_FREQUENT Short ear HP:0400005 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Small ears, annotated with Short ear (HP:0400005). HP:0400005 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"Twelve had small ears that measured below the 10th percentile (the other one had simple ears)."
Direct quantitative support for a VERY_FREQUENT band for small ears specifically (12 of 13 = 92%); the thirteenth patient had simple rather than small ears.
Simple ears HP:0020206 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Simple ear (HP:0020206). HP:0020206 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:20301719 SUPPORT Human Clinical
"tall forehead, downslanted palpebral fissures, small and simple ears"
GeneReviews names "small and simple ears" as a defining FGS1 feature.
PMID:24123922 SUPPORT Human Clinical
"small prominent ears with a simplified helical pattern"
Describes the simplified helical pattern that this term captures, distinct from ear size.
Protruding ear HP:0000411 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Protruding ear (HP:0000411). HP:0000411 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:19938245 SUPPORT Human Clinical
"small, simple, low-set, prominent ears"
The source adjective "prominent" maps to the HPO protruding-ear term. Bound separately from size and helical simplification so prominence is independently queryable.
PMID:24123922 SUPPORT Human Clinical
"small prominent ears with a simplified helical pattern"
Expert review independently names prominence among the FGS1 ear descriptors.
Limited pronation/supination of forearm OCCASIONAL HP:0006394 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Limited pronation/supination of forearm (HP:0006394). HP:0006394 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"Limited supination of the elbow was reported in six patients and may prove to be a useful sign in the older child evaluated in the outpatient clinic."
Direct count (6 of 23 = 26%) supports the OCCASIONAL band. The HPO term covers limited pronation and/or supination; the source names limited supination.
Affable, loquacious personality VERY_FREQUENT Overfriendliness HP:0100025 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Friendly, loquacious, eager-to-please personality, annotated with Overfriendliness (HP:0100025). HP:0100025 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:19938245 SUPPORT Human Clinical
"an affable personality (13 of 13)"
Direct quantitative support for the affable personality trait. The reported proportion is 13/13 (100%), which would map to OBLIGATE under the default convention; VERY_FREQUENT is used instead as a deliberate departure, because n=13 is a subset of the 23-male cohort and does not license an assertion of invariance.
PMID:19938245 SUPPORT Human Clinical
"They confirm the previously documented friendly, loquacious, eager-to-please personality with concurrent anxiety and need for sameness."
Characterizes the specific content of the distinctive social-behavioral profile.
PMID:18973276 SUPPORT Human Clinical
"Males with this MED12 mutation had deficits in communication skills compared to their socialization and daily living skills."
Quantitatively characterizes the adaptive-behavior profile using the Vineland scales in p.Arg961Trp-confirmed males.
Short attention span FREQUENT HP:0000736 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short attention span (HP:0000736). HP:0000736 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:18973276 SUPPORT Human Clinical
"during early childhood they were friendly, inquisitive, and hyperactive with a very short attention span"
Directly describes the very short attention span in early childhood, rather than relying on the generic maladaptive-behavior risk sentence.
Impulsivity OCCASIONAL HP:0100710 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Impulsivity (HP:0100710). HP:0100710 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20981778 SUPPORT Human Clinical
"They remain impulsive and can have aggressive outbursts when making the transition to adult life"
Documents persistent impulsivity in adult p.Arg961Trp-confirmed males.
Ocular anomalies FREQUENT Abnormality of the eye HP:0000478 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ocular anomaly (any), annotated with Abnormality of the eye (HP:0000478). HP:0000478 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:19938245 SUPPORT Human Clinical
"Eye anomalies were reported in 10 patients: strabismus/exotropia in 3 patients; optic nerve hypoplasia in 2; coloboma in 2; phthisis bulbi, nystagmus, retinal detachment, and cataract in 1 patient each."
Direct quantitative support: 10 of 23 confirmed patients (43%) had an ocular anomaly of some kind, supporting the FREQUENT band for the composite finding. The band applies to the composite, not to any individual ocular feature.
PMID:34670449 SUPPORT Human Clinical
"Commonly reoccurring reported eye and ocular adnexa features within the spectrum include ptosis, downslanting palpebral fissures, and hypertelorism. Other less common findings include strabismus, astigmatism, and optic nerve hypoplasia."
Systematic review of ocular features across MED12-related disorders confirms strabismus and optic nerve hypoplasia as recurring findings.
Optic nerve hypoplasia OCCASIONAL HP:0000609 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Optic nerve hypoplasia (HP:0000609). HP:0000609 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"optic nerve hypoplasia in 2"
Direct count (2 of 23 = 9%), supporting the OCCASIONAL band.
Pyloric stenosis HP:0002021 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pyloric stenosis (HP:0002021). HP:0002021 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"Megacolon, pyloric stenosis, renal cysts and stones, cryptorchidism"
Directly names pyloric stenosis among the additional FGS1 anomalies.
🧬

Genetic Associations

1
MED12
Gene: MED12 hgnc:11957 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is MED12 (hgnc:11957). hgnc:11957 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
X-linked recessive inheritance
Show evidence (3 references)
PMID:17334363 SUPPORT Human Clinical
"We report here that the original family for whom the condition is named and five other families have a recurrent mutation (2881C>T, leading to R961W) in MED12 (also called TRAP230 or HOPA), a gene located at Xq13"
Establishes MED12 as the causative gene and localizes it to Xq13.
PMID:20301719 SUPPORT Human Clinical
"The diagnosis of an MED12-related disorder is established in a male by identification of a hemizygous MED12 pathogenic variant on molecular genetic testing."
GeneReviews defines molecular diagnosis of MED12-related disorders, including FGS1, by hemizygous MED12 variant identification in males.
PMID:33925166 SUPPORT Other
"Missense variants in MED12 cause FG syndrome, Lujan-Fryns syndrome, and Ohdo syndrome, as well as non-syndromic intellectual disability (ID) in hemizygous males."
Places FGS1 within the MED12 missense allelic series and distinguishes it from the other MED12-related phenotypes.
🔬

Variants

2
MED12 c.2881C>T (p.Arg961Trp) Pathogenic
Gene: MED12 hgnc:11957 HUGO Gene Nomenclature Committee (hgnc) Relation: this variant is in this gene This variant is in MED12 (hgnc:11957). hgnc:11957 is a gene from the HUGO Gene Nomenclature Committee. missense
The defining FGS1 variant: NM_005120.3:c.2881C>T in exon 21 of MED12, causing the p.Arg961Trp missense substitution. It is germline and hemizygous in affected males, recurrent across unrelated families, and maternally transmitted rather than de novo in the reported cohort. Functionally it produces a pathway-selective altered-function defect rather than complete loss of MED12 function.
Show evidence (2 references)
PMID:17334363 SUPPORT Human Clinical
"a recurrent mutation (2881C>T, leading to R961W) in MED12"
Defines the exact nucleotide and protein change for the recurrent FGS1 variant.
PMID:18973276 SUPPORT Human Clinical
"In 2007, Risheg et al. identified an identical nucleotide substitution (c.2881C>T) in exon 21 of MED12 (p.R961W) in six families with Opitz-Kaveggia syndrome, including a surviving affected male from the original Opitz-Kaveggia family."
Localizes the variant to exon 21 and confirms its identity across six independently ascertained families including the original family.
MED12 p.Gly958Glu Likely Pathogenic
Gene: MED12 hgnc:11957 HUGO Gene Nomenclature Committee (hgnc) Relation: this variant is in this gene This variant is in MED12 (hgnc:11957). hgnc:11957 is a gene from the HUGO Gene Nomenclature Committee. missense
A second, non-recurrent MED12 missense variant reported in one family with three affected cousins whose clinical phenotype matched Opitz-Kaveggia syndrome. It demonstrated for the first time that FGS1 is not exclusively caused by p.Arg961Trp, although p.Arg961Trp remains the defining and by far the most common allele.
Show evidence (1 reference)
PMID:20507344 SUPPORT Human Clinical
"Here we report on a new family with three affected cousins, in which we identified a novel MED12 mutation (p.G958E). This is the first demonstration that other mutations in this gene can also lead to Opitz-Kaveggia syndrome."
Directly reports the second FGS1-causing MED12 allele and states its significance.
💊

Medical Actions

10
Early intervention and individualized education
Category: Therapeutic Action: early intervention servicesNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is early intervention services, annotated with Early Intervention (NCIT:C159524). NCIT:C159524 is a clinical intervention from the NCI Thesaurus. Ontology label: Early Intervention NCIT:C159524
Early individualized educational services and developmental intervention are the cornerstone of FGS1 management, targeting cognitive, motor, and adaptive development.
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"Treatment of manifestations: Early individualized education"
GeneReviews management guidance names early individualized education as first-line treatment of manifestations.
Physical therapy
Category: Therapeutic Action: physical therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is physical therapy (NCIT:C15302). NCIT:C15302 is a clinical intervention from the NCI Thesaurus. Ontology label: Physical Therapy NCIT:C15302
Physical therapy addresses congenital hypotonia, delayed motor milestones, contractures, and mobility. Some children achieve walking only in later childhood.
Target Phenotypes: Neonatal hypotonia HP:0001319 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Neonatal hypotonia (HP:0001319). HP:0001319 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"physical therapy, occupational therapy, and speech therapy for developmental delays"
GeneReviews management guidance names physical therapy for developmental delays in MED12-related disorders.
Occupational therapy
Category: Therapeutic Action: occupational therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is occupational therapy (NCIT:C121351). NCIT:C121351 is a clinical intervention from the NCI Thesaurus. Ontology label: Occupational Therapy NCIT:C121351
Occupational therapy supports adaptive and daily living skills, an area of relative strength that can be built on given the socialization profile.
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"physical therapy, occupational therapy, and speech therapy for developmental delays"
GeneReviews management guidance names occupational therapy for developmental delays in MED12-related disorders.
Speech and language therapy
Category: Therapeutic Action: speech therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is speech therapy, annotated with Speech Language Therapy (NCIT:C159273). NCIT:C159273 is a clinical intervention from the NCI Thesaurus. Ontology label: Speech Language Therapy NCIT:C159273
Sustained speech-language therapy, with augmentative and alternative communication where needed, targets the disproportionate communication deficit documented on the Vineland scales in p.Arg961Trp-confirmed males.
Target Phenotypes: Delayed speech and language development HP:0000750 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Delayed speech and language development (HP:0000750). HP:0000750 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"physical therapy, occupational therapy, and speech therapy for developmental delays"
GeneReviews management guidance names speech therapy for developmental delays in MED12-related disorders.
Behavioral management
Category: Therapeutic Action: individualized behavioral managementNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is individualized behavioral management, annotated with Behavioral Intervention (NCIT:C15184). NCIT:C15184 is a clinical intervention from the NCI Thesaurus. Ontology label: Behavioral Intervention NCIT:C15184
Individualized management of behavior problems, with structured routines, advance warning of transitions, and behavioral intervention. Mood stabilizers may be considered for adolescents and young adults with aggressive or self-injurious outbursts, and a careful medical examination should precede escalation since unrecognized medical problems (including constipation and ocular anomalies) can drive behavior change.
Target Phenotypes: Aggressive behavior HP:0000718 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Aggressive behavior (HP:0000718). HP:0000718 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:20301719 SUPPORT Human Clinical
"individualized management of behavior problems"
GeneReviews management guidance names individualized behavior management as a treatment of manifestations.
PMID:20981778 SUPPORT Human Clinical
"Young men who exhibit these behaviors may benefit from a careful examination to detect medical problems, use of mood stabilizers if needed, and/or behavioral intervention."
Specifies the recommended approach for the adolescent/adult behavioral phase, including the medical-examination-first principle.
Bowel management for chronic constipation
Category: Therapeutic Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: laxative NCIT:C29697 NCI Thesaurus (NCIT) Relation: this treatment uses this therapeutic agent This treatment uses laxative (NCIT:C29697). NCIT:C29697 is a therapeutic agent from the NCI Thesaurus.
Aggressive constipation management is required in essentially all affected individuals. Structural anorectal disease should be excluded or treated, since constipation may be functional, obstructive, or both.
Target Phenotypes: Chronic constipation HP:0012450 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Chronic constipation (HP:0012450). HP:0012450 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"imperforate anus, chronic constipation"
GeneReviews lists chronic constipation among the manifestations requiring routine management in MED12-related disorders.
Surgical repair of congenital anomalies
Category: Therapeutic Action: surgical procedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is surgical procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Surgical correction of imperforate anus and other anorectal malformations, repair of significant congenital heart defects, and orthopedic management of contractures, hip dysplasia, and spinal deformity as indicated.
Target Phenotypes: Anal atresia HP:0002023 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Anal atresia (HP:0002023). HP:0002023 is a phenotype from the Human Phenotype Ontology. Abnormal heart morphology HP:0001627 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Abnormal heart morphology (HP:0001627). HP:0001627 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"routine management of seizures, strabismus and other ocular anomalies, imperforate anus, chronic constipation, joint contractures, genitourinary anomalies, congenital heart defects, hearing loss, palate anomalies, and dental anomalies"
GeneReviews management guidance covers the surgically correctable anomalies addressed by this treatment entry.
Gastrostomy feeding
Category: Therapeutic Action: gastrostomyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is gastrostomy (NCIT:C52006). NCIT:C52006 is a clinical intervention from the NCI Thesaurus. Ontology label: Gastrostomy NCIT:C52006
Surgical gastrostomy placement for enteral feeding when severe infantile feeding difficulty is not met by oral intake, following feeding and swallowing assessment. Non-surgical nasogastric feeding is a distinct intervention and is not asserted by this entry.
Target Phenotypes: Feeding difficulties HP:0011968 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Feeding difficulties (HP:0011968). HP:0011968 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"At each visit, assess growth, development, behavior concerns, neurologic issues, gastrointestinal functioning, and musculoskeletal manifestations."
GeneReviews surveillance guidance covers growth and gastrointestinal functioning but does not itself specify gastrostomy; scored PARTIAL because the surveillance recommendation supports nutritional monitoring rather than the specific intervention.
Ophthalmologic and audiologic surveillance
Category: Monitoring Action: clinical surveillanceNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is clinical surveillance, annotated with Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
Formal ophthalmologic assessment at diagnosis (given that ocular anomalies occurred in 10 of 23 confirmed patients) and annual audiology evaluation.
Show evidence (2 references)
PMID:20301719 SUPPORT Human Clinical
"Annual audiology evaluation."
GeneReviews surveillance guidance specifies annual audiology evaluation in MED12-related disorders.
PMID:19938245 SUPPORT Human Clinical
"This justifies a formal ophthalmologic assessment when FG syndrome is being considered."
Directly recommends formal ophthalmologic assessment on the basis of the observed ocular anomaly burden.
Genetic counseling and family testing
Category: Counseling / Informational Action: genetic counselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is genetic counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. Ontology label: Genetic Counseling NCIT:C15240
X-linked counseling for the family: a heterozygous mother has a 50% transmission risk per pregnancy, sons who inherit the variant are affected, and daughters who inherit an FGS1-associated variant are typically unaffected carriers. Once the familial variant is known, heterozygote testing of at-risk female relatives and prenatal or preimplantation genetic testing are possible. Males with an MED12-related disorder are not known to reproduce.
Show evidence (2 references)
PMID:20301719 SUPPORT Human Clinical
"Once the MED12 pathogenic variant has been identified in an affected family member, heterozygote testing for at-risk female relatives and prenatal and preimplantation genetic testing for MED12-related disorders are possible."
GeneReviews genetic counseling section specifies the family testing options available after molecular confirmation.
PMID:20301719 SUPPORT Human Clinical
"If the mother of a proband is heterozygous for a pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be affected."
Provides the quantitative recurrence risk used in FGS1 counseling.
🔬

Diagnosis

4
MED12 molecular genetic testing
Diagnosis requires a compatible phenotype plus identification of a hemizygous pathogenic MED12 variant in a male, with p.Arg961Trp defining classic FGS1. Targeted testing for c.2881C>T is efficient when the classic phenotype or a known familial variant is present; otherwise an intellectual disability/congenital anomaly gene panel containing MED12, or exome/genome sequencing, is appropriate, followed by full MED12 gene sequencing if targeted analysis is negative.
Show evidence (2 references)
PMID:20301719 SUPPORT Human Clinical
"The diagnosis of an MED12-related disorder is established in a male by identification of a hemizygous MED12 pathogenic variant on molecular genetic testing."
GeneReviews states the molecular diagnostic criterion for MED12-related disorders in males.
PMID:19938245 SUPPORT Human Clinical
"when the clinical diagnosis of FG syndrome is suspected, we recommend first testing for the recurrent mutation, followed by gene sequencing if targeted mutation analysis is negative."
Gives the recommended tiered molecular testing strategy for suspected FGS1.
Clinical algorithm for targeted p.Arg961Trp testing
A six-criterion clinical algorithm derived from comparing 23 p.Arg961Trp-positive males with 48 mutation-negative patients carrying a clinical FG syndrome diagnosis. Criteria centre on the characteristic facies, affable personality, congenital anomaly (or an affected relative with one), small ears, macrocephaly, and the infantile hypotonia/feeding difficulty/constipation triad. It achieves 100% sensitivity and 90% specificity for the recurrent MED12 variant. It is best used as historical triage: contemporary practice generally reaches the diagnosis by sequencing.
Show evidence (2 references)
PMID:19938245 SUPPORT Human Clinical
"The algorithm identifies the p.R961W MED12 mutation-positive group with 100% sensitivity and 90% specificity."
Reports the diagnostic performance of the clinical triage algorithm.
PMID:19938245 SUPPORT Human Clinical
"These features were seen most often in affected male patients: characteristic facies (13 of 13), an affable personality (13 of 13), a congenital anomaly (11 of 13) or an affected relative with a congenital anomaly (2 of 13), and at least 1 of these 3 traits: infantile hypotonia, feeding..."
Enumerates the discriminating features that constitute the algorithm criteria.
Baseline echocardiography
Cardiac imaging is a core baseline evaluation at diagnosis, since congenital cardiac anomalies were documented in 11 of 18 evaluable molecularly confirmed males and congenital heart defects are among the manifestations GeneReviews directs to routine management.
Show evidence (2 references)
PMID:19938245 SUPPORT Human Clinical
"congenital cardiac anomalies (11 of 18)"
The high observed rate of congenital cardiac anomalies is the rationale for baseline cardiac imaging in a newly diagnosed individual.
PMID:20301719 SUPPORT Human Clinical
"congenital heart defects, hearing loss, palate anomalies, and dental anomalies"
GeneReviews places congenital heart defects among the manifestations requiring routine management; scored PARTIAL because it prescribes management rather than naming echocardiography as the baseline test.
Brain MRI
Brain imaging with specific attention to the corpus callosum is a core baseline evaluation, since agenesis or hypoplasia of the corpus callosum was present in all imaged individuals in the confirmed cohort.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"The most characteristic anomalies were agenesis or hypoplasia of the corpus callosum (13 of 13)"
Justifies neuroimaging as a high-yield baseline investigation.
📈

Progression

3
Neonatal and infantile presentation
Age: birth to 1 year
FGS1 presents at birth or in early infancy with congenital hypotonia, feeding difficulties, and constipation, together with structural anomalies (anorectal malformations, congenital heart defects, corpus callosum agenesis/hypoplasia) that may be recognized neonatally. Mortality is concentrated in this window; one or more affected males died in childhood in 8 of the 10 reported families.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"Although the 10 families reported here produced 30 live-born affected male patients, 1 or more affected individuals died in childhood in 8 of these 10 families."
Establishes that early-childhood mortality is a defining feature of the initial phase of the disorder.
Childhood
Age: 1 to 12 years
Developmental delay, cognitive impairment, and the characteristic behavioral profile (friendly, loquacious, hyperactive, short attention span) become evident. Facial gestalt is most readily recognized in early childhood. After the first year of life mortality is not markedly increased.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"However, after the first year of life, mortality does not seem to be significantly increased. Hypotonia improves or resolves with age."
Supports both the improved survival and the improvement of hypotonia beyond infancy.
Adolescence and adulthood
Age: 13 years and older
Hypotonia improves or resolves, but intellectual, speech, and adaptive limitations persist. Behavior may shift toward episodic aggressive, self-injurious, or obsessive-compulsive patterns emerging around puberty and early adulthood, with anxiety around transitions. Survival into the fifth and sixth decades is documented.
Show evidence (2 references)
PMID:20981778 SUPPORT Human Clinical
"These individuals had episodic and longstanding behavior patterns, sometimes aggressive or self-abusing, that occurred more frequently in puberty and early adulthood."
Documents the adolescent/adult behavioral trajectory in p.Arg961Trp-confirmed males.
PMID:19938245 SUPPORT Human Clinical
"Three of these male patients are doing well in their 5th and 6th decades."
Documents long-term adult survival and function in molecularly confirmed FGS1.
📊

Prevalence

1
Molecularly confirmed cases reported in the literature
Cases In Literature Ultra Rare
No population prevalence or incidence estimate exists for molecularly confirmed FGS1. The definitive series comprised 23 p.Arg961Trp-positive males from 10 families. Population-level figures for the historical clinical "FG syndrome" label should not be applied to this MED12-defined entity.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"We ascertained 23 males with the p.R961W mutation in MED12 from 9 previously reported FG syndrome families and 1 new family."
Establishes the size of the entire known molecularly confirmed FGS1 cohort at the time of the definitive phenotype review, supporting an ultra-rare classification based on literature case counts.
⚖️

Clinical Burden

High
Lifelong intellectual disability with communication impairment and dependence in daily living, chronic bowel dysfunction, structural congenital anomalies requiring surgery, and appreciable early-childhood mortality. Burden lessens after infancy: hypotonia improves with age and long-term survival into the fifth and sixth decades is documented.
Show evidence (1 reference)
PMID:19938245 SUPPORT Human Clinical
"FG syndrome can be life threatening. In these 10 families, early deaths and multiple miscarriages were common"
Documents the high early clinical burden and mortality risk in molecularly confirmed FGS1 families.
🔀

Differential Diagnoses

4

Conditions with similar clinical presentations that must be differentiated from FG Syndrome 1:

Lujan-Fryns syndrome
Overlapping Features An allelic MED12 disorder, classically caused by p.Asn1007Ser, sharing cognitive impairment, hypotonia, and corpus callosum abnormality with FGS1 but distinguished by a tall thin body habitus, long thin face, prominent nasal bridge, high narrow palate, and short philtrum rather than the FGS1 facial gestalt and anorectal malformations.
Distinguishing Features
  • Marfanoid tall thin body habitus and long thin face rather than the FGS1 gestalt
  • Short philtrum and high narrow palate
  • Absence of the FGS1 anorectal malformations and broad thumbs/halluces
  • Different MED12 missense variant (classically p.Asn1007Ser)
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"LS is further characterized by large head, tall thin body habitus, long thin face, prominent nasal bridge, high narrow palate, and short philtrum."
GeneReviews enumerates the features that distinguish Lujan syndrome from FGS1 within the MED12 spectrum.
X-linked Ohdo syndrome (Maat-Kievit-Brunner type)
Overlapping Features A further allelic MED12 disorder characterized by intellectual disability, blepharophimosis, and facial coarsening at an older age, distinguishing it from the FGS1 gestalt.
Distinguishing Features
  • Blepharophimosis
  • Progressive facial coarsening with age
  • Absence of the FGS1 tall forehead, frontal upsweep, and small simple ears
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"XLOS is characterized by intellectual disability, blepharophimosis, and facial coarsening."
GeneReviews gives the discriminating features of X-linked Ohdo syndrome within the MED12 spectrum.
Hardikar syndrome
Overlapping Features Caused by de novo MED12 protein-truncating variants in females, presenting with cleft lip/palate, biliary and liver anomalies, intestinal malrotation, pigmentary retinopathy, and coarctation of the aorta, and notably without intellectual disability. It is the female-restricted end of the MED12 spectrum and shares essentially no clinical overlap with FGS1.
Distinguishing Features
  • Occurs in females rather than hemizygous males
  • Intellectual disability is absent
  • Hepatobiliary anomalies, intestinal malrotation, and pigmentary retinopathy
  • Caused by de novo protein-truncating rather than missense MED12 variants
Show evidence (1 reference)
PMID:20301719 SUPPORT Human Clinical
"HS has been described in females with cleft lip and/or cleft palate, biliary and liver anomalies, intestinal malrotation, pigmentary retinopathy, and coarctation of the aorta. Developmental and cognitive concerns have not been reported in females with HS."
GeneReviews gives the discriminating clinical profile of Hardikar syndrome.
MED12-negative FG syndrome phenotypes
Overlapping Features The large majority of individuals historically given a clinical FG syndrome diagnosis do not carry a MED12 variant. Systematic re-evaluation of 30 such patients identified the recurrent variant in only the single individual with the typical phenotype, and a definite or possible alternative diagnosis was found in 10 of the remaining 29. Variants in FLNA, UPF3B, and BRWD3 account for some families previously mapped to "FG syndrome" loci.
Distinguishing Features
  • No MED12 variant identified on full gene sequencing
  • A broader, less specific picture of hypotonia, constipation, and relative macrocephaly
  • Absence of the full FGS1 facial gestalt and congenital anomaly burden
  • Alternative X-linked causes including FLNA, UPF3B, and BRWD3
Show evidence (2 references)
PMID:18805826 SUPPORT Human Clinical
"The R961W mutation was identified in the only patient who had the typical phenotype previously associated with this mutation. The remaining 29 patients displayed a wide variety of features and were shown to be negative for mutations in the entire MED12 gene. A definite or possible alternative..."
Directly quantifies how rarely a clinical FG syndrome diagnosis is molecularly confirmed and how often an alternative diagnosis emerges.
PMID:24123922 SUPPORT Human Clinical
"The existence of genetic heterogeneity was further supported by the identification of mutations in three X-linked genes, FLNA, BRWD3 and UPF3B"
Names the alternative X-linked genes accounting for part of the historical FG syndrome heterogeneity.
{ }

Source YAML

click to show 
name: FG Syndrome 1
creation_date: "2026-07-31T00:35:00Z"
category: Mendelian
description: >-
  FG syndrome 1 (FGS1, Opitz-Kaveggia syndrome) is a rare X-linked multiple congenital
  anomaly-intellectual disability syndrome caused by the recurrent MED12 c.2881C>T
  (p.Arg961Trp) missense variant at Xq13. The recognizable phenotype comprises
  congenital hypotonia, feeding difficulties and severe constipation, cognitive
  impairment ranging from borderline to severe, agenesis or hypoplasia of the corpus
  callosum, relative or absolute macrocephaly, a distinctive facial gestalt (tall
  prominent forehead, frontal hair upsweep, downslanted palpebral fissures, small
  simple ears), anal anomalies, congenital heart defects, broad thumbs and halluces,
  and a characteristic friendly, loquacious, eager-to-please personality with
  hyperactivity and short attention span. Mechanistically, MED12 is a subunit of the
  dissociable CDK8 kinase module of the Mediator complex, and p.Arg961Trp causes a
  pathway-selective transcriptional-regulatory defect rather than complete loss of
  MED12 function, disrupting REST/NRSF-dependent neuronal gene silencing,
  GLI3-dependent Sonic hedgehog target transcription, and immediate-early gene
  regulation. The molecularly defined entity must be distinguished from the older,
  purely clinical "FG syndrome" label, which is genetically heterogeneous: fewer than
  3% of individuals given that clinical diagnosis carry the MED12 p.Arg961Trp variant.
disease_term:
  preferred_term: FG syndrome 1
  term:
    id: MONDO:0010590
    label: FG syndrome 1
synonyms:
- FG syndrome type 1
- FGS1
- Opitz-Kaveggia syndrome
- MED12 FG syndrome
parents:
- hereditary disease
- syndromic intellectual disability
classifications:
  harrisons_chapter:
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
  - classification_value: NEUROLOGIC
references:
- reference: PMID:20301719
  title: "MED12-Related Disorders."
  tags:
  - GeneReviews
  findings:
  - statement: >-
      Authoritative GeneReviews chapter covering the MED12-related disorder spectrum
      (FGS1, Lujan syndrome, X-linked Ohdo syndrome, Hardikar syndrome, and
      nonspecific intellectual disability), including the FGS1 clinical
      characteristics baseline, diagnosis/testing approach, management, surveillance,
      and genetic counseling.
- reference: PMID:19938245
  title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
  findings:
  - statement: >-
      Definitive natural-history cohort of all 23 known p.Arg961Trp-positive males
      from 10 families, with quantitative phenotype denominators and a clinical
      algorithm for targeted MED12 testing (100% sensitivity, 90% specificity).
- reference: PMID:17334363
  title: "A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome."
  findings:
  - statement: >-
      Discovery paper establishing MED12 c.2881C>T (p.Arg961Trp) as the cause of FGS1,
      including in the original Opitz-Kaveggia family.
inheritance:
- name: X-linked recessive inheritance
  description: >-
    FGS1 is inherited in an X-linked manner. Affected individuals are hemizygous males;
    heterozygous carrier females in the reported FGS1 families are clinically and
    intellectually unaffected, so the pattern behaves as X-linked recessive. No de novo
    cases with a confirmed MED12 p.Arg961Trp variant have been documented in the core
    cohort; transmission is through obligate carrier mothers.
  inheritance_term:
    preferred_term: X-linked recessive inheritance
    term:
      id: HP:0001419
      label: X-linked recessive inheritance
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Carrier females in families with FGS1 and LS are typically unaffected.
    explanation: >-
      GeneReviews states that heterozygous carrier females in FGS1 families are
      typically unaffected, consistent with X-linked recessive expression.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      There are no mentally retarded females in these 10 families. All mothers in our
      series are intellectually normal and all are heterozygous for the p.R961W
      mutation in MED12.
    explanation: >-
      Direct cohort observation that obligate heterozygous mothers are intellectually
      normal, supporting recessive X-linked expression in this disorder.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      There have been no de novo patients with a confirmed MED12 mutation.
    explanation: >-
      Supports the statement that all molecularly confirmed FGS1 cases in the core
      cohort were maternally transmitted rather than de novo.
prevalence:
- population: Molecularly confirmed cases reported in the literature
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    No population prevalence or incidence estimate exists for molecularly confirmed
    FGS1. The definitive series comprised 23 p.Arg961Trp-positive males from 10
    families. Population-level figures for the historical clinical "FG syndrome" label
    should not be applied to this MED12-defined entity.
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We ascertained 23 males with the p.R961W mutation in MED12 from 9 previously
      reported FG syndrome families and 1 new family.
    explanation: >-
      Establishes the size of the entire known molecularly confirmed FGS1 cohort at
      the time of the definitive phenotype review, supporting an ultra-rare
      classification based on literature case counts.
clinical_burden:
  burden_level: HIGH
  rationale: >-
    Lifelong intellectual disability with communication impairment and dependence in
    daily living, chronic bowel dysfunction, structural congenital anomalies requiring
    surgery, and appreciable early-childhood mortality. Burden lessens after infancy:
    hypotonia improves with age and long-term survival into the fifth and sixth decades
    is documented.
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      FG syndrome can be life threatening. In these 10 families, early deaths and
      multiple miscarriages were common
    explanation: >-
      Documents the high early clinical burden and mortality risk in molecularly
      confirmed FGS1 families.
progression:
- phase: Neonatal and infantile presentation
  age_range: birth to 1 year
  notes: >-
    FGS1 presents at birth or in early infancy with congenital hypotonia, feeding
    difficulties, and constipation, together with structural anomalies (anorectal
    malformations, congenital heart defects, corpus callosum agenesis/hypoplasia) that
    may be recognized neonatally. Mortality is concentrated in this window; one or more
    affected males died in childhood in 8 of the 10 reported families.
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Although the 10 families reported here produced 30 live-born affected male
      patients, 1 or more affected individuals died in childhood in 8 of these 10
      families.
    explanation: >-
      Establishes that early-childhood mortality is a defining feature of the initial
      phase of the disorder.
- phase: Childhood
  age_range: 1 to 12 years
  notes: >-
    Developmental delay, cognitive impairment, and the characteristic behavioral
    profile (friendly, loquacious, hyperactive, short attention span) become evident.
    Facial gestalt is most readily recognized in early childhood. After the first year
    of life mortality is not markedly increased.
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, after the first year of life, mortality does not seem to be
      significantly increased. Hypotonia improves or resolves with age.
    explanation: >-
      Supports both the improved survival and the improvement of hypotonia beyond
      infancy.
- phase: Adolescence and adulthood
  age_range: 13 years and older
  notes: >-
    Hypotonia improves or resolves, but intellectual, speech, and adaptive limitations
    persist. Behavior may shift toward episodic aggressive, self-injurious, or
    obsessive-compulsive patterns emerging around puberty and early adulthood, with
    anxiety around transitions. Survival into the fifth and sixth decades is documented.
  evidence:
  - reference: PMID:20981778
    reference_title: "Behavioral features in young adults with FG syndrome (Opitz-Kaveggia syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These individuals had episodic and longstanding behavior patterns, sometimes
      aggressive or self-abusing, that occurred more frequently in puberty and early
      adulthood.
    explanation: >-
      Documents the adolescent/adult behavioral trajectory in p.Arg961Trp-confirmed
      males.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Three of these male patients are doing well in their 5th and 6th decades.
    explanation: >-
      Documents long-term adult survival and function in molecularly confirmed FGS1.
pathophysiology:
- name: MED12 p.Arg961Trp Alters CDK8 Kinase Module Function
  biological_scale: MOLECULAR
  description: >-
    MED12 is a subunit of the dissociable CDK8 kinase module (MED12, MED13, cyclin C,
    CDK8) that reversibly associates with core Mediator and acts as the hub through
    which DNA-bound transcription factors communicate with RNA polymerase II. The
    recurrent germline hemizygous c.2881C>T (p.Arg961Trp) missense substitution does
    not abolish MED12 function globally; the evidence favors a pathway-selective
    altered-function defect that impairs recruitment of, or response to, particular
    regulatory complexes while sparing others. This distinguishes FGS1 from complete
    MED12 loss of function, which has broader and developmentally more severe
    consequences.
  mechanism_confidence: ESTABLISHED
  gene:
    preferred_term: MED12
    term:
      id: hgnc:11957
      label: MED12
  protein_complexes:
  - preferred_term: Mediator CDK8 kinase module
    term:
      id: GO:1990508
      label: CKM complex
  molecular_functions:
  - preferred_term: transcription corepressor activity
    term:
      id: GO:0003714
      label: transcription corepressor activity
  biological_processes:
  - preferred_term: regulation of transcription by RNA polymerase II
    term:
      id: GO:0006357
      label: regulation of transcription by RNA polymerase II
  evidence:
  - reference: PMID:17334363
    reference_title: "A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report here that the original family for whom the condition is named and five
      other families have a recurrent mutation (2881C>T, leading to R961W) in MED12
      (also called TRAP230 or HOPA), a gene located at Xq13 that functions as a thyroid
      receptor-associated protein in the Mediator complex.
    explanation: >-
      Establishes the causal recurrent variant and localizes the defect to a Mediator
      complex subunit.
  - reference: PMID:33925166
    reference_title: "MED12-Related (Neuro)Developmental Disorders: A Question of Causality."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The kinase module consists of MED12, MED13, Cyclin C (CCNC), and cyclin-dependent
      kinase 8 (CDK8), and the paralogs MED12L, MED13L, and CDK19.
    explanation: >-
      Places MED12 within the dissociable Mediator kinase module, defining the
      molecular context of the lesion.
  - reference: PMID:33925166
    reference_title: "MED12-Related (Neuro)Developmental Disorders: A Question of Causality."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      MED12 interacts with DNA-bound transcription factors and hence acts as a hub for
      the communication of transcription factors with the kinase subunit and core
      Mediator
    explanation: >-
      Explains why a single MED12 missense change can selectively perturb the
      transcription-factor-specific arms of Mediator signalling.
  - reference: PMID:20630950
    reference_title: "Med12 is essential for early mouse development and for canonical Wnt and Wnt/PCP signaling."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      These mutants fail to develop beyond embryonic day 10 and have severe defects in
      neural tube closure, axis elongation, somitogenesis and heart formation.
    explanation: >-
      Supplies the contrast that makes "altered function, not loss of function" an
      argument rather than an assertion: mouse Med12 hypomorphs with drastically
      reduced protein are lethal by E10, whereas p.Arg961Trp is compatible with
      survival into the sixth decade. PARTIAL because this models near-null deficiency
      in mouse and not the human missense allele, so it bounds the severity of MED12
      loss without characterising the FGS1 variant itself.
  downstream:
  - target: Impaired REST-Dependent Silencing of Neuronal Genes
    causal_link_type: DIRECT
    description: >-
      The MED12 interface within Mediator is the physical link between REST/NRSF and
      G9a-dependent repressive chromatin marking; the FGS1 missense change disrupts
      that corepressor function.
  - target: Derepression of GLI3-Dependent Sonic Hedgehog Target Transcription
    causal_link_type: DIRECT
    description: >-
      MED12 normally restrains GLI3-dependent SHH target-gene transcription; the FGS1
      variant fails to restore that suppression and shows reduced CDK8 recruitment at
      GLI3 target sites.
  - target: Dysregulated Immediate-Early Gene Response
    causal_link_type: DIRECT
    description: >-
      Each MED12 patient variant, including p.Arg961Trp, produces its own
      immediate-early gene expression signature tracking MED12/Pol II promoter
      occupancy.
- name: Impaired REST-Dependent Silencing of Neuronal Genes
  biological_scale: MOLECULAR
  description: >-
    Mediator, the G9a histone methyltransferase, and the RE1 silencing transcription
    factor (REST/NRSF) form a protein interaction network that keeps neuronal genes
    silenced in non-neuronal cells, with the MED12 interface linking REST to
    G9a-dependent histone H3K9 dimethylation. Missense MED12 changes causing FG and
    Lujan syndromes disrupt this REST corepressor function, so neuronal genes escape
    scheduled repression. Rescue experiments indicate that p.Arg961Trp specifically
    fails to restore REST-mediated silencing while retaining beta-catenin rescue
    capacity, marking this as a pathway-selective, kinase-independent defect.
  mechanism_confidence: ESTABLISHED
  biological_processes:
  - preferred_term: negative regulation of transcription by RNA polymerase II
    term:
      id: GO:0000122
      label: negative regulation of transcription by RNA polymerase II
  - preferred_term: chromatin organization
    term:
      id: GO:0006325
      label: chromatin organization
  cell_types:
  - preferred_term: neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  evidence:
  - reference: PMID:18691967
    reference_title: "Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We show that the MED12 interface in Mediator links REST with G9a-dependent
      histone H3K9 dimethylation to suppress neuronal genes in nonneuronal cells.
      Notably, missense mutations in MED12 causing the X-linked mental retardation
      (XLMR) disorders FG syndrome and Lujan syndrome disrupt its REST corepressor
      function.
    explanation: >-
      Directly demonstrates that the FG syndrome MED12 missense change abolishes the
      REST corepressor activity of the MED12 interface.
  - reference: PMID:18691967
    reference_title: "Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      These findings implicate Mediator in epigenetic restriction of neuronal gene
      expression to the nervous system and suggest a pathologic basis for
      MED12-associated XLMR involving impaired REST-dependent neuronal gene regulation.
    explanation: >-
      States the proposed pathogenic mechanism linking impaired REST-dependent
      regulation to MED12-associated intellectual disability.
  downstream:
  - target: Impaired Neuronal Differentiation and Cortical Development
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      REST/NRSF silences neuronal genes in non-neuronal and progenitor cells, so
      unscheduled derepression is proposed to disturb the timing of neuronal
      differentiation directly; the link has not been demonstrated in affected
      human fetal tissue.
  - target: Failure of Corpus Callosum Formation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Callosal projection neurons must differentiate on schedule before their
      axons can cross the midline, so mistimed REST-dependent derepression is
      proposed to act on callosal formation via the neuronal-differentiation
      defect above rather than independently of it; not demonstrated in affected
      human fetal tissue.
- name: Derepression of GLI3-Dependent Sonic Hedgehog Target Transcription
  biological_scale: MOLECULAR
  description: >-
    Activated GLI3 physically targets the MED12 interface within Mediator to reverse
    Mediator-dependent suppression of Sonic hedgehog target-gene transcription,
    placing MED12 as a direct restraint on the pathway. In patient-derived
    lymphoblastoid lines carrying MED12 XLID variants, transcripts of the
    GLI3-dependent SHH targets CREB5, BMP4, and NEUROG2 are significantly elevated,
    and p.Arg961Trp fails to restore normal SHH inhibition while showing reduced CDK8
    recruitment at GLI3 sites. Because SHH-GLI signalling patterns the forebrain,
    craniofacial skeleton, limb, gut, and heart, this arm offers a plausible unifying
    explanation for the multi-system malformation pattern of FGS1.
  mechanism_confidence: ESTABLISHED
  biological_processes:
  - preferred_term: smoothened signaling pathway
    term:
      id: GO:0007224
      label: smoothened signaling pathway
  - preferred_term: regulation of transcription by RNA polymerase II
    term:
      id: GO:0006357
      label: regulation of transcription by RNA polymerase II
  evidence:
  - reference: PMID:23091001
    reference_title: "MED12 mutations link intellectual disability syndromes with dysregulated GLI3-dependent Sonic Hedgehog signaling."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      In FG/R961W and Lujan/N1007S patient-derived cells, we document enhanced SHH
      pathway activation and GLI3-target gene induction coincident with impaired
      recruitment of CDK8 onto promoters of GLI3-target genes, but not non-GLI3-target
      genes.
    explanation: >-
      The variant-specific demonstration of this arm: derepression is shown in cells
      carrying p.Arg961Trp itself, and is promoter-selective rather than a global
      transcriptional collapse.
  - reference: PMID:23091001
    reference_title: "MED12 mutations link intellectual disability syndromes with dysregulated GLI3-dependent Sonic Hedgehog signaling."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      MED12 mutations R961W and N1007S causing FG and Lujan syndromes, respectively,
      disrupt a Mediator-imposed constraint on GLI3-dependent Sonic Hedgehog (SHH)
      signaling.
    explanation: >-
      Names the FGS1 allele explicitly and identifies the disrupted constraint,
      establishing the mechanism for this disease rather than for MED12 generally.
  - reference: PMID:17000779
    reference_title: "Mediator modulates Gli3-dependent Sonic hedgehog signaling."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We propose that activated Gli3 physically targets the MED12 interface within
      Mediator in order to functionally reverse Mediator-dependent suppression of Shh
      target gene transcription.
    explanation: >-
      Establishes MED12 as a direct modulator of GLI3-dependent hedgehog target
      transcription. PARTIAL because this work characterises the MED12-GLI3 interface
      in general and does not study the FGS1 p.Arg961Trp allele; it supplies the
      background mechanism, not the disease-specific finding.
  - reference: PMID:30729724
    reference_title: "Dysregulations of sonic hedgehog signaling in MED12-related X-linked intellectual disability disorders."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Transcript levels of three Gli3-dependent SHH-signaling genes, CREB5, BMP4, and
      NEUROG2, were determined by quantitative RT-PCR and found to be significantly
      elevated in lymphoblasts from patients with three mutations in the MED12-LS
      domain.
    explanation: >-
      Independently replicates GLI3-target derepression in patient lymphoblasts.
      PARTIAL for the FGS1-specific claim: the three MED12-LS-domain variants studied
      here are p.Asn898Asp, p.Arg1214Cys and p.Arg1295His, not the FGS1 allele
      p.Arg961Trp. It corroborates the arm across the LS domain rather than
      demonstrating it for this disease.
  - reference: PMID:30729724
    reference_title: "Dysregulations of sonic hedgehog signaling in MED12-related X-linked intellectual disability disorders."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      These results support a critical role of MED12 in regulating Gli3-dependent SHH
      signaling and in developing ID and related congenital malformations in XLID
      syndromes.
    explanation: >-
      Links MED12-dependent SHH dysregulation to both the intellectual disability and
      the congenital malformations of the MED12 XLID disorders. PARTIAL for the same
      reason as the preceding item: the conclusion is drawn across LS-domain variants
      other than p.Arg961Trp, and the step from lymphoblast transcript levels to
      embryonic malformation is inferred rather than shown.
  downstream:
  - target: Failure of Corpus Callosum Formation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      GLI3 dose sets dorsoventral forebrain and midline patterning, and callosal
      agenesis is a recognised feature of GLI3-related disorders, making this the
      most plausible of the three arms for the callosal defect; not demonstrated
      directly in affected human tissue.
  - target: Impaired Neuronal Differentiation and Cortical Development
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      SHH-GLI3 signalling regulates cortical progenitor proliferation and the
      neurogenic-to-gliogenic transition, so altered GLI3-dependent output is a
      plausible route to disturbed neuronal differentiation; not demonstrated
      directly in affected human tissue.
  - target: Anorectal Malformation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      SHH-GLI3 signalling patterns hindgut and cloacal septation, and anorectal
      malformation is part of the Gli3-mutant and SHH-pathway phenotype, making
      this arm the plausible route to the anorectal defect; not demonstrated
      directly in affected human tissue.
  - target: Cardiac Septation Defect
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Hedgehog signalling in second-heart-field and atrial septal progenitors is
      required for normal septation, so altered GLI3-dependent output is a
      plausible route to the septal defect; not demonstrated directly in affected
      human tissue.
  - target: Craniofacial and Skeletal Dysmorphogenesis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      GLI3 is the principal SHH effector in frontonasal, palatal and limb
      patterning, and craniofacial and digital anomalies are cardinal features of
      GLI3-related disorders, making this arm the plausible route to the
      dysmorphic features; not demonstrated directly in affected human tissue.
- name: Dysregulated Immediate-Early Gene Response
  biological_scale: CELLULAR
  description: >-
    In EBV-immortalized lymphoblastoid cells from patients, individual MED12 variants
    including p.Arg961Trp generate variant-specific expression patterns of the
    immediate-early genes JUN, FOS, and EGR1, mirrored by the presence or absence of
    the MED12-containing complex and RNA polymerase II at their promoters. The effect
    is cell-type specific, and downstream late-response genes involved in neural
    plasticity and neuronal gene specification are consequently disturbed. This arm
    supports a model in which stimulus-responsive transcription, rather than
    constitutive housekeeping transcription, is the vulnerable process.
  mechanism_confidence: PROVISIONAL
  biological_processes:
  - preferred_term: transcription by RNA polymerase II
    term:
      id: GO:0006366
      label: transcription by RNA polymerase II
  evidence:
  - reference: PMID:28369444
    reference_title: "MED12-related XLID disorders are dose-dependent of immediate early genes (IEGs) expression."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Here, we investigated several MED12 patients mutations (p.R206Q, p.N898D,
      p.R961W, p.N1007S, p.R1148H, p.S1165P and p.R1295H) and show that each MED12
      mutations cause specific expression patterns of JUN, FOS and EGR1 immediate early
      genes (IEGs), reflected by the presence or absence of MED12 containing complex at
      their respective promoters.
    explanation: >-
      Demonstrates that p.Arg961Trp, among other MED12 variants, produces a distinct
      immediate-early gene signature tied to MED12 promoter occupancy.
  - reference: PMID:28369444
    reference_title: "MED12-related XLID disorders are dose-dependent of immediate early genes (IEGs) expression."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Our results suggest that the differences between MED12-related phenotypes are
      essentially the result of distinct IEGs expression patterns
    explanation: >-
      Proposes variant-specific immediate-early gene dysregulation as the basis for
      the distinct clinical syndromes within the MED12 allelic series.
  downstream:
  - target: Impaired Neuronal Differentiation and Cortical Development
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Immediate-early gene programmes couple extracellular cues to the
      activity-dependent transcription that neuronal differentiation and circuit
      maturation depend on, so variant-specific IEG dysregulation is proposed to
      impair that step; the evidence base is lymphoblastoid rather than
      tissue-resident, so the neural relevance is inferred.
  - target: Failure of Corpus Callosum Formation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Midline axon guidance and callosal targeting are activity- and
      stimulus-responsive, so disturbed IEG programmes are proposed to reach the
      callosal defect through the neuronal-differentiation step above; the
      evidence base is lymphoblastoid rather than tissue-resident.
- name: Failure of Corpus Callosum Formation
  biological_scale: TISSUE
  description: >-
    Agenesis or hypoplasia of the corpus callosum was present in all 13 individuals of
    the molecularly confirmed cohort who underwent neuroimaging, making it the single
    most characteristic structural consequence of the MED12 lesion. The developmental
    step that fails is midline commissural axon guidance and callosal tract formation.
    The link from the upstream transcriptional arms to this specific structure is
    biologically coherent but has not been demonstrated in affected human fetal brain.
  mechanism_confidence: PROVISIONAL
  biological_processes:
  - preferred_term: corpus callosum development
    term:
      id: GO:0022038
      label: corpus callosum development
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The most characteristic anomalies were agenesis or hypoplasia of the corpus
      callosum (13 of 13)
    explanation: >-
      Establishes callosal agenesis/hypoplasia as the dominant structural finding,
      with its own denominator (13 of 13 imaged individuals).

- name: Impaired Neuronal Differentiation and Cortical Development
  biological_scale: CELLULAR
  description: >-
    Loss of scheduled neuronal gene regulation is proposed to perturb neuronal
    differentiation and cortical development, yielding the universal cognitive
    impairment and the congenital hypotonia of FGS1. This node carries the cellular
    consequence; the evidence for the underlying regulatory defect is lymphoblastoid
    and engineered-rescue rather than neural, which is the subject of the
    HUMAN_MODEL_MISMATCH discussion.
  mechanism_confidence: PROVISIONAL
  biological_processes:
  - preferred_term: neuron differentiation
    term:
      id: GO:0030182
      label: neuron differentiation
  cell_types:
  - preferred_term: neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  evidence:
  - reference: PMID:30729724
    reference_title: "Dysregulations of sonic hedgehog signaling in MED12-related X-linked intellectual disability disorders."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      These results support a critical role of MED12 in regulating Gli3-dependent SHH
      signaling and in developing ID and related congenital malformations in XLID
      syndromes.
    explanation: >-
      Links the MED12-dependent transcriptional defect to intellectual disability, the
      organism-level readout of impaired neuronal differentiation.
  - reference: PMID:18691967
    reference_title: "Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      These findings implicate Mediator in epigenetic restriction of neuronal gene
      expression to the nervous system and suggest a pathologic basis for
      MED12-associated XLMR involving impaired REST-dependent neuronal gene regulation.
    explanation: >-
      States the proposed route from impaired REST-dependent neuronal gene regulation
      to the neurodevelopmental phenotype.

- name: Anorectal Malformation
  biological_scale: TISSUE
  description: >-
    Anal fistula, stenosis, and atresia occurred in 11 of 19 evaluable molecularly
    confirmed males. Hindgut and anorectal septation is a classic
    hedgehog-patterning-dependent process, which is why the GLI3 arm is the most
    plausible upstream route; enteric neuron development is placed here rather than on
    a pan-organ node because the severe constipation of FGS1 persists even without a
    structural anorectal defect.
  mechanism_confidence: PROVISIONAL
  cell_types:
  - preferred_term: enteric neuron
    term:
      id: CL:0007011
      label: enteric neuron
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      anal fistula, stenosis and atresia (11 of 19)
    explanation: >-
      Gives the anorectal malformation its own denominator (11 of 19 evaluable
      individuals), distinct from the callosal and cardiac findings.

- name: Cardiac Septation Defect
  biological_scale: TISSUE
  description: >-
    Congenital cardiac anomalies, including septal defects, were documented in 11 of 18
    evaluable molecularly confirmed males. This is the rationale for baseline
    echocardiography at diagnosis.
  mechanism_confidence: PROVISIONAL
  biological_processes:
  - preferred_term: ventricular septum development
    term:
      id: GO:0003281
      label: ventricular septum development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      congenital cardiac anomalies (11 of 18)
    explanation: >-
      Gives the cardiac malformation its own denominator (11 of 18 evaluable
      individuals).

- name: Craniofacial and Skeletal Dysmorphogenesis
  biological_scale: TISSUE
  description: >-
    The recognizable facial gestalt was present in all 13 fully evaluated
    mutation-positive males, accompanied by broad thumbs and halluces, syndactyly,
    pectus deformity, vertebral and rib anomalies, joint contractures, and hip
    dysplasia. Craniofacial and limb patterning are hedgehog-dependent, making the
    GLI3 arm the most plausible upstream route.
  mechanism_confidence: PROVISIONAL
  biological_processes:
  - preferred_term: neural crest cell differentiation
    term:
      id: GO:0014033
      label: neural crest cell differentiation
    modifier: ABNORMAL
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These features were seen most often in affected male patients: characteristic
      facies (13 of 13)
    explanation: >-
      Establishes the craniofacial gestalt as a near-universal finding in the
      confirmed cohort.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      skeletal anomalies including joint contractures, hip dysplasia, pectus
      deformities, vertebral and rib anomalies, syndactyly or oligodactyly of the
      fingers, and ocular anomalies were frequent.
    explanation: >-
      Enumerates the skeletal component of this node; no per-feature denominator is
      given, which is why the corresponding phenotype rows carry no frequency band.

phenotypes:
- category: Neurologic
  name: Intellectual disability
  frequency: OBLIGATE
  description: >-
    All molecularly confirmed males have cognitive impairment, but severity is
    variable from borderline to severe; most have IQ scores below 70. Even the least
    affected proband functions below his unaffected family members.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The degree of intellectual disability is variable from borderline to severe. All
      these individuals have cognitive disability. In most patients, IQ scores were
      below 70 or equivalent.
    explanation: >-
      Directly supports the presence of cognitive impairment in every member of the
      confirmed cohort, and its variable severity.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      there have been no convincing reports of FG syndrome in either heterozygous
      female carriers or in male patients whose intelligence is similar to their
      unaffected relatives
    explanation: >-
      This is the basis for OBLIGATE rather than VERY_FREQUENT, and it is a different
      argument from the counted-denominator one used elsewhere in this entry. Every
      other phenotype here with a 100% denominator is deliberately banded
      VERY_FREQUENT because n=13 of a 23-male cohort does not license an assertion of
      invariance. Intellectual disability departs from that rule because the claim
      does not rest on the count: no affected male without cognitive impairment has
      been reported at all, and cognitive impairment is an inclusion criterion for the
      diagnosis, so the phenotype is definitionally rather than statistically
      obligate.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All 13 patients are males with some degree of cognitive impairment
    explanation: >-
      Confirms cognitive impairment in every fully assessed mutation-positive male.
      Corroborative only: as with every other 100%-denominator phenotype in this
      entry, n=13 would not on its own license OBLIGATE. The band rests on the
      definitional argument in the preceding evidence item, not on this count.
- category: Neurologic
  name: Congenital hypotonia
  frequency: VERY_FREQUENT
  description: >-
    Congenital/infantile hypotonia is a hallmark presenting feature, part of the
    infantile triad (hypotonia, feeding difficulties, constipation) present in all 13
    fully evaluated mutation-positive males. Hypotonia improves or resolves with age.
  phenotype_term:
    preferred_term: Neonatal hypotonia
    term:
      id: HP:0001319
      label: Neonatal hypotonia
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Congenital hypotonia and poor gastrointestinal function, including feeding
      difficulties that required medical or occupational/ physical therapy, poor oral
      motor function, decreased gastric motility, reflux, and chronic constipation,
      are characteristic of FG syndrome and were present in all affected individuals.
    explanation: >-
      States directly that congenital hypotonia was present in all affected
      individuals in the molecularly confirmed cohort, supporting VERY_FREQUENT for
      hypotonia specifically rather than for a composite triad.
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      FGS1 and LS share the clinical findings of cognitive impairment, hypotonia, and
      abnormalities of the corpus callosum.
    explanation: >-
      GeneReviews lists hypotonia among the core FGS1 clinical findings.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hypotonia improves or resolves with age.
    explanation: >-
      Supports the natural history statement that hypotonia is not progressive.
- category: Gastrointestinal
  name: Chronic constipation
  frequency: VERY_FREQUENT
  description: >-
    Severe, chronic constipation is one of the defining features of FGS1, present with
    or without a structural anorectal malformation, and part of the infantile triad
    used in the diagnostic algorithm.
  phenotype_term:
    preferred_term: Chronic constipation
    term:
      id: HP:0012450
      label: Chronic constipation
    temporality: CHRONIC
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      FGS1 is further characterized by absolute or relative macrocephaly, tall
      forehead, downslanted palpebral fissures, small and simple ears, constipation
      and/or anal anomalies, broad thumbs and halluces, and characteristic behavior.
    explanation: >-
      GeneReviews lists constipation and/or anal anomalies as a defining FGS1 feature.
  - reference: PMID:18805826
    reference_title: "Clinical experience in the evaluation of 30 patients with a prior diagnosis of FG syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      FG syndrome (FGS) is an X-linked disorder characterised by mental retardation,
      hypotonia, particular dysmorphic facial features, broad thumbs and halluces, anal
      anomalies, constipation, and abnormalities of the corpus callosum.
    explanation: >-
      Lists constipation among the core FGS features. Scored PARTIAL because this
      sentence defines the historical pre-molecular label in a paper that then shows
      29 of 30 such patients are MED12-negative, so it is only indirect support for
      the molecularly defined entity.
- category: Gastrointestinal
  name: Feeding difficulties
  frequency: VERY_FREQUENT
  description: >-
    Infantile feeding difficulty is part of the presenting triad, was present in all
    affected individuals in the molecularly confirmed cohort, and may require
    nasogastric or gastrostomy feeding. It accompanies poor oral motor function,
    decreased gastric motility, and reflux.
  phenotype_term:
    preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Congenital hypotonia and poor gastrointestinal function, including feeding
      difficulties that required medical or occupational/ physical therapy, poor oral
      motor function, decreased gastric motility, reflux, and chronic constipation,
      are characteristic of FG syndrome and were present in all affected individuals.
    explanation: >-
      States directly that feeding difficulties requiring intervention were present in
      all affected individuals, supporting a VERY_FREQUENT band for the trait itself.
- category: Gastrointestinal
  name: Gastroesophageal reflux
  description: >-
    Gastroesophageal reflux is named alongside decreased gastric motility and chronic
    constipation within the poor gastrointestinal function present in all molecularly
    confirmed affected individuals. No per-feature denominator is given for reflux
    alone, so no frequency band is asserted.
  phenotype_term:
    preferred_term: Gastroesophageal reflux
    term:
      id: HP:0002020
      label: Gastroesophageal reflux
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      decreased gastric motility, reflux, and chronic constipation
    explanation: >-
      Names reflux as a component of the gastrointestinal dysfunction characteristic
      of molecularly confirmed FGS1. The surrounding sentence asserts that the
      combined gastrointestinal picture was present in all affected individuals, but
      does not give a reflux-specific count, so no band is asserted.
- category: Neurologic
  name: Agenesis or hypoplasia of the corpus callosum
  frequency: VERY_FREQUENT
  description: >-
    Agenesis or hypoplasia of the corpus callosum was present in all 13 individuals in
    the confirmed cohort who underwent neuroimaging. Note that the denominator is
    restricted to those imaged.
  phenotype_term:
    preferred_term: Agenesis or hypoplasia of the corpus callosum
    term:
      id: HP:0007370
      label: Aplasia/Hypoplasia of the corpus callosum
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The most characteristic anomalies were agenesis or hypoplasia of the corpus
      callosum (13 of 13)
    explanation: >-
      Direct quantitative support. The reported proportion is 13/13 (100%), which
      would map to OBLIGATE under the default convention; VERY_FREQUENT is used
      instead as a deliberate departure, because the denominator is the 13-member
      imaged subset of a 23-male cohort and n=13 does not license an assertion of
      invariance across all affected individuals.
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      FGS1 and LS share the clinical findings of cognitive impairment, hypotonia, and
      abnormalities of the corpus callosum.
    explanation: >-
      GeneReviews confirms corpus callosum abnormality as a core FGS1 finding.
- category: Gastrointestinal
  name: Anal anomalies
  frequency: FREQUENT
  description: >-
    Anal fistula, anal stenosis, and anal atresia (imperforate anus) together occurred
    in 11 of 19 evaluable molecularly confirmed males. Imperforate anus was one of the
    defining features in the original 1974 Opitz-Kaveggia family.
  phenotype_term:
    preferred_term: Abnormality of the anus
    term:
      id: HP:0004378
      label: Abnormality of the anus
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      anal fistula, stenosis and atresia (11 of 19)
    explanation: >-
      Direct quantitative support for a FREQUENT band (11/19 = 58%).
- category: Gastrointestinal
  name: Anal atresia
  description: >-
    Imperforate anus was one of the cardinal malformations in the original
    Opitz-Kaveggia description and remains part of the FGS1 anorectal spectrum.
  phenotype_term:
    preferred_term: Anal atresia
    term:
      id: HP:0002023
      label: Anal atresia
  evidence:
  - reference: PMID:18973276
    reference_title: "Behavior of 10 patients with FG syndrome (Opitz-Kaveggia syndrome) and the p.R961W mutation in the MED12 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      reported on a family of five affected males with distinctive facial appearance,
      mental retardation, macrocephaly, imperforate anus and hypotonia.
    explanation: >-
      Documents imperforate anus (anal atresia) as a cardinal feature in the founding
      Opitz-Kaveggia family, in which the p.Arg961Trp variant was later confirmed.
- category: Gastrointestinal
  name: Anal stenosis
  description: >-
    Anal stenosis is part of the anorectal malformation spectrum contributing to the
    severe constipation phenotype.
  phenotype_term:
    preferred_term: Anal stenosis
    term:
      id: HP:0002025
      label: Anal stenosis
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      anal fistula, stenosis and atresia (11 of 19)
    explanation: >-
      Anal stenosis is explicitly named within the quantified anorectal anomaly group.
- category: Cardiovascular
  name: Congenital heart defect
  frequency: FREQUENT
  description: >-
    Congenital cardiac anomalies were documented in 11 of 18 evaluable molecularly
    confirmed males, supporting baseline echocardiography in any newly diagnosed
    individual.
  phenotype_term:
    preferred_term: Abnormal heart morphology
    term:
      id: HP:0001627
      label: Abnormal heart morphology
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      congenital cardiac anomalies (11 of 18)
    explanation: >-
      Direct quantitative support for a FREQUENT band (11/18 = 61%).
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      routine management of seizures, strabismus and other ocular anomalies,
      imperforate anus, chronic constipation, joint contractures, genitourinary
      anomalies, congenital heart defects, hearing loss, palate anomalies, and dental
      anomalies
    explanation: >-
      GeneReviews management section confirms congenital heart defects as a
      manifestation requiring routine management in MED12-related disorders.
- category: Cardiovascular
  name: Atrial septal defect
  description: >-
    Atrial septal defect is documented as a case-level congenital cardiac finding in
    the molecularly confirmed cohort (including one that resolved by age 4). It is
    retained as a queryable specific lesion under the Congenital heart defect roll-up;
    no frequency band is asserted from case observations alone.
  phenotype_term:
    preferred_term: Atrial septal defect
    term:
      id: HP:0001631
      label: Atrial septal defect
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      An atrial septal defect resolved by the age of 4 years.
    explanation: >-
      Case-level documentation of ASD in a molecularly confirmed male. Supports
      presence, not a frequency band.
- category: Craniofacial
  name: Macrocephaly
  frequency: FREQUENT
  description: >-
    Head size is characteristically large, but absolute macrocephaly (head
    circumference above the 98th percentile) was confirmed in fewer than half of
    affected males (7 of 18), as was relative macrocephaly. In the fully evaluated
    subset, 10 of 13 had macrocephaly (five absolute, five relative).
  phenotype_term:
    preferred_term: Macrocephaly
    term:
      id: HP:0000256
      label: Macrocephaly
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Absolute macrocephaly (head circumference greater than the 98th percentile) was
      confirmed in fewer than half of patients (7 of 18) as was relative macrocephaly
      (head circumference percentile greater than height percentile).
    explanation: >-
      Direct quantitative support for a FREQUENT (not VERY_FREQUENT) band and an
      explicit correction of the historical assumption that macrocephaly is universal.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Ten had macrocephaly (five absolute, five relative).
    explanation: >-
      Provides the fully evaluated subset denominator (10 of 13) for combined absolute
      and relative macrocephaly.
- category: Craniofacial
  name: Relative macrocephaly
  frequency: FREQUENT
  description: >-
    Relative macrocephaly (head circumference percentile exceeding height percentile)
    is as common as absolute macrocephaly and is the form more often encountered in
    the clinic. Like absolute macrocephaly, it was confirmed in fewer than half of
    molecularly confirmed affected males.
  phenotype_term:
    preferred_term: Relative macrocephaly
    term:
      id: HP:0004482
      label: Relative macrocephaly
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      FGS1 is further characterized by absolute or relative macrocephaly
    explanation: >-
      GeneReviews explicitly names relative macrocephaly as a defining FGS1 feature.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Absolute macrocephaly (head circumference greater than the 98th percentile) was
      confirmed in fewer than half of patients (7 of 18) as was relative macrocephaly
      (head circumference percentile greater than height percentile).
    explanation: >-
      Establishes that relative macrocephaly, like absolute, is present in fewer than
      half of mutation-positive males. Read strictly this gives only an upper bound:
      the "(7 of 18)" is parenthetical to absolute macrocephaly, and "as was relative
      macrocephaly" carries over the predicate alone, so this sentence bounds the
      figure below 50% without setting a floor. The FREQUENT band is anchored by the
      count in the following evidence item, not by this sentence. Note also that this
      is the mutation-POSITIVE denominator; the separate "15 of 18 had macrocephaly"
      figure elsewhere in this paper belongs to the Italian mutation-NEGATIVE
      comparison group and must not be applied to FGS1.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Ten had macrocephaly (five absolute, five relative).
    explanation: >-
      The count that anchors the band: 5 of the 13 examined mutation-positive males
      had relative macrocephaly, 38%, within FREQUENT (30-79%). It also corroborates
      the absolute-macrocephaly figure, 5/13 against 7/18, both approximately 38%.
- category: Craniofacial
  name: Characteristic facial gestalt
  frequency: VERY_FREQUENT
  description: >-
    A recognizable facial appearance was present in all 13 fully evaluated
    mutation-positive males and comprises a tall prominent forehead, frontal hair
    upsweep, ocular hypertelorism, downslanted palpebral fissures, and small simple
    ears. The gestalt is most readily recognized in early childhood.
  phenotype_term:
    preferred_term: Characteristic FG syndrome facial gestalt
    term:
      id: HP:0001999
      label: Abnormal facial shape
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These features were seen most often in affected male patients: characteristic
      facies (13 of 13)
    explanation: >-
      Direct quantitative support for the composite facial gestalt. The reported
      proportion is 13/13 (100%), which would map to OBLIGATE under the default
      convention; VERY_FREQUENT is used instead as a deliberate departure, because
      n=13 is a subset of the 23-male cohort and does not license an assertion of
      invariance.
- category: Craniofacial
  name: Dolichocephaly
  description: >-
    A dolichocephalic (long, narrow) head shape is listed among the key elements of
    the molecularly confirmed FGS1 clinical phenotype. No per-feature denominator is
    given, so no frequency band is asserted.
  phenotype_term:
    preferred_term: Dolichocephaly
    term:
      id: HP:0000268
      label: Dolichocephaly
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The key elements of the clinical phenotype are absolute or relative
      macrocephaly with a long narrow face; tall forehead; dolicocephalic head
      shape; an open mouth; small, simple, low-set, prominent ears; and puffy
      eyelids.
    explanation: >-
      Names dolichocephaly (source spelling "dolicocephalic") among the key elements
      of the FGS1 phenotype. Presence claim only; no count.
- category: Craniofacial
  name: Open mouth
  description: >-
    An open-mouth appearance is listed among the key facial elements of molecularly
    confirmed FGS1. No per-feature denominator is given, so no frequency band is
    asserted.
  phenotype_term:
    preferred_term: Open mouth
    term:
      id: HP:0000194
      label: Open mouth
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      an open mouth; small, simple, low-set, prominent ears
    explanation: >-
      Names open mouth among the key facial elements that define the FGS1 gestalt.
      Presence claim only; no count.
- category: Craniofacial
  name: High forehead
  description: >-
    A tall, prominent forehead is a component of the FGS1 facial gestalt and one of
    the features enumerated in the GeneReviews clinical characteristics. No
    per-feature denominator is reported, so no frequency band is asserted.
  phenotype_term:
    preferred_term: High forehead
    term:
      id: HP:0000348
      label: High forehead
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      tall forehead, downslanted palpebral fissures, small and simple ears
    explanation: >-
      GeneReviews enumerates the component facial features, including the tall
      forehead bound here.
- category: Craniofacial
  name: Downslanted palpebral fissures
  description: >-
    Downslanting palpebral fissures are a component of the FGS1 facial gestalt and one
    of the features listed in the GeneReviews clinical characteristics.
  phenotype_term:
    preferred_term: Downslanted palpebral fissures
    term:
      id: HP:0000494
      label: Downslanted palpebral fissures
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      tall forehead, downslanted palpebral fissures, small and simple ears
    explanation: >-
      GeneReviews lists downslanted palpebral fissures among the defining FGS1 facial
      features.
- category: Craniofacial
  name: Frontal upsweep of hair
  description: >-
    An upswept frontal hairline is one of the more distinctive components of the FGS1
    facial gestalt and was even noted in one obligate carrier mother.
  phenotype_term:
    preferred_term: Frontal upsweep of hair
    term:
      id: HP:0002236
      label: Frontal upsweep of hair
  evidence:
  - reference: PMID:24123922
    reference_title: "MED12 related disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Facial characteristics included a prominent forehead, upswept frontal hairline,
      downslanting palpebral fissures, ocular hypertelorism, and small prominent ears
      with a simplified helical pattern.
    explanation: >-
      Expert review enumerates the frontal hair upsweep among the FGS1 facial
      characteristics.
- category: Craniofacial
  name: Ocular hypertelorism
  description: >-
    Ocular hypertelorism is part of the classic FGS1 facial description from the
    original family onward.
  phenotype_term:
    preferred_term: Hypertelorism
    term:
      id: HP:0000316
      label: Hypertelorism
  evidence:
  - reference: PMID:24123922
    reference_title: "MED12 related disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Facial characteristics included a prominent forehead, upswept frontal hairline,
      downslanting palpebral fissures, ocular hypertelorism, and small prominent ears
      with a simplified helical pattern.
    explanation: >-
      Expert review lists ocular hypertelorism among the FGS1 facial characteristics.
- category: Craniofacial
  name: Small ears
  frequency: VERY_FREQUENT
  description: >-
    Ears measuring below the 10th percentile were documented in 12 of 13 fully
    evaluated mutation-positive males, and ear size is one of the six criteria in the
    diagnostic algorithm.
  phenotype_term:
    preferred_term: Small ears
    term:
      id: HP:0400005
      label: Short ear
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Twelve had small ears that measured below the 10th percentile (the other one had
      simple ears).
    explanation: >-
      Direct quantitative support for a VERY_FREQUENT band for small ears specifically
      (12 of 13 = 92%); the thirteenth patient had simple rather than small ears.
- category: Craniofacial
  name: Simple ears
  description: >-
    The helical pattern is simplified. This is a distinct feature from ear size: one
    of the 13 fully evaluated males had simple ears without measured small size, and
    GeneReviews lists "small and simple ears" as two co-occurring descriptors. No
    per-feature denominator is reported for simplification, so no frequency band is
    asserted.
  phenotype_term:
    preferred_term: Simple ear
    term:
      id: HP:0020206
      label: Simple ear
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      tall forehead, downslanted palpebral fissures, small and simple ears
    explanation: >-
      GeneReviews names "small and simple ears" as a defining FGS1 feature.
  - reference: PMID:24123922
    reference_title: "MED12 related disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      small prominent ears with a simplified helical pattern
    explanation: >-
      Describes the simplified helical pattern that this term captures, distinct from
      ear size.
- category: Craniofacial
  name: Low-set ears
  description: >-
    Low-set ear position is listed among the key facial elements of molecularly
    confirmed FGS1 ("small, simple, low-set, prominent ears"). No per-feature
    denominator is given for position alone, so no frequency band is asserted.
  phenotype_term:
    preferred_term: Low-set ears
    term:
      id: HP:0000369
      label: Low-set ears
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      small, simple, low-set, prominent ears
    explanation: >-
      Names low-set position among the key facial elements that define the FGS1
      gestalt. Separated from the Small ears and Simple ears rows so ear position is
      independently queryable; the source does not give a position-specific count.
- category: Craniofacial
  name: Protruding ear
  description: >-
    Prominence of the ears is listed with the other ear descriptors in the key facial
    elements of molecularly confirmed FGS1. No per-feature denominator is given, so
    no frequency band is asserted.
  phenotype_term:
    preferred_term: Protruding ear
    term:
      id: HP:0000411
      label: Protruding ear
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      small, simple, low-set, prominent ears
    explanation: >-
      The source adjective "prominent" maps to the HPO protruding-ear term. Bound
      separately from size and helical simplification so prominence is independently
      queryable.
  - reference: PMID:24123922
    reference_title: "MED12 related disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      small prominent ears with a simplified helical pattern
    explanation: >-
      Expert review independently names prominence among the FGS1 ear descriptors.
- category: Skeletal
  name: Broad thumbs
  description: >-
    Broad, flat thumbs are one of the cardinal skeletal features described from the
    original Opitz-Kaveggia family onward and are listed by GeneReviews as a defining
    FGS1 feature.
  phenotype_term:
    preferred_term: Broad thumb
    term:
      id: HP:0011304
      label: Broad thumb
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      broad thumbs and halluces
    explanation: >-
      GeneReviews lists broad thumbs among the defining FGS1 clinical characteristics.
  - reference: PMID:18805826
    reference_title: "Clinical experience in the evaluation of 30 patients with a prior diagnosis of FG syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      broad thumbs and halluces
    explanation: >-
      Lists broad thumbs among the core FGS features. Scored PARTIAL because the
      sentence characterizes the historical pre-molecular label rather than the
      MED12-confirmed cohort.
- category: Skeletal
  name: Broad halluces
  description: >-
    Broad great toes accompany the broad thumbs, reflecting a shared distal limb
    patterning effect.
  phenotype_term:
    preferred_term: Broad hallux
    term:
      id: HP:0010055
      label: Broad hallux
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      broad thumbs and halluces
    explanation: >-
      GeneReviews lists broad halluces among the defining FGS1 clinical
      characteristics.
- category: Skeletal
  name: Prominent fingertip pads
  description: >-
    Persistent fetal fingertip pads are a recognized soft dysmorphic sign in
    molecularly confirmed FGS1.
  phenotype_term:
    preferred_term: Prominent fingertip pads
    term:
      id: HP:0001212
      label: Prominent fingertip pads
  evidence:
  - reference: PMID:24123922
    reference_title: "MED12 related disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      His characteristic facial features included small and simple ears, tall and
      prominent forehead, frontal hair upsweep, down slanting palpebral fissures, broad
      thumbs and halluces, fetal fingertips pads, and characteristic friendly behavior
    explanation: >-
      Describes fetal fingertip pads in the single MED12 p.R961W-positive patient
      identified in the Lyons diagnostic series.
- category: Skeletal
  name: Joint contractures
  description: >-
    Joint contractures, hip dysplasia, pectus deformities, vertebral and rib anomalies,
    and syndactyly or oligodactyly of the fingers were reported as frequent
    accompaniments in the confirmed cohort, but the source gives no per-feature
    denominator, so no frequency band is asserted. Limited forearm
    pronation/supination is curated as a separate phenotype with its own count.
  phenotype_term:
    preferred_term: Flexion contracture
    term:
      id: HP:0001371
      label: Flexion contracture
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      skeletal anomalies including joint contractures, hip dysplasia, pectus
      deformities, vertebral and rib anomalies, syndactyly or oligodactyly of the
      fingers, and ocular anomalies were frequent.
    explanation: >-
      Documents joint contractures within the FGS1 skeletal spectrum. The source word
      is "frequent" but applies to a loose list of features with no per-feature
      denominator, so no frequency band is asserted.
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      routine management of seizures, strabismus and other ocular anomalies,
      imperforate anus, chronic constipation, joint contractures, genitourinary
      anomalies, congenital heart defects, hearing loss, palate anomalies, and dental
      anomalies
    explanation: >-
      GeneReviews management guidance confirms joint contractures as a recognized
      manifestation.
- category: Skeletal
  name: Limited pronation/supination of forearm
  frequency: OCCASIONAL
  description: >-
    Limited supination of the elbow was reported in six of 23 molecularly confirmed
    males and may be a useful clinical sign in the older child evaluated in clinic.
  phenotype_term:
    preferred_term: Limited pronation/supination of forearm
    term:
      id: HP:0006394
      label: Limited pronation/supination of forearm
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Limited supination of the elbow was reported in six patients and may prove to
      be a useful sign in the older child evaluated in the outpatient clinic.
    explanation: >-
      Direct count (6 of 23 = 26%) supports the OCCASIONAL band. The HPO term covers
      limited pronation and/or supination; the source names limited supination.
- category: Skeletal
  name: Hip dysplasia
  description: >-
    Hip dysplasia is among the skeletal anomalies reported as frequent in the
    molecularly confirmed cohort.
  phenotype_term:
    preferred_term: Hip dysplasia
    term:
      id: HP:0001385
      label: Hip dysplasia
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      skeletal anomalies including joint contractures, hip dysplasia, pectus
      deformities, vertebral and rib anomalies, syndactyly or oligodactyly of the
      fingers, and ocular anomalies were frequent.
    explanation: >-
      Explicitly names hip dysplasia among the frequent FGS1 skeletal anomalies.
- category: Skeletal
  name: Pectus deformity
  description: >-
    Pectus excavatum and related chest wall deformities are part of the FGS1 skeletal
    spectrum.
  phenotype_term:
    preferred_term: Pectus excavatum
    term:
      id: HP:0000767
      label: Pectus excavatum
  evidence:
  - reference: PMID:24123922
    reference_title: "MED12 related disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Skeletal manifestations included stature in the lower range of normal, broad and
      flat thumbs and halluces, partial syndactyly, pectus excavatum, joint
      contractures, and spinal curvature.
    explanation: >-
      Expert review names pectus excavatum within the FGS1 skeletal manifestations.
- category: Skeletal
  name: Syndactyly
  description: >-
    Partial syndactyly (and less commonly oligodactyly) of the fingers is reported in
    molecularly confirmed FGS1.
  phenotype_term:
    preferred_term: Syndactyly
    term:
      id: HP:0001159
      label: Syndactyly
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      syndactyly or oligodactyly of the fingers
    explanation: >-
      Directly names finger syndactyly among the reported FGS1 skeletal anomalies.
- category: Skeletal
  name: Abnormal vertebral morphology
  description: >-
    Vertebral and rib anomalies, and spinal curvature, are reported among the FGS1
    axial skeletal findings.
  phenotype_term:
    preferred_term: Abnormal vertebral morphology
    term:
      id: HP:0003468
      label: Abnormal vertebral morphology
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      vertebral and rib anomalies
    explanation: >-
      Directly names vertebral anomalies among the reported FGS1 skeletal findings.
- category: Behavioral
  name: Affable, loquacious personality
  frequency: VERY_FREQUENT
  description: >-
    A friendly, loquacious, eager-to-please personality with socially oriented,
    attention-seeking behavior was present in all 13 fully evaluated mutation-positive
    males and is one of the most discriminating features of FGS1. It coexists with
    anxiety and a need for sameness, and communication skills lag behind socialization
    and daily living skills.
  phenotype_term:
    preferred_term: Friendly, loquacious, eager-to-please personality
    term:
      id: HP:0100025
      label: Overfriendliness
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      an affable personality (13 of 13)
    explanation: >-
      Direct quantitative support for the affable personality trait. The reported
      proportion is 13/13 (100%), which would map to OBLIGATE under the default
      convention; VERY_FREQUENT is used instead as a deliberate departure, because
      n=13 is a subset of the 23-male cohort and does not license an assertion of
      invariance.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      They confirm the previously documented friendly, loquacious, eager-to-please
      personality with concurrent anxiety and need for sameness.
    explanation: >-
      Characterizes the specific content of the distinctive social-behavioral profile.
  - reference: PMID:18973276
    reference_title: "Behavior of 10 patients with FG syndrome (Opitz-Kaveggia syndrome) and the p.R961W mutation in the MED12 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Males with this MED12 mutation had deficits in communication skills compared to
      their socialization and daily living skills.
    explanation: >-
      Quantitatively characterizes the adaptive-behavior profile using the Vineland
      scales in p.Arg961Trp-confirmed males.
- category: Behavioral
  name: Hyperactivity
  frequency: VERY_FREQUENT
  description: >-
    Hyperactivity with a very short attention span is a very frequent feature in young
    boys with the p.Arg961Trp variant.
  phenotype_term:
    preferred_term: Hyperactivity
    term:
      id: HP:0000752
      label: Hyperactivity
  evidence:
  - reference: PMID:18973276
    reference_title: "Behavior of 10 patients with FG syndrome (Opitz-Kaveggia syndrome) and the p.R961W mutation in the MED12 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The previously defined behavior phenotype of hyperactivity, affability, and
      excessive talkativeness is very frequent in young boys with this mutation, along
      with socially oriented, attention-seeking behaviors.
    explanation: >-
      Explicit "very frequent" qualitative statement in mutation-confirmed males,
      mapping to the VERY_FREQUENT band.
- category: Behavioral
  name: Short attention span
  frequency: FREQUENT
  description: >-
    A very short attention span accompanies the hyperactivity and inattention profile,
    with increased risk for inattention documented on standardized behavior measures.
  phenotype_term:
    preferred_term: Short attention span
    term:
      id: HP:0000736
      label: Short attention span
  evidence:
  - reference: PMID:18973276
    reference_title: "Behavior of 10 patients with FG syndrome (Opitz-Kaveggia syndrome) and the p.R961W mutation in the MED12 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      during early childhood they were friendly, inquisitive, and hyperactive with a
      very short attention span
    explanation: >-
      Directly describes the very short attention span in early childhood, rather than
      relying on the generic maladaptive-behavior risk sentence.
- category: Behavioral
  name: Anxiety
  description: >-
    Anxiety coexists with the affable personality and is often linked to a need for
    sameness and difficulty with transitions. Unlike the affable personality itself,
    anxiety occurs in both mutation-positive and mutation-negative groups and is
    therefore not diagnostically discriminating.
  phenotype_term:
    preferred_term: Anxiety
    term:
      id: HP:0000739
      label: Anxiety
  evidence:
  - reference: PMID:18973276
    reference_title: "Behavior of 10 patients with FG syndrome (Opitz-Kaveggia syndrome) and the p.R961W mutation in the MED12 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In addition, they were at increased risk for maladaptive behavior, with a
      propensity towards aggression, anxiety, and inattention.
    explanation: >-
      Documents anxiety as a maladaptive-behavior risk in p.Arg961Trp-confirmed males.
      No frequency band is assigned: "increased risk" and "a propensity towards" are
      qualitative and carry no proportion, and the cohort paper gives no denominator
      for anxiety alone.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      whereas anxiety, which is present in both groups, is less discriminatory
    explanation: >-
      Records that anxiety occurs in both the mutation-positive and mutation-negative
      groups, which is why it is not used as a diagnostic discriminator.
- category: Behavioral
  name: Aggressive behavior
  frequency: OCCASIONAL
  description: >-
    Episodic aggressive and self-injurious behavior emerges more frequently around
    puberty and early adulthood; it affects some but not all individuals and is
    described alongside impulsivity and obsessive-compulsive traits.
  phenotype_term:
    preferred_term: Aggressive behavior
    term:
      id: HP:0000718
      label: Aggressive behavior
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Some individuals can be aggressive, impulsive, and/or obsessive-compulsive.
    explanation: >-
      "Some individuals" maps to the OCCASIONAL band per the literature-term mapping
      table in docs/frequency-evidence-guidelines.md.
  - reference: PMID:20981778
    reference_title: "Behavioral features in young adults with FG syndrome (Opitz-Kaveggia syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These individuals had episodic and longstanding behavior patterns, sometimes
      aggressive or self-abusing, that occurred more frequently in puberty and early
      adulthood.
    explanation: >-
      Documents the age-dependent emergence of aggressive/self-injurious behavior.
- category: Behavioral
  name: Compulsive behaviors
  frequency: OCCASIONAL
  description: >-
    Obsessive-compulsive traits and a need for sameness are reported in a subset of
    affected males.
  phenotype_term:
    preferred_term: Compulsive behaviors
    term:
      id: HP:0000722
      label: Compulsive behaviors
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Some individuals can be aggressive, impulsive, and/or obsessive-compulsive.
    explanation: >-
      "Some individuals" maps to the OCCASIONAL band for obsessive-compulsive traits.
- category: Behavioral
  name: Impulsivity
  frequency: OCCASIONAL
  description: >-
    Impulsivity persists into adult life and complicates transitions to community
    living.
  phenotype_term:
    preferred_term: Impulsivity
    term:
      id: HP:0100710
      label: Impulsivity
  evidence:
  - reference: PMID:20981778
    reference_title: "Behavioral features in young adults with FG syndrome (Opitz-Kaveggia syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      They remain impulsive and can have aggressive outbursts when making the
      transition to adult life
    explanation: >-
      Documents persistent impulsivity in adult p.Arg961Trp-confirmed males.
- category: Neurologic
  name: Delayed speech and language development
  frequency: FREQUENT
  description: >-
    Communication skills are disproportionately impaired relative to socialization and
    daily living skills, making speech-language therapy and augmentative communication
    a management priority.
  phenotype_term:
    preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:18973276
    reference_title: "Behavior of 10 patients with FG syndrome (Opitz-Kaveggia syndrome) and the p.R961W mutation in the MED12 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Males with this MED12 mutation had deficits in communication skills compared to
      their socialization and daily living skills.
    explanation: >-
      Vineland-based demonstration of a specific communication deficit in
      p.Arg961Trp-confirmed males.
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      physical therapy, occupational therapy, and speech therapy for developmental
      delays
    explanation: >-
      GeneReviews management recommendations presuppose speech-affecting developmental
      delay in MED12-related disorders.
- category: Behavioral
  name: Sleep disturbance
  frequency: FREQUENT
  description: >-
    Insomnia and sleep apnea are common in FGS1 and, together with headaches, may
    exacerbate maladaptive behavior. This makes sleep an explicit target when
    behavioral problems escalate, alongside the search for other unrecognized medical
    causes such as reflux and constipation.
  phenotype_term:
    preferred_term: Sleep disturbance
    term:
      id: HP:0002360
      label: Sleep disturbance
  evidence:
  - reference: PMID:20981778
    reference_title: "Behavioral features in young adults with FG syndrome (Opitz-Kaveggia syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Headaches, insomnia and sleep apnea are also common and may exacerbate
      maladaptive behaviors.
    explanation: >-
      The qualitative term "common" maps to the FREQUENT band, and the statement is
      made specifically about p.Arg961Trp-confirmed FG syndrome males.
- category: Neurologic
  name: Seizures
  description: >-
    Seizures occur in a subset of individuals, and occasional EEG abnormalities were
    noted from the original family description onward. GeneReviews includes routine
    seizure management in the FGS1 care plan.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      routine management of seizures, strabismus and other ocular anomalies,
      imperforate anus, chronic constipation, joint contractures, genitourinary
      anomalies, congenital heart defects, hearing loss, palate anomalies, and dental
      anomalies
    explanation: >-
      GeneReviews management guidance confirms seizures as a manifestation requiring
      routine management in MED12-related disorders.
  - reference: PMID:24123922
    reference_title: "MED12 related disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The corpus callosum was deficient or absent altogether, with occasional EEG
      abnormalities.
    explanation: >-
      Documents occasional EEG abnormality in the classic FGS1 description. This
      supports abnormal cortical electrical activity, not seizures as such, so no
      frequency band is asserted for seizures from this item.
- category: Ophthalmologic
  name: Ocular anomalies
  frequency: FREQUENT
  description: >-
    Eye anomalies were reported in 10 of the 23 molecularly confirmed patients:
    strabismus/exotropia in 3, optic nerve hypoplasia in 2, coloboma in 2, and
    phthisis bulbi, nystagmus, retinal detachment, and cataract in 1 each. This
    justifies formal ophthalmologic assessment at diagnosis.
  phenotype_term:
    preferred_term: Ocular anomaly (any)
    term:
      id: HP:0000478
      label: Abnormality of the eye
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Eye anomalies were reported in 10 patients: strabismus/exotropia in 3 patients;
      optic nerve hypoplasia in 2; coloboma in 2; phthisis bulbi, nystagmus, retinal
      detachment, and cataract in 1 patient each.
    explanation: >-
      Direct quantitative support: 10 of 23 confirmed patients (43%) had an ocular
      anomaly of some kind, supporting the FREQUENT band for the composite finding.
      The band applies to the composite, not to any individual ocular feature.
  - reference: PMID:34670449
    reference_title: "Eye and ocular adnexa manifestations of MED12-related disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Commonly reoccurring reported eye and ocular adnexa features within the spectrum
      include ptosis, downslanting palpebral fissures, and hypertelorism. Other less
      common findings include strabismus, astigmatism, and optic nerve hypoplasia.
    explanation: >-
      Systematic review of ocular features across MED12-related disorders confirms
      strabismus and optic nerve hypoplasia as recurring findings.
- category: Ophthalmologic
  name: Strabismus
  frequency: OCCASIONAL
  description: >-
    Strabismus or exotropia was documented in 3 of the 23 molecularly confirmed males
    and is one of the recurring ocular findings across MED12-related disorders.
  phenotype_term:
    preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      strabismus/exotropia in 3 patients
    explanation: >-
      Direct count (3 of 23 = 13%), supporting the OCCASIONAL band for strabismus
      specifically.
- category: Ophthalmologic
  name: Optic nerve hypoplasia
  frequency: OCCASIONAL
  description: >-
    Optic nerve hypoplasia was documented in 2 of the 23 molecularly confirmed males
    and is one of the recurring ocular findings across MED12-related disorders.
  phenotype_term:
    preferred_term: Optic nerve hypoplasia
    term:
      id: HP:0000609
      label: Optic nerve hypoplasia
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      optic nerve hypoplasia in 2
    explanation: >-
      Direct count (2 of 23 = 9%), supporting the OCCASIONAL band.
- category: Genitourinary
  name: Cryptorchidism
  description: >-
    Undescended testes are the most common genitourinary anomaly in FG syndrome, and
    GeneReviews includes routine management of genitourinary anomalies in the care
    plan. No frequency band is asserted: the two available sources point to different
    bands and neither supplies a clean FGS1 denominator (see evidence).
  phenotype_term:
    preferred_term: Cryptorchidism
    term:
      id: HP:0000028
      label: Cryptorchidism
  evidence:
  - reference: PMID:17574621
    reference_title: "Genitourinary anomalies of pediatric FG syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In boys the most common abnormalities were cryptorchidism (24%), hypospadias
      (14%) and hernia or hydrocele (13%).
    explanation: >-
      The only per-feature quantitative estimate available for this phenotype: 24%,
      which would fall in the OCCASIONAL band. PARTIAL, and deliberately NOT used to
      assign a band, because the 228-patient series was assembled on clinical
      diagnosis and predates routine MED12 testing, so its denominator is the
      historical clinical FG syndrome population of which fewer than 3% is
      molecularly confirmed FGS1. Banding FGS1 from a cohort that is ~97% not-FGS1
      would assert more than the source supports.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Megacolon, pyloric stenosis, renal cysts and stones, cryptorchidism, skeletal
      anomalies including joint contractures, hip dysplasia, pectus deformities,
      vertebral and rib anomalies, syndactyly or oligodactyly of the fingers, and
      ocular anomalies were frequent.
    explanation: >-
      Names cryptorchidism among the additional anomalies in the mutation-positive
      cohort — the right population, but the word "frequent" is applied collectively
      to a ten-item list with no per-feature denominator, so it does not establish a
      per-feature band. Together with the preceding item this is why the phenotype
      carries no frequency: the source with the correct population gives only a
      collective qualitative term, and the source with a per-feature number is drawn
      from the wrong population. Asserting either band would be an overreach, and
      preferring the number here would invert the standard applied to Anxiety in this
      same entry, where a qualitative statement was judged insufficient to license a
      band.
- category: Genitourinary
  name: Hypospadias
  description: >-
    Hypospadias is among the genitourinary anomalies of FG syndrome, reported in 14%
    of boys in the only systematic genitourinary series. As with cryptorchidism, no
    frequency band is asserted because that series is clinically rather than
    molecularly defined.
  phenotype_term:
    preferred_term: Hypospadias
    term:
      id: HP:0000047
      label: Hypospadias
  evidence:
  - reference: PMID:17574621
    reference_title: "Genitourinary anomalies of pediatric FG syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In boys the most common abnormalities were cryptorchidism (24%), hypospadias
      (14%) and hernia or hydrocele (13%).
    explanation: >-
      Documents hypospadias as one of the three most common genitourinary findings.
      PARTIAL, and not used to assign a band, for the same reason as the other two:
      the 228-patient series predates routine MED12 testing, so fewer than 3% of its
      denominator is molecularly confirmed FGS1.
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      routine management of seizures, strabismus and other ocular anomalies,
      imperforate anus, chronic constipation, joint contractures, genitourinary
      anomalies, congenital heart defects, hearing loss, palate anomalies, and
      dental anomalies
    explanation: >-
      GeneReviews includes genitourinary anomalies among the manifestations receiving
      routine management in MED12-related disorders.
- category: Renal
  name: Renal cysts
  description: >-
    Renal cysts are reported among the additional anomalies in the molecularly
    confirmed cohort. No per-feature denominator is given, so no frequency band is
    asserted.
  phenotype_term:
    preferred_term: Renal cyst
    term:
      id: HP:0000107
      label: Renal cyst
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      renal cysts and stones
    explanation: >-
      Names renal cysts among the additional FGS1 anomalies.
- category: Renal
  name: Nephrolithiasis
  description: >-
    Renal stones are reported alongside renal cysts among the additional anomalies in
    the molecularly confirmed cohort. No per-feature denominator is given, so no
    frequency band is asserted.
  phenotype_term:
    preferred_term: Nephrolithiasis
    term:
      id: HP:0000787
      label: Nephrolithiasis
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      renal cysts and stones
    explanation: >-
      Names renal stones among the additional FGS1 anomalies; bound separately from
      the cyst term so nephrolithiasis is independently queryable.
- category: Gastrointestinal
  name: Pyloric stenosis
  description: >-
    Pyloric stenosis is one of the less common gastrointestinal malformations in the
    confirmed cohort.
  phenotype_term:
    preferred_term: Pyloric stenosis
    term:
      id: HP:0002021
      label: Pyloric stenosis
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Megacolon, pyloric stenosis, renal cysts and stones, cryptorchidism
    explanation: >-
      Directly names pyloric stenosis among the additional FGS1 anomalies.
- category: Gastrointestinal
  name: Megacolon
  description: >-
    Megacolon is named among the additional anomalies that were frequent in the
    molecularly confirmed cohort, and at least one confirmed male underwent partial
    colonic resection for megacolon. No per-feature denominator is given, so no
    frequency band is asserted.
  phenotype_term:
    preferred_term: Megacolon
    term:
      id: HP:6000852
      label: Megacolon
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Megacolon, pyloric stenosis, renal cysts and stones, cryptorchidism, skeletal
      anomalies including joint contractures, hip dysplasia, pectus deformities,
      vertebral and rib anomalies, syndactyly or oligodactyly of the fingers, and
      ocular anomalies were frequent.
    explanation: >-
      Names megacolon among the additional FGS1 anomalies. The word "frequent" is
      applied collectively to a multi-item list with no per-feature denominator, so
      no frequency band is asserted.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      He had surgery for pyloric stenosis and a partial colonic resection for
      megacolon.
    explanation: >-
      Case-level documentation that megacolon required surgical resection in a
      molecularly confirmed male.
- category: Craniofacial
  name: Craniosynostosis
  frequency: OCCASIONAL
  description: >-
    Craniosynostosis was found in 2 of the 23 molecularly confirmed males.
  phenotype_term:
    preferred_term: Craniosynostosis
    term:
      id: HP:0001363
      label: Craniosynostosis
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Craniosynostosis was found in two patients.
    explanation: >-
      Direct count (2 of 23 = 9%), supporting the OCCASIONAL band.
- category: Growth
  name: Short stature
  description: >-
    Stature is characteristically in the lower range of normal rather than frankly
    short; historical descriptions of "short stature with relative macrocephaly" are
    partly an artifact of the broadened, pre-molecular FG syndrome label.
  phenotype_term:
    preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  evidence:
  - reference: PMID:24123922
    reference_title: "MED12 related disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Skeletal manifestations included stature in the lower range of normal
    explanation: >-
      The source describes stature in the lower range of normal rather than frank
      short stature, so this evidence is scored PARTIAL and no frequency band is
      asserted. The row is retained to document that height is shifted downward
      without meeting the threshold for short stature.
- category: Otologic
  name: Hearing loss
  description: >-
    Hearing loss is listed among the manifestations requiring routine management and
    annual audiology surveillance in MED12-related disorders.
  phenotype_term:
    preferred_term: Hearing impairment
    term:
      id: HP:0000365
      label: Hearing impairment
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      congenital heart defects, hearing loss, palate anomalies, and dental anomalies
    explanation: >-
      GeneReviews names hearing loss among the manifestations requiring routine
      management in MED12-related disorders.
- category: Genitourinary
  name: Inguinal hernia
  description: >-
    Hernias were among the associated defects in the original Opitz-Kaveggia family
    description, and remain among the most common genitourinary findings. No
    frequency band is asserted, for the same reason as cryptorchidism.
  phenotype_term:
    preferred_term: Inguinal hernia
    term:
      id: HP:0000023
      label: Inguinal hernia
  evidence:
  - reference: PMID:17574621
    reference_title: "Genitourinary anomalies of pediatric FG syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In boys the most common abnormalities were cryptorchidism (24%), hypospadias
      (14%) and hernia or hydrocele (13%).
    explanation: >-
      The only per-feature quantitative estimate available: 13%, which would fall in
      the OCCASIONAL band, and even that is the composite of hernia and hydrocele
      rather than inguinal hernia alone. PARTIAL, and not used to assign a band, for
      the same reason as cryptorchidism: the series is clinically rather than
      molecularly defined, so its denominator is not an FGS1 denominator.
  - reference: PMID:24123922
    reference_title: "MED12 related disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Associated defects included anal stenosis or other malformations of the
      intestinal tract and heart, hernias, and craniosynostosis
    explanation: >-
      Expert review names hernias among the associated defects in classic FGS1.
genetic:
- name: MED12
  notes: >-
    MED12 (Xq13.1) encodes the largest subunit of the Mediator CDK8 kinase module.
    Classic FGS1 is defined by the single recurrent hemizygous missense variant
    c.2881C>T (p.Arg961Trp) in exon 21. Other MED12 missense variants cause allelic
    but distinct disorders (Lujan-Fryns syndrome, classically p.Asn1007Ser; X-linked
    Ohdo syndrome), and de novo protein-truncating variants in females cause Hardikar
    syndrome or a severe syndromic intellectual disability phenotype; none of these
    should be labelled FGS1. A second FGS1-causing missense variant, p.Gly958Glu, has
    been reported in one family, showing that p.Arg961Trp is not strictly the only
    FGS1 allele.
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  gene_term:
    preferred_term: MED12
    term:
      id: hgnc:11957
      label: MED12
  inheritance:
  - name: X-linked recessive inheritance
    inheritance_term:
      preferred_term: X-linked recessive inheritance
      term:
        id: HP:0001419
        label: X-linked recessive inheritance
  evidence:
  - reference: PMID:17334363
    reference_title: "A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report here that the original family for whom the condition is named and five
      other families have a recurrent mutation (2881C>T, leading to R961W) in MED12
      (also called TRAP230 or HOPA), a gene located at Xq13
    explanation: >-
      Establishes MED12 as the causative gene and localizes it to Xq13.
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The diagnosis of an MED12-related disorder is established in a male by
      identification of a hemizygous MED12 pathogenic variant on molecular genetic
      testing.
    explanation: >-
      GeneReviews defines molecular diagnosis of MED12-related disorders, including
      FGS1, by hemizygous MED12 variant identification in males.
  - reference: PMID:33925166
    reference_title: "MED12-Related (Neuro)Developmental Disorders: A Question of Causality."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Missense variants in MED12 cause FG syndrome, Lujan-Fryns syndrome, and Ohdo
      syndrome, as well as non-syndromic intellectual disability (ID) in hemizygous
      males.
    explanation: >-
      Places FGS1 within the MED12 missense allelic series and distinguishes it from
      the other MED12-related phenotypes.
variants:
- name: MED12 c.2881C>T (p.Arg961Trp)
  description: >-
    The defining FGS1 variant: NM_005120.3:c.2881C>T in exon 21 of MED12, causing the
    p.Arg961Trp missense substitution. It is germline and hemizygous in affected
    males, recurrent across unrelated families, and maternally transmitted rather than
    de novo in the reported cohort. Functionally it produces a pathway-selective
    altered-function defect rather than complete loss of MED12 function.
  type: missense
  clinical_significance: PATHOGENIC
  gene:
    preferred_term: MED12
    term:
      id: hgnc:11957
      label: MED12
  evidence:
  - reference: PMID:17334363
    reference_title: "A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a recurrent mutation (2881C>T, leading to R961W) in MED12
    explanation: >-
      Defines the exact nucleotide and protein change for the recurrent FGS1 variant.
  - reference: PMID:18973276
    reference_title: "Behavior of 10 patients with FG syndrome (Opitz-Kaveggia syndrome) and the p.R961W mutation in the MED12 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In 2007, Risheg et al. identified an identical nucleotide substitution
      (c.2881C>T) in exon 21 of MED12 (p.R961W) in six families with Opitz-Kaveggia
      syndrome, including a surviving affected male from the original Opitz-Kaveggia
      family.
    explanation: >-
      Localizes the variant to exon 21 and confirms its identity across six
      independently ascertained families including the original family.
- name: MED12 p.Gly958Glu
  description: >-
    A second, non-recurrent MED12 missense variant reported in one family with three
    affected cousins whose clinical phenotype matched Opitz-Kaveggia syndrome. It
    demonstrated for the first time that FGS1 is not exclusively caused by
    p.Arg961Trp, although p.Arg961Trp remains the defining and by far the most common
    allele.
  type: missense
  clinical_significance: LIKELY_PATHOGENIC
  gene:
    preferred_term: MED12
    term:
      id: hgnc:11957
      label: MED12
  evidence:
  - reference: PMID:20507344
    reference_title: "A novel mutation in MED12 causes FG syndrome (Opitz-Kaveggia syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here we report on a new family with three affected cousins, in which we
      identified a novel MED12 mutation (p.G958E). This is the first demonstration that
      other mutations in this gene can also lead to Opitz-Kaveggia syndrome.
    explanation: >-
      Directly reports the second FGS1-causing MED12 allele and states its
      significance.
diagnosis:
- name: MED12 molecular genetic testing
  description: >-
    Diagnosis requires a compatible phenotype plus identification of a hemizygous
    pathogenic MED12 variant in a male, with p.Arg961Trp defining classic FGS1.
    Targeted testing for c.2881C>T is efficient when the classic phenotype or a known
    familial variant is present; otherwise an intellectual disability/congenital
    anomaly gene panel containing MED12, or exome/genome sequencing, is appropriate,
    followed by full MED12 gene sequencing if targeted analysis is negative.
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The diagnosis of an MED12-related disorder is established in a male by
      identification of a hemizygous MED12 pathogenic variant on molecular genetic
      testing.
    explanation: >-
      GeneReviews states the molecular diagnostic criterion for MED12-related
      disorders in males.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      when the clinical diagnosis of FG syndrome is suspected, we recommend first
      testing for the recurrent mutation, followed by gene sequencing if targeted
      mutation analysis is negative.
    explanation: >-
      Gives the recommended tiered molecular testing strategy for suspected FGS1.
- name: Clinical algorithm for targeted p.Arg961Trp testing
  description: >-
    A six-criterion clinical algorithm derived from comparing 23 p.Arg961Trp-positive
    males with 48 mutation-negative patients carrying a clinical FG syndrome
    diagnosis. Criteria centre on the characteristic facies, affable personality,
    congenital anomaly (or an affected relative with one), small ears, macrocephaly,
    and the infantile hypotonia/feeding difficulty/constipation triad. It achieves
    100% sensitivity and 90% specificity for the recurrent MED12 variant. It is best
    used as historical triage: contemporary practice generally reaches the diagnosis
    by sequencing.
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The algorithm identifies the p.R961W MED12 mutation-positive group with 100%
      sensitivity and 90% specificity.
    explanation: >-
      Reports the diagnostic performance of the clinical triage algorithm.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These features were seen most often in affected male patients: characteristic
      facies (13 of 13), an affable personality (13 of 13), a congenital anomaly (11 of
      13) or an affected relative with a congenital anomaly (2 of 13), and at least 1
      of these 3 traits: infantile hypotonia, feeding difficulties, and constipation
      (13 of 13).
    explanation: >-
      Enumerates the discriminating features that constitute the algorithm criteria.
- name: Baseline echocardiography
  description: >-
    Cardiac imaging is a core baseline evaluation at diagnosis, since congenital
    cardiac anomalies were documented in 11 of 18 evaluable molecularly confirmed
    males and congenital heart defects are among the manifestations GeneReviews
    directs to routine management.
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      congenital cardiac anomalies (11 of 18)
    explanation: >-
      The high observed rate of congenital cardiac anomalies is the rationale for
      baseline cardiac imaging in a newly diagnosed individual.
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      congenital heart defects, hearing loss, palate anomalies, and dental anomalies
    explanation: >-
      GeneReviews places congenital heart defects among the manifestations requiring
      routine management; scored PARTIAL because it prescribes management rather than
      naming echocardiography as the baseline test.
- name: Brain MRI
  description: >-
    Brain imaging with specific attention to the corpus callosum is a core baseline
    evaluation, since agenesis or hypoplasia of the corpus callosum was present in all
    imaged individuals in the confirmed cohort.
  evidence:
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The most characteristic anomalies were agenesis or hypoplasia of the corpus
      callosum (13 of 13)
    explanation: >-
      Justifies neuroimaging as a high-yield baseline investigation.
differential_diagnoses:
- name: Lujan-Fryns syndrome
  description: >-
    An allelic MED12 disorder, classically caused by p.Asn1007Ser, sharing cognitive
    impairment, hypotonia, and corpus callosum abnormality with FGS1 but distinguished
    by a tall thin body habitus, long thin face, prominent nasal bridge, high narrow
    palate, and short philtrum rather than the FGS1 facial gestalt and anorectal
    malformations.
  distinguishing_features:
  - Marfanoid tall thin body habitus and long thin face rather than the FGS1 gestalt
  - Short philtrum and high narrow palate
  - Absence of the FGS1 anorectal malformations and broad thumbs/halluces
  - Different MED12 missense variant (classically p.Asn1007Ser)
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      LS is further characterized by large head, tall thin body habitus, long thin
      face, prominent nasal bridge, high narrow palate, and short philtrum.
    explanation: >-
      GeneReviews enumerates the features that distinguish Lujan syndrome from FGS1
      within the MED12 spectrum.
- name: X-linked Ohdo syndrome (Maat-Kievit-Brunner type)
  description: >-
    A further allelic MED12 disorder characterized by intellectual disability,
    blepharophimosis, and facial coarsening at an older age, distinguishing it from
    the FGS1 gestalt.
  distinguishing_features:
  - Blepharophimosis
  - Progressive facial coarsening with age
  - Absence of the FGS1 tall forehead, frontal upsweep, and small simple ears
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      XLOS is characterized by intellectual disability, blepharophimosis, and facial
      coarsening.
    explanation: >-
      GeneReviews gives the discriminating features of X-linked Ohdo syndrome within
      the MED12 spectrum.
- name: Hardikar syndrome
  description: >-
    Caused by de novo MED12 protein-truncating variants in females, presenting with
    cleft lip/palate, biliary and liver anomalies, intestinal malrotation, pigmentary
    retinopathy, and coarctation of the aorta, and notably without intellectual
    disability. It is the female-restricted end of the MED12 spectrum and shares
    essentially no clinical overlap with FGS1.
  distinguishing_features:
  - Occurs in females rather than hemizygous males
  - Intellectual disability is absent
  - Hepatobiliary anomalies, intestinal malrotation, and pigmentary retinopathy
  - Caused by de novo protein-truncating rather than missense MED12 variants
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      HS has been described in females with cleft lip and/or cleft palate, biliary and
      liver anomalies, intestinal malrotation, pigmentary retinopathy, and coarctation
      of the aorta. Developmental and cognitive concerns have not been reported in
      females with HS.
    explanation: >-
      GeneReviews gives the discriminating clinical profile of Hardikar syndrome.
- name: MED12-negative FG syndrome phenotypes
  description: >-
    The large majority of individuals historically given a clinical FG syndrome
    diagnosis do not carry a MED12 variant. Systematic re-evaluation of 30 such
    patients identified the recurrent variant in only the single individual with the
    typical phenotype, and a definite or possible alternative diagnosis was found in
    10 of the remaining 29. Variants in FLNA, UPF3B, and BRWD3 account for some
    families previously mapped to "FG syndrome" loci.
  distinguishing_features:
  - No MED12 variant identified on full gene sequencing
  - A broader, less specific picture of hypotonia, constipation, and relative macrocephaly
  - Absence of the full FGS1 facial gestalt and congenital anomaly burden
  - Alternative X-linked causes including FLNA, UPF3B, and BRWD3
  evidence:
  - reference: PMID:18805826
    reference_title: "Clinical experience in the evaluation of 30 patients with a prior diagnosis of FG syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The R961W mutation was identified in the only patient who had the typical
      phenotype previously associated with this mutation. The remaining 29 patients
      displayed a wide variety of features and were shown to be negative for mutations
      in the entire MED12 gene. A definite or possible alternative diagnosis was
      identified in 10 of these patients.
    explanation: >-
      Directly quantifies how rarely a clinical FG syndrome diagnosis is molecularly
      confirmed and how often an alternative diagnosis emerges.
  - reference: PMID:24123922
    reference_title: "MED12 related disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The existence of genetic heterogeneity was further supported by the
      identification of mutations in three X-linked genes, FLNA, BRWD3 and UPF3B
    explanation: >-
      Names the alternative X-linked genes accounting for part of the historical FG
      syndrome heterogeneity.
treatments:
- name: Early intervention and individualized education
  description: >-
    Early individualized educational services and developmental intervention are the
    cornerstone of FGS1 management, targeting cognitive, motor, and adaptive
    development.
  action_category: THERAPEUTIC
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: early intervention services
    term:
      id: NCIT:C159524
      label: Early Intervention
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Treatment of manifestations: Early individualized education
    explanation: >-
      GeneReviews management guidance names early individualized education as
      first-line treatment of manifestations.
- name: Physical therapy
  description: >-
    Physical therapy addresses congenital hypotonia, delayed motor milestones,
    contractures, and mobility. Some children achieve walking only in later childhood.
  action_category: THERAPEUTIC
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: physical therapy
    term:
      id: NCIT:C15302
      label: Physical Therapy
  target_phenotypes:
  - preferred_term: Neonatal hypotonia
    term:
      id: HP:0001319
      label: Neonatal hypotonia
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      physical therapy, occupational therapy, and speech therapy for developmental
      delays
    explanation: >-
      GeneReviews management guidance names physical therapy for developmental delays
      in MED12-related disorders.
- name: Occupational therapy
  description: >-
    Occupational therapy supports adaptive and daily living skills, an area of
    relative strength that can be built on given the socialization profile.
  action_category: THERAPEUTIC
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: occupational therapy
    term:
      id: NCIT:C121351
      label: Occupational Therapy
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      physical therapy, occupational therapy, and speech therapy for developmental
      delays
    explanation: >-
      GeneReviews management guidance names occupational therapy for developmental
      delays in MED12-related disorders.
- name: Speech and language therapy
  description: >-
    Sustained speech-language therapy, with augmentative and alternative communication
    where needed, targets the disproportionate communication deficit documented on
    the Vineland scales in p.Arg961Trp-confirmed males.
  action_category: THERAPEUTIC
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: speech therapy
    term:
      id: NCIT:C159273
      label: Speech Language Therapy
  target_phenotypes:
  - preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      physical therapy, occupational therapy, and speech therapy for developmental
      delays
    explanation: >-
      GeneReviews management guidance names speech therapy for developmental delays in
      MED12-related disorders.
- name: Behavioral management
  description: >-
    Individualized management of behavior problems, with structured routines, advance
    warning of transitions, and behavioral intervention. Mood stabilizers may be
    considered for adolescents and young adults with aggressive or self-injurious
    outbursts, and a careful medical examination should precede escalation since
    unrecognized medical problems (including constipation and ocular anomalies) can
    drive behavior change.
  action_category: THERAPEUTIC
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: individualized behavioral management
    term:
      id: NCIT:C15184
      label: Behavioral Intervention
  target_phenotypes:
  - preferred_term: Aggressive behavior
    term:
      id: HP:0000718
      label: Aggressive behavior
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      individualized management of behavior problems
    explanation: >-
      GeneReviews management guidance names individualized behavior management as a
      treatment of manifestations.
  - reference: PMID:20981778
    reference_title: "Behavioral features in young adults with FG syndrome (Opitz-Kaveggia syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Young men who exhibit these behaviors may benefit from a careful examination to
      detect medical problems, use of mood stabilizers if needed, and/or behavioral
      intervention.
    explanation: >-
      Specifies the recommended approach for the adolescent/adult behavioral phase,
      including the medical-examination-first principle.
- name: Bowel management for chronic constipation
  description: >-
    Aggressive constipation management is required in essentially all affected
    individuals. Structural anorectal disease should be excluded or treated, since
    constipation may be functional, obstructive, or both.
  action_category: THERAPEUTIC
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: laxative
      term:
        id: NCIT:C29697
        label: Laxative
  target_phenotypes:
  - preferred_term: Chronic constipation
    term:
      id: HP:0012450
      label: Chronic constipation
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      imperforate anus, chronic constipation
    explanation: >-
      GeneReviews lists chronic constipation among the manifestations requiring routine
      management in MED12-related disorders.
  notes: >-
    GeneReviews specifies routine management rather than a named agent or regimen; the
    laxative class is recorded here without asserting a specific validated drug or dose.
- name: Surgical repair of congenital anomalies
  description: >-
    Surgical correction of imperforate anus and other anorectal malformations, repair
    of significant congenital heart defects, and orthopedic management of contractures,
    hip dysplasia, and spinal deformity as indicated.
  action_category: THERAPEUTIC
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  target_phenotypes:
  - preferred_term: Anal atresia
    term:
      id: HP:0002023
      label: Anal atresia
  - preferred_term: Abnormal heart morphology
    term:
      id: HP:0001627
      label: Abnormal heart morphology
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      routine management of seizures, strabismus and other ocular anomalies,
      imperforate anus, chronic constipation, joint contractures, genitourinary
      anomalies, congenital heart defects, hearing loss, palate anomalies, and dental
      anomalies
    explanation: >-
      GeneReviews management guidance covers the surgically correctable anomalies
      addressed by this treatment entry.
- name: Gastrostomy feeding
  description: >-
    Surgical gastrostomy placement for enteral feeding when severe infantile
    feeding difficulty is not met by oral intake, following feeding and swallowing
    assessment. Non-surgical nasogastric feeding is a distinct intervention and is
    not asserted by this entry.
  action_category: THERAPEUTIC
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: gastrostomy
    term:
      id: NCIT:C52006
      label: Gastrostomy
  target_phenotypes:
  - preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      At each visit, assess growth, development, behavior concerns, neurologic issues,
      gastrointestinal functioning, and musculoskeletal manifestations.
    explanation: >-
      GeneReviews surveillance guidance covers growth and gastrointestinal functioning
      but does not itself specify gastrostomy; scored PARTIAL because the surveillance
      recommendation supports nutritional monitoring rather than the specific
      intervention.
- name: Ophthalmologic and audiologic surveillance
  description: >-
    Formal ophthalmologic assessment at diagnosis (given that ocular anomalies
    occurred in 10 of 23 confirmed patients) and annual audiology evaluation.
  action_category: MONITORING
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: clinical surveillance
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Annual audiology evaluation.
    explanation: >-
      GeneReviews surveillance guidance specifies annual audiology evaluation in
      MED12-related disorders.
  - reference: PMID:19938245
    reference_title: "FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This justifies a formal ophthalmologic assessment when FG syndrome is being
      considered.
    explanation: >-
      Directly recommends formal ophthalmologic assessment on the basis of the observed
      ocular anomaly burden.
- name: Genetic counseling and family testing
  description: >-
    X-linked counseling for the family: a heterozygous mother has a 50% transmission
    risk per pregnancy, sons who inherit the variant are affected, and daughters who
    inherit an FGS1-associated variant are typically unaffected carriers. Once the
    familial variant is known, heterozygote testing of at-risk female relatives and
    prenatal or preimplantation genetic testing are possible. Males with an
    MED12-related disorder are not known to reproduce.
  action_category: COUNSELING_INFORMATIONAL
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Once the MED12 pathogenic variant has been identified in an affected family
      member, heterozygote testing for at-risk female relatives and prenatal and
      preimplantation genetic testing for MED12-related disorders are possible.
    explanation: >-
      GeneReviews genetic counseling section specifies the family testing options
      available after molecular confirmation.
  - reference: PMID:20301719
    reference_title: "MED12-Related Disorders."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      If the mother of a proband is heterozygous for a pathogenic variant, the chance
      of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic
      variant will be affected.
    explanation: >-
      Provides the quantitative recurrence risk used in FGS1 counseling.
discussions:
- discussion_id: fgs1_tissue_relevance_of_mechanism
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >-
    Do the REST-silencing, GLI3-SHH, and immediate-early gene defects demonstrated in
    patient-derived EBV-immortalized lymphoblastoid cells actually operate in the human
    tissues that are malformed in FGS1 (developing cortex and callosal projection
    neurons, enteric nervous system, cardiac outflow tract, anorectal mesenchyme)?
  attaches_to:
  - pathophysiology#Impaired Neuronal Differentiation and Cortical Development
  - pathophysiology#Failure of Corpus Callosum Formation
  rationale: >-
    All three mechanistic arms of FGS1 rest on lymphoblastoid cell lines or engineered
    MED12-null rescue systems. Lymphoblasts do not model developing cortical neurons,
    enteric neurons, cardiomyocytes, or anorectal mesenchyme, and the immediate-early
    gene effect is explicitly reported to be cell-type specific. Evidence therefore
    exists but its translational validity to the affected human tissues is the open
    question, which is a model-fidelity gap rather than an absence of data. No knock-in
    model reproducing the complete human FGS1 phenotype has been reported.
  proposed_experiments:
  - experiment_id: fgs1_isogenic_ipsc_lineage_panel
    name: Isogenic MED12 p.Arg961Trp knock-in human iPSC lineage panel
    description: >-
      Generate isogenic MED12 p.Arg961Trp knock-in human iPSC lines and differentiate
      them into cortical neurons, enteric neural crest derivatives, and cardiomyocytes.
      Profile REST target derepression, GLI3-dependent SHH target expression (CREB5,
      BMP4, NEUROG2), and stimulus-evoked immediate-early gene responses, comparing
      each lineage against the published lymphoblastoid signatures.
    decision_criterion: >-
      Concordance of the neural, enteric, and cardiac signatures with the
      lymphoblastoid findings would support tissue generality; lineage-restricted or
      divergent signatures would establish that lymphoblastoid data cannot be
      extrapolated to the malformed tissues.
  - experiment_id: fgs1_knockin_mouse_phenotyping
    name: MED12 p.Arg961Trp knock-in mouse phenotyping
    description: >-
      Generate and phenotype a Med12 p.Arg961Trp knock-in mouse for callosal,
      anorectal, cardiac, and behavioural phenotypes, with parallel transcriptomic
      profiling of the affected tissues during the relevant developmental windows.
    decision_criterion: >-
      Recapitulation of callosal and anorectal defects would establish an in vivo model
      for FGS1; failure to recapitulate would itself constitute an informative
      human-model mismatch requiring human-derived systems.
  evidence:
  - reference: PMID:28369444
    reference_title: "MED12-related XLID disorders are dose-dependent of immediate early genes (IEGs) expression."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Moreover, the effect of MED12 mutations has cell-type specificity on IEG
      expression.
    explanation: >-
      Explicit demonstration that the mechanistic readout is cell-type dependent, which
      is precisely why lymphoblastoid findings cannot be assumed to hold in the
      affected tissues.
  - reference: PMID:33925166
    reference_title: "MED12-Related (Neuro)Developmental Disorders: A Question of Causality."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      We propose an isogenic iNeuron model to establish the unique gene expression
      patterns that are associated with the specific MED12 variants.
    explanation: >-
      Independent expert proposal of exactly the isogenic neuronal model needed to
      resolve the mismatch, confirming this is a recognized open question.
notes: >-
  Scope note: this entry covers the molecularly defined MED12-related entity
  (MONDO:0010590, OMIM:305450). It deliberately does not curate the historical,
  purely clinical "FG syndrome" label (MONDO:0002010), which is genetically
  heterogeneous and encompasses FLNA (FGS2), CASK (FGS4), UPF3B (FGS6), and BRWD3
  (FGS7) loci; fewer than 3% of clinically diagnosed cases carry the MED12 variant.
  Quantitative phenotype frequencies in this entry derive from a single cohort of 23
  molecularly confirmed males from 10 families with variable per-feature denominators;
  they are descriptive cohort proportions and should not be read as population
  penetrance estimates. There is overlap with the existing
  Mediator_Complex_Neurodevelopmental_Disorder entry, which models the broader
  mediatoropathy spectrum (MED12/MED13/MED13L/MED23) at the disease-family level; this
  entry provides the gene- and variant-specific FGS1 detail.
📚

References & Deep Research

References

3
PMID:20301719
MED12-Related Disorders.
1 finding
Authoritative GeneReviews chapter covering the MED12-related disorder spectrum (FGS1, Lujan syndrome, X-linked Ohdo syndrome, Hardikar syndrome, and nonspecific intellectual disability), including the FGS1 clinical characteristics baseline, diagnosis/testing approach, management, surveillance, and genetic counseling.
PMID:19938245
FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing.
1 finding
Definitive natural-history cohort of all 23 known p.Arg961Trp-positive males from 10 families, with quantitative phenotype denominators and a clinical algorithm for targeted MED12 testing (100% sensitivity, 90% specificity).
PMID:17334363
A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome.
1 finding
Discovery paper establishing MED12 c.2881C>T (p.Arg961Trp) as the cause of FGS1, including in the original Opitz-Kaveggia family.

Deep Research

1
Falcon ▸
FG Syndrome 1: Disease-Characteristics Research Report
Edison Scientific Literature 23 citations 2026-07-31T00:47:23.141431

FG Syndrome 1: Disease-Characteristics Research Report

Executive summary and scope

FG syndrome 1 (FGS1) is the molecularly defined, X-linked multiple-congenital-anomaly/neurodevelopmental disorder classically called Opitz–Kaveggia syndrome, caused by the recurrent germline MED12 c.2881C>T (p.Arg961Trp; p.R961W) variant. It must be distinguished from the older, phenotype-based label “FG syndrome,” which includes genetically heterogeneous and MED12-negative cases. Only about 3% of patients historically assigned a clinical FG-syndrome diagnosis were found to carry p.Arg961Trp in one diagnostic series. The principal evidence base remains a small cohort—23 molecularly confirmed males from 10 families—so frequencies below are descriptive, not population estimates. (clark2009fgsyndromean pages 1-2, clark2009fgsyndromean pages 7-7, clark2009fgsyndromean pages 4-6)

No substantial FGS1-specific clinical or therapeutic advances were identified from 2023–2024. Recent work on MED12 has primarily refined the wider allelic spectrum and mechanisms of Mediator-complex dysfunction rather than changing FGS1 diagnosis or care. The most relevant modern synthesis is van de Plassche and de Brouwer, published April 2021, DOI: 10.3390/genes12050663. Its abstract states: “Missense variants in MED12 cause FG syndrome, Lujan-Fryns syndrome, and Ohdo syndrome, as well as non-syndromic intellectual disability (ID) in hemizygous males.” This statement concerns the broader MED12 spectrum; the classic FGS1 diagnosis is specifically anchored to p.Arg961Trp. (graham2013med12relateddisorders pages 1-2, plassche2021med12related(neuro)developmentaldisorders pages 7-10)

domain finding/statistic evidence type interpretation/limitation
Molecular definition FG syndrome 1 / Opitz-Kaveggia syndrome is the molecularly confirmed MED12-associated disorder caused by recurrent MED12 c.2881C>T (p.Arg961Trp, p.R961W) (clark2009fgsyndromean pages 7-7, graham2013med12relateddisorders pages 1-2) Human clinical genetics + review Important to distinguish from broader “FG syndrome” phenotypes that are genetically heterogeneous and often MED12-negative (clark2009fgsyndromean pages 7-7, graham2013med12relateddisorders pages 2-3)
Molecularly confirmed cohort 23 affected males from 10 families with MED12 p.Arg961Trp; broader paper also discusses 30 live-born affected males in 10 families and compares 48 clinically diagnosed but mutation-negative cases (clark2009fgsyndromean pages 6-7, clark2009fgsyndromean pages 1-2) Human cohort/case series Denominators vary by analysis subset and by availability of records; avoid mixing molecularly confirmed cases with historical phenotypic FG cases (clark2009fgsyndromean pages 6-7, clark2009fgsyndromean pages 1-2)
Inheritance X-linked disorder affecting males; heterozygous females reported as clinically unaffected and intellectually normal in the core cohort (clark2009fgsyndromean pages 6-7, clark2009fgsyndromean pages 4-6) Human pedigree/cohort Evidence supports male-limited expression in known families, but formal penetrance estimates are not established (clark2009fgsyndromean pages 6-7)
Core early phenotype Infantile hypotonia and constipation in 23/23 affected males (clark2009fgsyndromean pages 6-7) Human cohort/case series Strongest recurring early clinical features; useful for recognition but not specific outside the syndromic context (clark2009fgsyndromean pages 4-6, clark2009fgsyndromean pages 6-7)
Neuroanatomy Corpus callosum agenesis/hypoplasia in 13/13 imaged individuals (clark2009fgsyndromean pages 6-7) Human imaging within cohort High frequency among imaged patients, but denominator is only those who underwent neuroimaging (clark2009fgsyndromean pages 6-7)
Gastrointestinal/anorectal anomalies Anal anomaly (fistula/stenosis/atresia) in 11/19 (clark2009fgsyndromean pages 6-7) Human cohort/case series Denominator reflects patients with evaluable data; severe constipation can also occur without a major structural anal defect (graham2013med12relateddisorders pages 2-3, clark2009fgsyndromean pages 6-7)
Cardiac anomalies Congenital cardiac anomaly in 11/18 (clark2009fgsyndromean pages 6-7) Human cohort/case series Substantial but not universal; supports baseline cardiology evaluation in suspected cases (clark2009fgsyndromean pages 4-6, clark2009fgsyndromean pages 6-7)
Craniofacial features Small ears in 12/13 where specifically measured/supported (clark2009fgsyndromean pages 2-3) Human cohort/case series One of the more discriminating facial findings, but facial gestalt remains composite rather than single-feature based (clark2009fgsyndromean pages 6-7, clark2009fgsyndromean pages 4-6)
Head size Macrocephaly reported with denominator variation: 15/18 in one summary, 7/18 absolute macrocephaly in another analysis (clark2009fgsyndromean pages 2-3, clark2009fgsyndromean pages 6-7) Human cohort/case series Variation likely reflects different definitions/ascertainment (absolute vs relative macrocephaly, age-specific data); should be reported with denominator and wording preserved (clark2009fgsyndromean pages 6-7, clark2009fgsyndromean pages 2-3)
Diagnostic performance Historical clinical algorithm for targeted MED12 p.Arg961Trp testing showed 100% sensitivity and 90% specificity (clark2009fgsyndromean pages 1-2) Human diagnostic study Useful as historical triage, but modern practice generally prioritizes sequencing-based diagnosis; performance derived from limited retrospective cohorts (clark2009fgsyndromean pages 7-7, clark2009fgsyndromean pages 1-2)
Mechanism: immediate-early genes In patient EBV-immortalized lymphoblastoid cells, MED12 p.Arg961Trp dysregulated immediate-early genes, with JUN downregulation and FOS upregulation; promoter Pol II/MED12 recruitment paralleled expression changes (donnio2017med12relatedxliddisorders pages 10-14) Human patient-cell functional study Mechanistic evidence is from lymphoblastoid cells, so tissue relevance to brain/gut/heart phenotypes is inferential rather than directly demonstrated (donnio2017med12relatedxliddisorders pages 10-14)
Mechanism: SHH/GLI3 In patient lymphoblast cell lines, MED12-related XLID variants including FG-associated p.Arg961Trp showed elevated GLI3-dependent SHH target-gene transcripts such as CREB5, BMP4, and NEUROG2 (srivastava2019dysregulationsofsonic pages 1-2) Human patient-cell functional study Supports pathway-selective transcriptional dysregulation; does not fully explain organ-specific manifestations or phenotypic variability (plassche2021med12related(neuro)developmentaldisorders pages 7-10, srivastava2019dysregulationsofsonic pages 1-2)
Mechanistic synthesis Expert review concludes p.Arg961Trp causes selective MED12 pathway dysfunction affecting enhancer/transcriptional control rather than complete loss of MED12 function (plassche2021med12related(neuro)developmentaldisorders pages 7-10, plassche2021med12related(neuro)developmentaldisorders pages 6-7) Expert review/mechanistic synthesis Current model integrates REST/IEG/SHH findings, but no unified causal chain has been proven across all affected tissues (plassche2021med12related(neuro)developmentaldisorders pages 7-10, plassche2021med12related(neuro)developmentaldisorders pages 6-7)
Prognosis/natural history Early deaths/deceased male infants occurred in many families, but after infancy prognosis improves; some affected males were functioning well in the 5th-6th decades and hypotonia may improve with age (clark2009fgsyndromean pages 6-7) Human natural history within cohort Mortality is concentrated early; long-term adult survival is clearly possible, but formal survival curves are unavailable (clark2009fgsyndromean pages 6-7)
Treatment landscape No disease-modifying therapy, validated biomarker-directed treatment, or FG syndrome 1-specific interventional clinical trial was identified; management is supportive and multidisciplinary (graham2013med12relateddisorders pages 2-3, clark2009fgsyndromean pages 6-7) Review + cohort-based expert management Current care targets complications and development rather than MED12-specific molecular correction; evidence base is largely expert opinion and case-series practice (graham2013med12relateddisorders pages 2-3)

Table: This table summarizes the most actionable evidence for molecularly confirmed FG syndrome 1, including defining variant, cohort size, major phenotype frequencies, mechanism, diagnostic performance, prognosis, and treatment gaps. It is useful for separating MED12 p.Arg961Trp-associated disease from the broader heterogeneous FG phenotype.

1. Disease information

Definition and history

FGS1 is a congenital, lifelong Mendelian disorder characterized by developmental delay/intellectual disability, congenital hypotonia, severe constipation or anorectal abnormalities, characteristic craniofacial morphology and behavior, and variable brain, cardiac, skeletal, ocular, and genitourinary anomalies. Opitz and Kaveggia originally described five affected males—three brothers and two male first cousins—in 1974. The causal recurrent MED12 variant was established in 2007. (clark2009fgsyndromean pages 1-2, graham2013med12relateddisorders pages 1-2)

Identifiers and synonyms

  • OMIM: 305450, FG syndrome 1/Opitz–Kaveggia syndrome.
  • Causal gene: MED12, OMIM 300188, Xq13.
  • Synonyms: FG syndrome type 1; FGS1; Opitz–Kaveggia syndrome; FG syndrome, MED12-related.
  • MONDO: A dedicated current MONDO identifier could not be verified from the retrieved primary literature; a knowledge-base ingest should resolve the live MONDO release rather than infer an identifier.
  • Orphanet: A current subtype-specific number was not verified in the retrieved evidence.
  • ICD-10/ICD-11 and MeSH: No specific FGS1 code was established. Cases are generally represented under broader congenital-malformation, syndromic intellectual-disability, or rare genetic-disease categories.

The evidence summarized here is aggregated disease-level literature, mostly pedigrees, dysmorphology examinations, records, imaging, and patient-derived cell experiments—not individual EHR data.

2. Etiology

Cause and genetic risk

FGS1 is caused by the germline hemizygous MED12 NM_005120.3:c.2881C>T, p.(Arg961Trp) missense variant in affected males. It is an X-linked disorder: transmission through heterozygous females produces at-risk sons, while male-to-male transmission does not occur. No environmental, infectious, lifestyle, occupational, or toxic cause has been demonstrated. (clark2009fgsyndromean pages 6-7, clark2009fgsyndromean pages 7-7, graham2013med12relateddisorders pages 1-2)

The core cohort found clinically unaffected, intellectually normal heterozygous females. This supports sex-dependent expression, probably influenced by X-inactivation, but does not establish a numerical penetrance estimate for every carrier population. Expressivity among affected males is variable, particularly for congenital malformations and intellectual severity. No validated modifier gene, protective allele, founder haplotype, anticipation, or reproducible germline-mosaicism rate has been defined. (clark2009fgsyndromean pages 6-7)

Protective factors and gene–environment interaction

No genetic or environmental factor is known to prevent expression in a hemizygous male. No reproducible gene–environment interaction has been reported. Good nutrition, early therapy, constipation control, and treatment of cardiac or feeding complications can reduce secondary morbidity but are not etiologic protection.

3. Phenotypes

The best quantitative data derive from incompletely assessed subsets of 23 confirmed males; denominators therefore vary. (clark2009fgsyndromean pages 4-6, clark2009fgsyndromean pages 6-7)

Phenotype Type, onset, frequency/course Suggested HPO term
Developmental delay/intellectual disability Neurodevelopmental sign; childhood recognition; borderline to severe, most tested IQ values below 70; lifelong HP:0001263; HP:0001249
Congenital hypotonia Sign; neonatal; 23/23 in the main cohort; often improves with age HP:0008936
Feeding difficulty Symptom; neonatal/infancy; frequent and sometimes requires nasogastric or gastrostomy feeding HP:0011968
Constipation/GI dysmotility Symptom; infancy onward; reported in all 23; chronic and sometimes severe HP:0002019; HP:0012450
Anal stenosis, atresia, or fistula Congenital malformation; 11/19 evaluable HP:0002025; HP:0004378; HP:0010447
Corpus-callosum agenesis/hypoplasia Imaging/anatomic sign; congenital; 13/13 imaged HP:0001274; HP:0002079
Congenital heart defect Malformation; congenital; 11/18 evaluable, including septal defects HP:0001627; HP:0001631; HP:0001629
Macrocephaly/relative macrocephaly Physical sign; infancy/childhood; ascertainment varies—15/18 in one summary but 7/18 for absolute macrocephaly in another analysis HP:0000256; HP:0011451
Characteristic face Long/narrow face, tall or prominent forehead, frontal hair upsweep, puffy eyelids, open mouth, small low-set ears HP:0000276; HP:0011220; HP:0000286; HP:0000194; HP:0000369
Small ears Physical sign; congenital; 12/13 in one measured subset HP:0008551
Hand/skeletal findings Broad thumbs, fetal pads, syndactyly, pectus or vertebral/rib anomalies, contractures, hip dysplasia, limited elbow supination; variable HP:0011304; HP:0001212; HP:0001159; HP:0001371
Ocular abnormalities Clinical sign; approximately 10 patients in the principal series; optic-nerve hypoplasia reported HP:0001098; HP:0000609
Speech/language impairment Developmental/behavioral; articulation, syntax, pragmatics and intonation affected; often functionally important HP:0000750; HP:0002465
Behavioral phenotype Affable/eager-to-please, talkative; hyperactivity, short attention span, anxiety, frustration, and insistence on sameness may coexist HP:0000752; HP:0000736; HP:0000729

Characteristic facies, affable behavior, and infantile hypotonia/feeding difficulty/constipation were each reported in all 13 subjects in one deeply characterized subset; congenital anomalies occurred in 11/13. These figures are vulnerable to referral and publication bias. (clark2009fgsyndromean pages 2-3, clark2009fgsyndromean pages 3-4)

Quality-of-life studies using EQ-5D, SF-36, PROMIS, or an FGS1-specific instrument were not found. Major burdens are communication impairment, dependence in daily living, chronic bowel dysfunction, anxiety with transitions, mobility limitations, feeding problems, sleep disturbance, and consequences of congenital anomalies. Socialization may be a relative strength. (graham2013med12relateddisorders pages 2-3)

4. Genetic and molecular information

  • Gene: MED12, mediator complex subunit 12; Xq13; HGNC symbol MED12.
  • Defining FGS1 variant: c.2881C>T, p.Arg961Trp, missense; germline and hemizygous in affected males.
  • Population frequency: No numerical gnomAD frequency was established in the retrieved evidence. Its recurrence in affected pedigrees, segregation, rarity, and functional evidence support pathogenicity; a current clinical report should query the live gnomAD and ClinVar releases.
  • Functional class: Not simple whole-gene loss of function. Evidence favors a pathway-selective altered-function/hypomorphic transcriptional-regulatory defect. Complete MED12 loss has broader and often developmentally severe consequences. (plassche2021med12related(neuro)developmentaldisorders pages 7-10, plassche2021med12related(neuro)developmentaldisorders pages 6-7)

Other MED12 variants cause different allelic disorders, including Lujan syndrome—classically p.Asn1007Ser—X-linked Ohdo syndrome and broader male or female neurodevelopmental phenotypes. Protein-truncating MED12 variants in females can cause Hardikar syndrome or other severe syndromic presentations and should not automatically be called FGS1. (graham2013med12relateddisorders pages 1-2, plassche2021med12related(neuro)developmentaldisorders pages 7-10)

No validated FGS1 modifier gene or disease-specific epigenetic signature is known. Large deletions, duplications, translocations, aneuploidy, repeat expansions, mitochondrial variants, and somatic MED12 mutations are not the defining cause of FGS1.

5. Environmental information

Environmental toxins, radiation, pollution, diet, smoking, alcohol, exercise, occupational exposures, and infectious agents have no established causal role. Environmental care affects complications: inadequate hydration or mobility can worsen constipation, and poorly structured transitions may exacerbate anxiety and behavior. These are management interactions, not demonstrated etiologic gene–environment effects. FGS1 is neither infectious nor zoonotic.

6. Mechanism and pathophysiology

Upstream molecular defect

MED12 is part of the Mediator kinase module and helps couple transcription factors and regulatory signals to RNA polymerase II. p.Arg961Trp does not appear to abolish all MED12 functions; it selectively impairs recruitment or response at particular regulatory complexes. MED12 loss can reduce super-enhancer capacity by approximately 50% and disturb enhancer–promoter interactions, although these broader loss experiments are not equivalent to FGS1. (plassche2021med12related(neuro)developmentaldisorders pages 7-10, plassche2021med12related(neuro)developmentaldisorders pages 6-7)

Supported pathway effects

  1. Immediate-early genes and Pol II recruitment—human patient cells. In EBV-immortalized lymphoblastoid cells from p.Arg961Trp patients, JUN was downregulated and FOS upregulated. Chromatin immunoprecipitation showed that MED12 and RNA polymerase II promoter recruitment tracked these changes; impaired TCF4 recruitment was observed at JUN, while altered ELK-factor occupancy occurred at FOS. This supports stimulus-responsive transcriptional dysregulation. DOI: 10.1093/hmg/ddx099, published June 2017. (donnio2017med12relatedxliddisorders pages 10-14)

  2. SHH–GLI3 signaling—patient cells and rescue experiments. MED12 normally constrains GLI3-dependent Sonic Hedgehog transcription. Patient lymphoblast lines carrying MED12 XLID variants, including p.Arg961Trp, had increased transcripts of GLI3-regulated targets including CREB5, BMP4, and NEUROG2. p.Arg961Trp failed to restore normal SHH inhibition in a MED12-null experimental setting and showed reduced CDK8 recruitment at GLI3 sites while retaining recruitment at unrelated PPARγ targets. DOI: 10.1002/mgg3.569, published February 2019. (srivastava2019dysregulationsofsonic pages 8-9, plassche2021med12related(neuro)developmentaldisorders pages 7-10, srivastava2019dysregulationsofsonic pages 1-2)

  3. REST/neural-gene repression. Experimental rescue studies indicate that p.Arg961Trp fails to restore REST-mediated silencing while retaining β-catenin rescue capacity. Unscheduled derepression of neural genes could disrupt neuronal differentiation. This effect appears kinase-independent and therefore differs mechanistically from the CDK8-dependent SHH defect. (plassche2021med12related(neuro)developmentaldisorders pages 6-7)

Proposed causal chain

Germline MED12 p.Arg961Trp → selective disruption of signal-responsive Mediator assembly/recruitment → altered Pol II occupancy, immediate-early-gene expression, REST repression, and SHH/GLI3 developmental transcription → abnormal neurodevelopment and morphogenesis → intellectual disability, hypotonia, corpus-callosum, craniofacial, anorectal, cardiac, and skeletal phenotypes. The downstream organ links are biologically plausible but not proven directly in fetal human brain, enteric nervous system, heart, or anorectal tissue.

Suggested annotations include GO:0016592 mediator complex; GO:0006357 regulation of transcription by RNA polymerase II; GO:0007224 smoothened signaling pathway; GO:0045664 regulation of neuron differentiation; GO:0007417 central nervous system development; GO:0060536 cartilage morphogenesis. Candidate cell types—not demonstrated selective targets—include neural progenitor cell (CL:0011020), neuron (CL:0000540), enteric neuron (CL:0007011), cardiomyocyte (CL:0000746), and chondrocyte (CL:0000138).

No FGS1-specific single-cell, spatial-transcriptomic, proteomic, metabolomic, lipidomic, or multi-omic human-tissue dataset was identified. No characteristic immune, inflammatory, metabolic, mitochondrial, aggregation, fibrosis, or tissue-necrosis mechanism has been demonstrated.

7. Anatomical structures affected

  • Nervous system: cerebral commissures, especially corpus callosum; pituitary/sella and optic nerve can be abnormal. Suggested UBERON: UBERON:0002336 corpus callosum, UBERON:0000007 pituitary gland, UBERON:0000966 retina, UBERON:0001908 optic nerve.
  • Digestive/anorectal system: anus, distal bowel, and functional intestinal motility; UBERON: UBERON:0001245 anus, UBERON:0000160 intestine, UBERON:0001988 rectum.
  • Cardiovascular: congenital structural heart disease; UBERON:0000948 heart.
  • Musculoskeletal: skull, vertebrae/ribs, chest wall, joints, hips, hands/thumbs; UBERON:0003129 skull, UBERON:0002416 vertebral column, UBERON:0001464 hand.
  • Craniofacial and ear structures: face and external ear; UBERON:0001456 face, UBERON:0003102 external ear.

The relevant subcellular site is principally the nucleus and chromatin-associated Mediator/transcription machinery: GO:0005634 nucleus, GO:0000785 chromatin, GO:0016592 mediator complex. No characteristic lateralization has been reported. (clark2009fgsyndromean pages 4-6, clark2009fgsyndromean pages 6-7)

8. Temporal development

FGS1 begins prenatally as a developmental disorder. Hypotonia, feeding problems, constipation, dysmorphism, cardiac disease, and anorectal malformations may be apparent neonatally; developmental and behavioral differences emerge during infancy and childhood. Facial recognition may be easiest in early childhood. (clark2009fgsyndromean pages 4-6, clark2009fgsyndromean pages 6-7)

The course is chronic and lifelong, not episodic or relapsing-remitting. Congenital malformations are structurally stable unless corrected; hypotonia often improves with age, while intellectual, speech, and adaptive limitations persist. No formal stages, progression rate, remission pattern, or validated critical therapeutic window has been defined, although early feeding, cardiac, bowel, developmental, speech, and vision intervention is clinically important. Some children achieve walking only in later childhood, while surviving adults can function into their fifth or sixth decades. (clark2009fgsyndromean pages 6-7, clark2009fgsyndromean pages 3-4)

9. Inheritance and population

Inheritance is X-linked. A heterozygous carrier has a 50% probability of transmitting the variant in each pregnancy; a son inheriting it is expected to be affected, whereas a daughter inheriting it is generally an asymptomatic carrier based on the core pedigrees. An affected male transmits the variant to all daughters and no sons, assuming reproductive fitness. This is standard X-linked counseling and should be individualized for maternal mosaicism and X-inactivation.

Formal incidence, prevalence per 100,000, carrier frequency, ethnic enrichment, geographic concentration, and sex ratio from a registry are unavailable. FGS1 is ultra-rare and reported across unrelated families. The clinical cohort consists almost entirely of males because of X-linked hemizygous expression. No founder effect, consanguinity association, anticipation, or population-specific risk has been established. Early family histories often included deceased male infants, miscarriages, or X-linked intellectual disability. (clark2009fgsyndromean pages 6-7, clark2009fgsyndromean pages 1-2)

10. Diagnostics

Recommended approach

Diagnosis requires a compatible phenotype plus identification of a pathogenic MED12 variant, with p.Arg961Trp defining classic FGS1. Modern testing should use an intellectual-disability/congenital-anomaly panel containing MED12 or exome/genome sequencing, with confirmation and segregation testing. Targeted testing for c.2881C>T is efficient where the classic phenotype or familial variant is known. A historical phenotype algorithm achieved 100% sensitivity and approximately 90% specificity and reduced targeted testing by 74%, but it was derived from small retrospective cohorts and should not replace contemporary sequencing. (clark2009fgsyndromean pages 1-2, clark2009fgsyndromean pages 2-3)

WES/WGS is useful for atypical cases and for detecting alternative diagnoses. Copy-number analysis should be considered when sequencing is negative or the phenotype suggests a genomic disorder. Karyotyping, FISH, mitochondrial sequencing, repeat-expansion tests, biopsy, metabolomics, and liquid biopsy are not routine FGS1 tests.

Baseline clinical evaluation

Recommended assessments include developmental and neurologic examination; brain MRI with attention to the corpus callosum; echocardiography and ECG; formal ophthalmology; hearing evaluation; feeding/swallow and nutritional assessment; gastrointestinal/anorectal examination; renal/genitourinary evaluation when indicated; and orthopedic review. Routine blood or urine chemistry has no diagnostic biomarker. (clark2009fgsyndromean pages 4-6, clark2009fgsyndromean pages 6-7)

Differential diagnosis

Important differentials include Lujan syndrome and X-linked Ohdo syndrome caused by other MED12 variants; broader MED12-related neurodevelopmental disorders; FLNA-, UPF3B-, and BRWD3-associated X-linked intellectual disability; Xq28 duplication syndromes; fragile X syndrome; Mowat–Wilson syndrome; Coffin–Siris spectrum; and other syndromic causes of hypotonia, constipation, macrocephaly, callosal abnormality, and anal or cardiac malformations. A MED12-negative patient with nonspecific “FG-like” findings should not automatically retain an FGS1 label. (clark2009fgsyndromean pages 7-7, graham2013med12relateddisorders pages 2-3, graham2013med12relateddisorders pages 1-2)

There is no population newborn screen. Cascade testing of relatives is appropriate after molecular confirmation.

11. Outcome and prognosis

Early mortality occurred in 8 of the 10 reported families, although the literature does not provide a reliable disease-specific mortality rate or survival curve. Congenital cardiac, respiratory, feeding, and gastrointestinal complications likely contribute, but causes cannot be assigned uniformly. Among survivors beyond infancy, mortality did not appear markedly elevated in the small series, and three males were reportedly functioning into their fifth or sixth decades. (clark2009fgsyndromean pages 6-7)

Long-term morbidity includes intellectual and speech disability, chronic constipation, anxiety/behavioral dysregulation, sleep disturbance, orthopedic problems, and residual consequences of congenital anomalies. Recovery from the underlying disorder is not expected, but hypotonia, mobility, communication, comfort, and participation may improve. No validated molecular prognostic biomarker or FGS1-specific quality-of-life statistic exists.

12. Treatment

There is no disease-modifying, gene, RNA, cell, targeted, or approved MED12-directed therapy for FGS1. No FGS1-specific interventional clinical trial or treatment-response rate was identified. Care is individualized and multidisciplinary. (graham2013med12relateddisorders pages 2-3, clark2009fgsyndromean pages 6-7)

  • Feeding therapy, nutritional support, and gastrostomy when required — suggested MAXO:0001006 nutritional therapy, MAXO:0001175 gastrostomy.
  • Aggressive constipation management, reflux treatment, and evaluation for structural anorectal disease; surgery where indicated — MAXO:0000088 surgical procedure, MAXO:0000011 therapeutic procedure.
  • Cardiology surveillance and repair of significant congenital defects — MAXO:0000487 echocardiography, surgical-procedure terms as appropriate.
  • Physical and occupational therapy for hypotonia, mobility, contractures, and adaptive skills — MAXO:0000015 physical therapy, MAXO:0000017 occupational therapy.
  • Early, sustained speech-language and augmentative-communication support — MAXO:0000018 speech therapy.
  • Structured routines, advance warnings for transitions, educational support, and behavioral/psychological treatment for anxiety, attention problems, or sleep disturbance.
  • Ophthalmic, hearing, orthopedic, neurologic, dental, and genitourinary treatment according to findings.

Reported real-world interventions include tube feeding, gastrostomy, fundoplication, congenital-heart surgery, orthopedic management, and developmental therapies. Pharmacotherapy is symptom-directed; no FGS1 pharmacogenomic guidance or evidence-based combination regimen exists. (graham2013med12relateddisorders pages 2-3, clark2009fgsyndromean pages 3-4)

13. Prevention

The inherited molecular defect cannot be prevented by diet, vaccination, lifestyle change, or environmental avoidance. Primary reproductive prevention options after identification of a familial variant include genetic counseling, carrier testing, preimplantation genetic testing, chorionic-villus sampling, amniocentesis, and use of donor gametes. Secondary prevention consists of early molecular diagnosis and prompt detection of cardiac, feeding, bowel, visual, hearing, and developmental complications. Tertiary prevention includes bowel regimens, nutrition, rehabilitation, communication support, safety planning, and surveillance for known congenital anomalies. No vaccine, preventive medication, public-health exposure intervention, or population screening program is applicable.

14. Other species and natural disease

MED12 is evolutionarily conserved in vertebrates, but no naturally occurring veterinary disorder established as an exact orthologue of human MED12 p.Arg961Trp FGS1 was identified. Consequently, no breed, VBO term, animal incidence, veterinary transmission, or zoonotic potential applies. Orthologues include Med12 in mouse (Mus musculus, NCBI Taxonomy 10090) and med12 in zebrafish (Danio rerio, Taxonomy 7955); exact live NCBI Gene IDs should be resolved during database ingestion.

15. Model organisms and experimental systems

The strongest FGS1-specific functional evidence comes from patient-derived EBV-immortalized lymphoblastoid cells, promoter ChIP/qPCR, and MED12-null/rescue cellular experiments. These models demonstrate altered JUN/FOS regulation, Pol II/MED12 recruitment, REST silencing, and SHH/GLI3 target expression. Their major limitation is that lymphoblasts do not model developing cortical neurons, enteric neurons, cardiomyocytes, or anorectal mesenchyme. (plassche2021med12related(neuro)developmentaldisorders pages 7-10, plassche2021med12related(neuro)developmentaldisorders pages 6-7, srivastava2019dysregulationsofsonic pages 1-2, donnio2017med12relatedxliddisorders pages 10-14)

Conditional and reduced-expression Med12 mouse models establish that MED12 is essential for embryogenesis and tissue development, but constitutive loss is often embryonic lethal and is not equivalent to the selective p.Arg961Trp disorder. A validated knock-in model shown to reproduce the complete human FGS1 phenotype was not identified in the retrieved evidence. No established FGS1 zebrafish, Drosophila, C. elegans, organoid, or patient-iPSC neuronal model with comprehensive phenotypic validation was found. Experts have proposed isogenic induced-neuron models to distinguish pathogenic MED12-specific expression signatures, underscoring that this remains a research need rather than a clinical assay. (plassche2021med12related(neuro)developmentaldisorders pages 7-10, plassche2021med12related(neuro)developmentaldisorders pages 6-7)

Evidence limitations and current expert assessment

The defining clinical dataset is small, familial, retrospective, and enriched for recognizable severe cases. Frequencies should therefore retain their original denominators and should not be interpreted as penetrance estimates. Mechanistic studies consistently indicate selective transcriptional-network dysfunction, but most were performed in lymphoblastoid or engineered cells rather than affected fetal tissues. As of the searched 2023–2024 literature, no prospective natural-history registry, standardized patient-reported outcome, validated biomarker, disease-modifying therapy, or FGS1-specific intervention trial was evident. The immediate priorities are longitudinal natural-history collection, modern variant curation, patient-derived neural and enteric models, and tissue-relevant multi-omic analysis.

Principal sources

  1. Clark RD et al. FG syndrome, an X-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing. Genetics in Medicine, published November 2009. DOI: 10.1097/GIM.0b013e3181bd3d90. (clark2009fgsyndromean pages 6-7, clark2009fgsyndromean pages 1-2)
  2. Graham JM, Schwartz CE. MED12 related disorders. American Journal of Medical Genetics Part A, published November 2013. DOI: 10.1002/ajmg.a.36183. (graham2013med12relateddisorders pages 2-3, graham2013med12relateddisorders pages 1-2)
  3. Donnio LM et al. MED12-related XLID disorders are dose-dependent of immediate early genes (IEGs) expression. Human Molecular Genetics, published June 2017. DOI: 10.1093/hmg/ddx099. (donnio2017med12relatedxliddisorders pages 10-14)
  4. Srivastava S et al. Dysregulations of sonic hedgehog signaling in MED12-related X-linked intellectual disability disorders. Molecular Genetics & Genomic Medicine, published February 2019. DOI: 10.1002/mgg3.569. (srivastava2019dysregulationsofsonic pages 8-9, srivastava2019dysregulationsofsonic pages 1-2)
  5. van de Plassche SR, de Brouwer APM. MED12-Related (Neuro)Developmental Disorders: A Question of Causality. Genes, published April 2021. DOI: 10.3390/genes12050663. (plassche2021med12related(neuro)developmentaldisorders pages 7-10, plassche2021med12related(neuro)developmentaldisorders pages 6-7)

References

  1. (clark2009fgsyndromean pages 1-2): Robin Dawn Clark, John M. Graham, Michael J. Friez, Joe J. Hoo, Kenneth Lyons Jones, Carole McKeown, John B. Moeschler, F. Lucy Raymond, R. Curtis Rogers, Charles E. Schwartz, Agatino Battaglia, Michael J. Lyons, and Roger E. Stevenson. Fg syndrome, an x-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing. Genetics in Medicine, 11:769-775, Nov 2009. URL: https://doi.org/10.1097/gim.0b013e3181bd3d90, doi:10.1097/gim.0b013e3181bd3d90. This article has 49 citations and is from a highest quality peer-reviewed journal.

  2. (clark2009fgsyndromean pages 7-7): Robin Dawn Clark, John M. Graham, Michael J. Friez, Joe J. Hoo, Kenneth Lyons Jones, Carole McKeown, John B. Moeschler, F. Lucy Raymond, R. Curtis Rogers, Charles E. Schwartz, Agatino Battaglia, Michael J. Lyons, and Roger E. Stevenson. Fg syndrome, an x-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing. Genetics in Medicine, 11:769-775, Nov 2009. URL: https://doi.org/10.1097/gim.0b013e3181bd3d90, doi:10.1097/gim.0b013e3181bd3d90. This article has 49 citations and is from a highest quality peer-reviewed journal.

  3. (clark2009fgsyndromean pages 4-6): Robin Dawn Clark, John M. Graham, Michael J. Friez, Joe J. Hoo, Kenneth Lyons Jones, Carole McKeown, John B. Moeschler, F. Lucy Raymond, R. Curtis Rogers, Charles E. Schwartz, Agatino Battaglia, Michael J. Lyons, and Roger E. Stevenson. Fg syndrome, an x-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing. Genetics in Medicine, 11:769-775, Nov 2009. URL: https://doi.org/10.1097/gim.0b013e3181bd3d90, doi:10.1097/gim.0b013e3181bd3d90. This article has 49 citations and is from a highest quality peer-reviewed journal.

  4. (graham2013med12relateddisorders pages 1-2): John M. Graham and Charles E. Schwartz. Med12 related disorders. American Journal of Medical Genetics Part A, 161:2734-2740, Nov 2013. URL: https://doi.org/10.1002/ajmg.a.36183, doi:10.1002/ajmg.a.36183. This article has 97 citations.

  5. (plassche2021med12related(neuro)developmentaldisorders pages 7-10): Stijn R. van de Plassche and Arjan P. M. de Brouwer. Med12-related (neuro)developmental disorders: a question of causality. Genes, 12 5:663, Apr 2021. URL: https://doi.org/10.3390/genes12050663, doi:10.3390/genes12050663. This article has 28 citations.

  6. (graham2013med12relateddisorders pages 2-3): John M. Graham and Charles E. Schwartz. Med12 related disorders. American Journal of Medical Genetics Part A, 161:2734-2740, Nov 2013. URL: https://doi.org/10.1002/ajmg.a.36183, doi:10.1002/ajmg.a.36183. This article has 97 citations.

  7. (clark2009fgsyndromean pages 6-7): Robin Dawn Clark, John M. Graham, Michael J. Friez, Joe J. Hoo, Kenneth Lyons Jones, Carole McKeown, John B. Moeschler, F. Lucy Raymond, R. Curtis Rogers, Charles E. Schwartz, Agatino Battaglia, Michael J. Lyons, and Roger E. Stevenson. Fg syndrome, an x-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing. Genetics in Medicine, 11:769-775, Nov 2009. URL: https://doi.org/10.1097/gim.0b013e3181bd3d90, doi:10.1097/gim.0b013e3181bd3d90. This article has 49 citations and is from a highest quality peer-reviewed journal.

  8. (clark2009fgsyndromean pages 2-3): Robin Dawn Clark, John M. Graham, Michael J. Friez, Joe J. Hoo, Kenneth Lyons Jones, Carole McKeown, John B. Moeschler, F. Lucy Raymond, R. Curtis Rogers, Charles E. Schwartz, Agatino Battaglia, Michael J. Lyons, and Roger E. Stevenson. Fg syndrome, an x-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing. Genetics in Medicine, 11:769-775, Nov 2009. URL: https://doi.org/10.1097/gim.0b013e3181bd3d90, doi:10.1097/gim.0b013e3181bd3d90. This article has 49 citations and is from a highest quality peer-reviewed journal.

  9. (donnio2017med12relatedxliddisorders pages 10-14): Lise-Marie Donnio, Baptiste Bidon, Satoru Hashimoto, Melanie May, Alexey Epanchintsev, Colm Ryan, William Allen, Anna Hackett, Jozef Gecz, Cindy Skinner, Roger E. Stevenson, Arjan P.M. de Brouwer, Charles Coutton, Christine Francannet, Pierre-Simon Jouk, Charles E. Schwartz, and Jean-Marc Egly. Med12-related xlid disorders are dose-dependent of immediate early genes (iegs) expression. Human Molecular Genetics, 26:2062–2075, Jun 2017. URL: https://doi.org/10.1093/hmg/ddx099, doi:10.1093/hmg/ddx099. This article has 33 citations and is from a domain leading peer-reviewed journal.

  10. (srivastava2019dysregulationsofsonic pages 1-2): Siddharth Srivastava, Tejasvi Niranjan, Melanie M. May, Patrick Tarpey, William Allen, Anna Hackett, Pierre‐Simon Jouk, Lucy Raymond, Slyvain Briault, Cindy Skinner, Annick Toutain, Jozef Gecz, William Heath, Roger E. Stevenson, Charles E. Schwartz, and Tao Wang. Dysregulations of sonic hedgehog signaling in med12‐related x‐linked intellectual disability disorders. Molecular Genetics & Genomic Medicine, Feb 2019. URL: https://doi.org/10.1002/mgg3.569, doi:10.1002/mgg3.569. This article has 21 citations and is from a peer-reviewed journal.

  11. (plassche2021med12related(neuro)developmentaldisorders pages 6-7): Stijn R. van de Plassche and Arjan P. M. de Brouwer. Med12-related (neuro)developmental disorders: a question of causality. Genes, 12 5:663, Apr 2021. URL: https://doi.org/10.3390/genes12050663, doi:10.3390/genes12050663. This article has 28 citations.

  12. (clark2009fgsyndromean pages 3-4): Robin Dawn Clark, John M. Graham, Michael J. Friez, Joe J. Hoo, Kenneth Lyons Jones, Carole McKeown, John B. Moeschler, F. Lucy Raymond, R. Curtis Rogers, Charles E. Schwartz, Agatino Battaglia, Michael J. Lyons, and Roger E. Stevenson. Fg syndrome, an x-linked multiple congenital anomaly syndrome: the clinical phenotype and an algorithm for diagnostic testing. Genetics in Medicine, 11:769-775, Nov 2009. URL: https://doi.org/10.1097/gim.0b013e3181bd3d90, doi:10.1097/gim.0b013e3181bd3d90. This article has 49 citations and is from a highest quality peer-reviewed journal.

  13. (srivastava2019dysregulationsofsonic pages 8-9): Siddharth Srivastava, Tejasvi Niranjan, Melanie M. May, Patrick Tarpey, William Allen, Anna Hackett, Pierre‐Simon Jouk, Lucy Raymond, Slyvain Briault, Cindy Skinner, Annick Toutain, Jozef Gecz, William Heath, Roger E. Stevenson, Charles E. Schwartz, and Tao Wang. Dysregulations of sonic hedgehog signaling in med12‐related x‐linked intellectual disability disorders. Molecular Genetics & Genomic Medicine, Feb 2019. URL: https://doi.org/10.1002/mgg3.569, doi:10.1002/mgg3.569. This article has 21 citations and is from a peer-reviewed journal.

Artifacts